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Abstract 25 
Background & Aims  26 
Polymorbidity (also known as multimorbidity) - defined as the co-occurrence of at least 27 
two chronic health conditions - is highly prevalent, particularly in the hospitalized 28 
population. Nonetheless, clinical guidelines largely address individual diseases and 29 
rarely account for polymorbidity. The aim of this project was to develop guidelines on 30 
nutritional support for polymorbid patients hospitalized in medical wards. 31 
Methods  32 
The methodology used for the development of the current project follows the standard 33 
operating procedures for ESPEN guidelines. It started with an initial meeting of the 34 
Working Group in January 2015, where twelve key clinical questions were developed 35 
that encompassed different aspects of nutritional support: indication, route of feeding, 36 
energy and protein requirements, micronutrient requirements, disease-specific 37 
nutrients, timing, monitoring and procedure of intervention. Systematic literature 38 
searches were conducted in three different databases (Medline, Embase and the 39 
Cochrane Library), as well as in secondary sources (e.g. published guidelines), until 40 
April 2016. Retrieved abstracts were screened to identify relevant studies that were 41 
used to develop recommendations, which was followed by submission to Delphi voting 42 
rounds. 43 
Results  44 
From a total of 4532 retrieved abstracts, 38 relevant studies were analyzed and used 45 
to generate a guideline draft that proposed 22 recommendations and four statements. 46 
The results of the first online voting showed a strong consensus (agreement of >90%) 47 
in 68% of recommendations and 75% of statements, and consensus (agreement of 48 
>75-90%) in 32% of recommendations and 25% of statements. At the final consensus 49 
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conference, a consensus greater than 89% was reached for all of the 50 
recommendations. 51 
Conclusions 52 
Despite the methodological difficulties in creating non-disease specific guidelines, the 53 
evidence behind several important aspects of nutritional support for polymorbid 54 
medical inpatients was reviewed and summarized into practical clinical 55 
recommendations. Use of these guidelines offer an evidence-based nutritional 56 
approach to the polymorbid medical inpatients and may improve their outcomes. 57 
Keywords 58 
guidelines, polymorbidity, multimorbidity, nutritional support, hospitalized patients 59 
Abbreviations  60 
BI - Barthel Index 61 
βHMB - β-hydroxy β-methylbutyrate  62 
CG - Control Group 63 
DRM - disease-related malnutrition 64 
EN - enteral nutrition  65 
GEB - Guidelines Editorial Board  66 
IC - indirect calorimetry  67 
IG - Intervention Group 68 
LOS - length of hospital stay 69 
MNA(-sf) - Mini Nutritional Assessment (short form) 70 
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NRS 2002 - Nutritional Risk Score 2002   71 
ONS - oral nutritional supplement(s) 72 
PICO - population of interest, interventions, comparisons, outcomes 73 
PN - parenteral nutrition 74 
QoL - quality of life 75 
REE - resting energy expenditure  76 
RCT - randomized controlled trial  77 
SGA - Subjective Global Assessment  78 
SIGN - Scottish Intercollegiate Guidelines Network  79 
TEE - total energy expenditure  80 
WG - Working Group 81 
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1. Introduction  82 
1.1. What is the definition of polymorbidity? 83 
Although there is no universally accepted definition of polymorbidity (also known as 84 
multimorbidity), some authors define it as being the co-occurrence of at least two 85 
chronic health conditions in the same person. That is also the definition used for the 86 
purposes of this guideline, based on literature recommendations [1-3] and discussions 87 
within the guideline Working Group (WG).  88 
The health and nutrition implications of suffering from more than one disease at the 89 
same time differ from the corresponding interactions between disease and aging. 90 
Polymorbidity is often, but not necessarily, observed in older persons, in contrast to 91 
the geriatric context when multimorbidity is always combined with functional limitations 92 
and other age-related degenerative expressions. As life expectancy increases and 93 
individuals acquire a variety of chronic illnesses, polymorbidity becomes one of the 94 
main challenges that many healthcare and social services face worldwide. 95 
 96 
1.2. Why do we need to develop nutritional support guidelines for polymorbid 97 
medical inpatients? 98 
As stated by Lefevre et al., "we know, for example, how to educate a diabetic patient, 99 
a chronic bronchitis patient, and a hypertensive patient, but we do not know, in 100 
practical terms, how to educate a patient with all three diseases" [1]. In fact, we do not 101 
know if the screening, assessment and treatment of disease-related malnutrition 102 
(DRM) in polymorbid medical inpatients should differ from the approach used in 103 
patients with a single disease. 104 
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Polymorbidity is highly prevalent, affecting more than 70% of the hospitalized adult 105 
population, and is associated with higher mortality and healthcare burden [4]. Other 106 
consequences of polymorbidity include disability, functional decline, poor quality of life 107 
(QoL) and higher healthcare costs [3]. Whilst the prevalence increases with age, more 108 
than half of all people affected with this problem are younger than 65 years [5]. In this 109 
context, the current single-disease healthcare approach has been challenged, as 110 
clinical guidelines are largely created for individual diseases and rarely account for 111 
polymorbidity [5]. Fried et al. showed that clinicians struggle with the uncertainties of 112 
applying disease-specific guidelines to their patients with multiple conditions, and 113 
would therefore benefit from a number of tools to assist them in decision making for 114 
this population [6]. Limited, if any, accounting for polymorbidity applies to current 115 
nutritional guidelines that focus on single diseases (e.g. nutritional support in renal 116 
failure) or on patient groups (e.g. older adults). To date, it is unknown whether there is 117 
a synergistic negative effect of several diseases on nutritional status, or on clinical 118 
outcome. Therefore, there is a need for a consensus on how to provide nutritional 119 
support for the polymorbid medical inpatient population.  120 
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2. Materials and Methods 121 
2.1. Pragmatic definition of polymorbidity for the current project  122 
Guideline development is based on clinical trials that investigate the effects of 123 
screening and nutritional support on different outcomes. Because these population-124 
based trials usually report an average number of comorbidities or number of 125 
drugs/medications, a pragmatic definition of the polymorbid inpatient population was 126 
established as:  127 
• at least 2 co-occurring chronic diseases present in at least 50% of the study 128 
population (in a few of the studies it is stated that x% of the study population 129 
suffers from disease A, y% of the study population suffers from disease B, and 130 
so on) 131 
or, alternatively, 132 
• a Charlson comorbidity index in the study population as being more than 1.5  133 
• a mean number of diseases or drugs (medications) over 1.5 134 
In many studies, only this information is provided instead of the list of comorbidities 135 
and the proportion of the study population affected by each disease. 136 
Polypharmacy is considered to be an important and acceptable marker of 137 
polymorbidity, with polypharmacy and polymorbidity having been described as being 138 
"two sides of the same coin" [7]. Additionally, it has been shown that the greater the 139 
number of medications, the higher the risk of weight loss [8], which suggests that 140 
polypharmacy has a potentially negative effect on nutritional status. The Charlson 141 
comorbidity index is the most extensively studied comorbidity index and is considered 142 
a valid and reliable method to measure comorbidity that can be used in clinical 143 
research [9].  144 
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In cases of uncertainty about the way that comorbidities were reported, the study 145 
authors were contacted in order to obtain additional information. In the event that they 146 
could not be reached a consensus decision within the guideline WG was taken about 147 
whether or not to include the study. Some of the included studies were conducted in 148 
older populations, since many polymorbid patients are also of an older age. For each 149 
included study, the criteria used to consider the study population as being polymorbid 150 
was recorded (and reported in the evidence table, in appendix 2). 151 
 152 
2.2. Guideline development 153 
The guideline WG was composed of a multidisciplinary team of 15 European 154 
specialists in nutritional support, who are the authors of the current paper. Following 155 
the standard operating procedures for the development of ESPEN guidelines [10], the 156 
guideline WG had an initial meeting in Zurich, in January 2015, to discuss the several 157 
stages of this project, and to define all of the clinical questions as well as the inclusion 158 
and exclusion criteria (table 1). Other relevant clinical questions which could not be 159 
developed in the "PICO" format (i.e. containing the 4 elements of population of 160 
interest, interventions, comparisons and outcomes (PICO)) have been included in the 161 
discussion. 162 
 163 
Table 1 - Inclusion and exclusion criteria  164 
Criteria Inclusion Exclusion 
Patients 
characteristics 
- Human adults aged ≥ 18 years - Non human,  ≤ 18 years, pregnant 
women 
- Patients hospitalized in acute care 
wards 
- Patients admitted to critical/intensive 
care units 
- Surgical patients 
- Patients living on long-term care 
facilities 
- Outpatients 
- Patients receiving end of life care 
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 165 
Twelve questions in the PICO format covering nine topics of nutritional support 166 
(indication, route of feeding, energy and protein requirements, micronutrients 167 
requirements, disease-specific nutrients, timing, monitoring and procedure of 168 
intervention) were developed by the WG. These questions, the search key words 169 
proposed for each question, and the inclusion and exclusion criteria were discussed 170 
within the WG, and later approved by the ESPEN Guidelines Editorial Board (GEB). 171 
A systematic literature search was conducted, first in secondary sources by searching 172 
published guidelines (e.g. from the National Institute for Health and Care Excellence, 173 
the Scottish Intercollegiate Guidelines Network (SIGN), the American Society for 174 
Parenteral and Enteral Nutrition) and systematic reviews potentially relevant for each 175 
question, followed by a search in primary sources. This primary sources search was 176 
- Polymorbid inpatients population 
as defined by 
a) at least 2 co-occurring chronic 
diseases are present in at least 
50% of the study population 
or 
b) mean number of diseases or 
drugs/medication or the Charlson 
comorbidity index in the study 
population as being more than 1.5 
 
In case of uncertainties about the 
way comorbidities are reported, the 
trials' authors are contacted in 
order to get more information; if 
contact is not possible, the WG 
makes a consensus decision about 
the inclusion/exclusion of the 
studies. 
- Healthy population 
- Less than 50% of the study 
population has 2 co-occurring 
diseases 
Outcomes 
Nutritional outcomes (e.g. weight, 
energy and protein intake) 
 
Clinical outcomes (e.g. mortality, 
infections) 
Patient-centred outcomes (e.g. 
quality of life) 
Healthcare resources 
Language and 
year 
English; no restriction on 
publication year  
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conducted by the same author in three databases (Medline, Embase and the 177 
Cochrane Library), until April 2016, using the GEB approved search terms proposed 178 
for each question. An example of a search strategy used can be found in Appendix 1 179 
("Search strategy used for question 2 in the Cochrane Library"). 180 
For each question, the results from each database were combined and exported to 181 
Endnote, followed by removal of duplicates and exportation to a Word document, 182 
allowing a single person (one of the WG coordinators) to undertake the screening of 183 
the final number of abstracts, in a standardized and systematic way. 184 
Many studies required the assessment of the full paper to ascertain whether it met all 185 
of the inclusion criteria, and for a proportion of the papers (n=32), the authors were 186 
contacted and requested to provide more information, which was usually to clarify 187 
whether their study population suffered from multiple comorbidities. For those studies 188 
whose authors could not be reached (n=17), 11 were included and 6 excluded, as per 189 
the WG consensus decision. 190 
Each WG member was allocated with one clinical question and was responsible for: 191 
validation of the literature, quality assessment and assignment of level of evidence for 192 
each paper relevant for the recommendations (e.g. using SIGN checklists), generation 193 
of first draft of recommendations, including the supporting text and grade of 194 
recommendation. 195 
The classification of the literature into levels of evidence and grades of 196 
recommendation were performed according to the SIGN grading system [11], as 197 
exemplified in tables 2 and 3. 198 
 199 
Table 2. Levels of evidence (SIGN grading system) [11] 200 
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1++ High quality meta-analyses, systematic reviews of RCTs, or RCTs with a 
very low risk of bias 
1+ Well-conducted meta-analyses, systematic reviews, or RCTs with a low 
risk of bias. 
1- Meta-analyses, systematic reviews, or RCTs with a high risk of bias 
2++ High quality systematic reviews of case control or cohort studies. High 
quality case control or cohort studies with a very low risk of confounding 
or bias and a high probability that the relationship is causal 
2+ Well-conducted case control or cohort studies with a low risk of 
confounding or bias and a moderate probability that the relationship is 
causal 
2- Case control or cohort studies with a high risk of confounding or bias and 
a significant risk that the relationship is not causal 
3 Non-analytic studies, e.g. case reports, case series 
4 Expert opinion 
 201 
Table 3. Grades and forms of recommendations (SIGN grading system) [11] 202 
a. Grades of recommendation 
A At least one meta-analysis, systematic review, or RCT rated as 1 ++, 
and directly applicable to the target population; or 
A body of evidence consisting principally of studies rated as 1 +, 
directly applicable to the target population, and demonstrating overall 
consistency of results 
B A body of evidence including studies rated as 2 ++, directly applicable 
to the target population; or 
A body of evidence including studies rated as 2 +, directly applicable to 
the target population, and demonstrating overall consistency of results; 
or 
Extrapolated evidence from studies rated as 1 ++ or 1 + 
0 Evidence level 3 or 4; or 
Extrapolated evidence from studies rated as 2 ++ or 2 + 
GPP Good practice points / expert consensus: Recommended best practice 
based on the clinical experience of the guideline development group 
b. Forms of recommendation 
Judgment Recommendation 
Undesirable consequences clearly 
outweigh desirable consequences 
Strong recommendation against 
Undesirable consequences probably 
outweigh desirable consequences 
Conditional recommendation against 
Balance between desirable and 
undesirable consequences is closely 
balanced or uncertain 
Recommendation for research and 
possibly conditional recommendation 
for use restricted to trials 
Desirable consequences probably 
outweigh undesirable consequences 
Conditional recommendation for 
Desirable consequences clearly 
outweigh undesirable consequences 
Strong recommendation for 
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A total of 4532 abstracts were screened. The details of the primary searches can be 203 
found in table 4. 204 
 205 
Table 4 - Number of abstracts retrieved for each question, in each database, and 206 
number of studies included for analysis 207 
 208 
  
Number of abstracts found in:  
Included 
studies 
  
Medline Embase Cochrane Library 
Total 
(without 
duplicates) 
Question 1  369 737 381 1401 2 
Question 2 188 267 183 404 11 
Question 3 318 532 327 859 1 
Question 4 114 156 26 189 1 
Question 5 162 220 82 395 2 
Question 6 3 8 2 13 0 
Question 7 116 174 102 223 2 
Question 8 349 462 282 598 2 
Question 9 6 4 10 19 10 
Question 10 61 95 141 260 2 
Question 11 18 23 7 25 2 
Question 12 89 93 28 146 3 
 209 
Thirty-eight studies were analyzed and included for the development of the 210 
recommendations. An evidence table with the number of studies allocated to each 211 
question, study details, evidence of polymorbidity for each study population, study type 212 
and level of evidence is presented in appendix 2 ("supplementary data: evidence 213 
table"). These studies can also be identified in the present document through the 214 
assignment of the respective evidence level in the text below each recommendation, in 215 
bold, e.g. "Level of evidence 2+". 216 
The WG generated a guideline draft with a total of 22 recommendations and 4 217 
statements (approved by the WG and the GEB office), which was followed by the start 218 
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of the consensus procedure, by sending that draft to the members of the ESPEN 219 
guideline project for online voting (Delphi method) in February 2017. The results of this 220 
online voting were a strong consensus (agreement of >90%) in 68% of 221 
recommendations and 75% of statements, and consensus (agreement of >75-90%) in 222 
32% of recommendations and 25% of statements. None of the recommendations or 223 
statements reached an agreement of below 75%.  224 
The feedback received during the online voting was used to modify and to improve the 225 
recommendations in order to reach a higher degree of acceptance at the final 226 
consensus meeting. The revised text was sent to the GEB office for approval. 227 
The recommendations and statements with an agreement equal or lower than 90% 228 
were discussed in the final consensus meeting (organized by ESPEN), which took 229 
place in Frankfurt/Main, Germany, on the 24th April 2017. The consensus meeting was 230 
attended also by Cees Smith, who represented the patients interests and views. After 231 
the voting, all of the selected recommendations were discussed and amended as 232 
required, and consensus greater than 89% was reached for all of the 233 
recommendations. 234 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
15 
 
3. Results 235 
A summary of all of the clinical questions and the recommendations, including the 236 
grade of recommendation and level of consensus achieved at the final consensus 237 
conference, is presented in appendix 3 ("supplementary data: summary of clinical 238 
questions and recommendations"). 239 
 240 
Question 1. Does nutritional support based on screening and/or 241 
assessment versus no screening and/or assessment improve 242 
outcomes in polymorbid inpatients? 243 
Recommendation 1.1. 244 
In polymorbid medical inpatients, a quick and simple nutritional screening 245 
method using different validated tools should be applied to identify malnutrition 246 
risk. In patients at risk, a more detailed assessment should be performed and a 247 
treatment plan should be developed, to consent an early adequate nutritional 248 
therapy and to define quality outcome measures of success.  249 
Grade of recommendation B - strong consensus (100% agreement) 250 
Commentary: 251 
Polymorbid medical inpatients are at high risk of malnutrition. Several prospective 252 
cohort studies showed a prevalence of approximately 40-50% in a hospitalized 253 
population of tertiary centers [12-14]. Observational studies have shown the frequency 254 
of complications in untreated at-risk patients to be three times higher than in patients 255 
not at-risk, and furthermore length of hospital stay (LOS) is 50% longer, which has a 256 
negative influence on clinical outcomes [15]. Scoring systems for determining 257 
nutritional risk, such as the Nutritional Risk Score 2002 (NRS 2002) and the Mini 258 
Nutritional Assessment (MNA-sf) link nutritional risk assessment to treatment by 259 
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predicting that nutritional interventions will have a positive influence on variable 260 
outcomes [16-19]. Both of these tools are rapid, easily undertaken and show a high 261 
degree of content validity and reliability, thereby making them suitable in polymorbid 262 
inpatients including those patients with cognitive dysfunction [20, 21]. If patients 263 
screen positive a more detailed assessment should be performed and a treatment plan 264 
should be developed. The effectiveness of the care plan should be measured by a 265 
subsequent monitoring including dietary intake, body weight, and measurements of 266 
mental and physical function and of clinical outcome. 267 
In a controlled trial, Rypkema et al. demonstrated that a standardized, early nutritional 268 
intervention in older polymorbid inpatients at nutritional risk, determined by the MNA-269 
sf, is effective and does not significantly increase hospital costs. The intervention 270 
resulted in both a more pronounced weight gain (0.92 ± 0.27 Kg in the intervention 271 
group (IG) vs. -0.76 ± 0.28 kg in the control group (CG), p<0.001) and a significant 272 
lower rate of nosocomial infections (23.6% vs. 36.7%, p=0.01) [22] (Level of evidence 273 
2+).  274 
In a prospective, non-randomized cohort study, Jie et al. found nutritional support was 275 
beneficial for polymorbid inpatients at nutritional risk as defined by the NRS 2002 [13] 276 
(Level of evidence 2+)). The overall complication rate was significantly lower in the 277 
group with nutritional therapy than in the no-support group (20.3% versus 28.1%, 278 
p=0.009), primarily because of the lower rate of infectious complications (10.5% 279 
versus 18.9%, p<0.001). These effects were robust after multivariate adjustment. Also 280 
in the same study, the effects of each medical nutrition therapy were analyzed 281 
separately, and significantly lower complication rates were found only in patients who 282 
received enteral nutrition (EN) compared to the group without nutritional support (8.2% 283 
vs. 28.1%, p<0.001).  284 
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Question 2. In polymorbid inpatients whose nutritional requirements 285 
can be met orally, does the use of oral nutritional supplements 286 
(ONS), with or without nutritional counseling, versus no ONS, 287 
improve outcomes? 288 
Recommendation 2.1. 289 
In malnourished polymorbid medical inpatients or those at high risk of 290 
malnutrition who can safely reach their nutritional requirements orally, ONS 291 
high in energy and protein shall be considered to improve their nutritional 292 
status and quality of life.  293 
Grade of recommendation A - strong consensus (95% agreement) 294 
Commentary: 295 
Provision of ONS high in protein and energy in acutely ill hospitalized patients or 296 
inpatients at risk of developing malnutrition has been found to improve nutritional 297 
status. Hegerova el al. conducted a prospective randomized controlled trial (RCT) in 298 
200 inpatients from an internal medicine department and found that the provision of 299 
ONS (combined with physiotherapy) increased the overall nutritional intake, mainly 300 
energy (1954 ± 429 Kcal in the IG vs. 1401 ± 364 Kcal, p<0.001) and protein (76.3 in 301 
the IG ± 16.1 vs. 55.5 in the CG ± 13.7, p<0.001), without negatively affecting the 302 
hospital food consumption (72.8% in the IG vs. 71.3% in the CG, p=0.528) [23] (Level 303 
of evidence 1++). This supplementation resulted in significant preservation of muscle 304 
mass (lean body mass difference between admission and 3 months after discharge 305 
was -3.5 Kg in CG patients, and +1.3 in the IG) and independence (the difference in 306 
the Barthel Index (BI) values between admission and 3 months showed a statistically 307 
significant decline in the CG (p<0.01) vs. a non-significant decline in the IG). 308 
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Therefore, ONS have a supplemental role in the provision of nutrition during 309 
hospitalization. 310 
Gariballa et al. found in a double blind RCT with 445 hospitalized patients that ONS 311 
provision significantly improved nutritional status (as indicated by the significant 312 
increase in serum albumin, red-cell folate and plasma vitamin B12 concentrations of 313 
the IG) and reduced the number of non-elective re-admissions in the 6-month follow-314 
up period (adjusted HR 0.68, 95% CI 0.49-0.94) [24] (Level of Evidence 1++). Similar 315 
results were also shown in other RCTs, where ONS provision (in addition to 316 
oxandrolone provided to both intervention and control groups) resulted in 317 
improvements of several parameters used to assess nutritional status, which were 318 
dependent on the level of DRM [25] (Level of evidence 1-). Moreover, according to 319 
Starke et al., individualized nutritional support which included the provision of ONS in 320 
malnourished medical hospitalized patients resulted in improvement of their nutritional 321 
status (mean weight change from admission to discharge was 0.0 ± 2.9 kg in the IG 322 
vs. -1.4 ± 3.2 kg in the CG, p=0.008) and quality of life (Short Form-36 function 323 
summary scale was 37 ± 11 % in the IG vs. 32 ± 9 in the CG %, p=0.030), and 324 
reduction of complications during their hospital stay (4/66 in the IG vs. 13/66 in the 325 
CG, p=0.035) [19] (Level of Evidence 1++). According to Volkert et al, provision of 326 
ONS to malnourished geriatric hospitalized patients resulted in improvements in 327 
nutritional status (e.g. in the IG with good acceptance, the mean weight gain was +0.4 328 
kg, when compared with a loss of -1.6 kg in the IG with poor acceptance and -0.1 kg in 329 
CG) and recovery rate (e.g. in the IG with good acceptance, the proportion of 330 
independent patients (BI score >65 points) increased from 36% at admission to 63% at 331 
discharge and to 72% after 6 months, and was significantly higher compared to CG at 332 
discharge (19%, p<0.05) and after 6 months (39%, p<0.05)) [26] (Level of Evidence 333 
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2+). Lastly, according to Potter et al, in a RCT of 381 malnourished older hospitalized 334 
patients, the provision of ONS resulted in a reduction in unintentional weight loss 335 
(p=0.003), as well as in mortality (14.7% in the IG vs. 35% in the CG, p<0.05) when 336 
the analysis was confined to the severely undernourished group [27] (Level of 337 
evidence 2++).  338 
Recommendation 2.2. 339 
In malnourished polymorbid medical inpatients or those at high risk of 340 
malnutrition, nutrient-specific ONS should be administered, when they may 341 
maintain muscle mass, reduce mortality or improve quality of life.  342 
Grade of recommendation B - consensus (89% agreement) 343 
Commentary: 344 
Several specialized nutrient specific ONS have been tested for their effectiveness on 345 
the improvement of outcomes in hospitalized patients. According to the NOURISH 346 
study, a multicenter RCT which included 652 malnourished inpatients, high protein – 347 
β-Hydroxy β-Methylbutyrate (βHMB) ONS may not yield a difference when compared 348 
with placebo on readmission rates, but may help with the maintenance of muscle mass 349 
during hospital stay and result in a significant decrease in post-discharge mortality (90-350 
day mortality was 4.8% in the IG vs. 9.7% in the CG; RR 0.49 (95%CI 0.27 to 0.90), 351 
p=0.018) [28] (Level of evidence 1++).  In addition, provision of ONS containing 995 352 
Kcal from macronutrients and covering 100% of the RDA for healthy older adults in 353 
vitamins and minerals led to a lower incidence of depressive symptoms (p=0.021) in 354 
older medical inpatients, with no other effect on their cognitive performance but with a 355 
significant positive effect on their self-reported quality of life (i.e. the treatment effect in 356 
quality-of-life scores using the SF-36 form at 6 months was 7.0 (95%CI 0.5 to 13.6), 357 
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p=0.04 for physical function, 10.2 (95%CI 0.1–20.2), p=0.047 for role physical, and 7.8 358 
(95%CI 0.0 to15.5), p=0.05 for social function domains, compared to placebo). 359 
[29, 30] (Level of evidence 1++ for both). Although these results are interesting and 360 
promising, the available studies remain limited.  361 
Recommendation 2.3. 362 
In polymorbid medical inpatients who are malnourished or at high risk of 363 
malnutrition and can safely reach their nutritional requirements orally, ONS 364 
should be considered as a cost-effective way of intervention towards improved 365 
outcomes.  366 
Grade of recommendation B - strong consensus (95% agreement)  367 
Commentary: 368 
Early detection and intervention against DRM has been shown to improve nutritional 369 
status and reduce complications during hospital stay [19] and non-elective re-370 
admissions [24, 28] (Level of Evidence 1++ for both). According to a cost-371 
effectiveness analysis by Philipson et al., in a retrospective study from 2000 to 2010, 372 
the provision of ONS to malnourished medical inpatients resulted in a reduction in LOS 373 
of 2.3 days (95%CI –2.42 to –2.16) that subsequently decreased annual hospital costs 374 
by 4734$ (95%CI –4754$ to –4714$), and reduced the readmission rate by 6.7%, from 375 
34.3% to 32.0% [31] (Level of evidence 2++). The greatest benefit was recorded in 376 
the most severely ill patients, which was a finding in general agreement with the "Feed 377 
Or Ordinary Diet" multi-center RCT, in which routine ONS (independent of baseline 378 
nutritional status) did not offer significant benefits to a mostly well-nourished stroke 379 
patient population (OR of death or poor outcome was 1.03 (95%CI 0.91 to 1.17) for the 380 
overall group and 0.78 (95% CI 0.46 to 1·35) in the small undernourished subgroup). 381 
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This stresses the importance of focusing nutritional support on those most in need [32] 382 
(Level of Evidence 1++).  383 
Question 3. In patients where nutritional requirements cannot be met 384 
orally, does the use of enteral nutrition (EN) compared to parenteral 385 
nutrition (PN) (total or supplemental) result in improved outcomes in 386 
polymorbid inpatients? 387 
Recommendation 3.1. 388 
In polymorbid medical inpatients whose nutritional requirements cannot be met 389 
orally, EN can be administered. In these cases, the use of EN may be superior to 390 
PN because of a lower risk of infectious and non-infectious complications.  391 
Grade of recommendation 0 - strong consensus (100% agreement) 392 
Commentary: 393 
Reaching energy goals in medical inpatients is important to prevent weight loss and 394 
the loss of muscle mass that may lead to poorer functional outcomes. However, in the 395 
acute care setting many obstacles may prevent patients from meeting their nutritional 396 
requirements orally[33]. These obstacles include loss of appetite due to acute illness, 397 
delayed gastric emptying causing both nausea and early satiety, inability to swallow, 398 
and vomiting, among others. In these situations, use of EN or PN can help increase 399 
nutritional intake until oral intake is sufficient [34, 35]. Several randomized studies 400 
have compared the effect of nutritional support on outcomes of medical inpatients. A 401 
recent meta-analysis incorporating 22 RCTs conducted in medical inpatients found a 402 
significantly higher energy and protein intake, as well as beneficial effects on weight 403 
when comparing nutritional IG (including counseling and oral and enteral feeding) to 404 
CG [36]. When the analysis was restricted to the subgroup of malnourished patients, 405 
those receiving nutritional interventions had lower risk for readmission and shorter 406 
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hospital stays, but no significant effect on mortality, infections and functional outcomes 407 
was found. Other studies also used nutritional strategies with EN and/or PN compared 408 
to usual care or other feeding strategies in the medical inpatient setting [37-39]; these 409 
studies, however, did not directly compare the two feeding modalities. There are also 410 
several studies that investigated whether EN compared to PN resulted in better 411 
outcomes. While most studies examined the critical care setting [40] and patients with 412 
acute pancreatitis [41, 42], there is some observational evidence for the polymorbid 413 
medical inpatient population [13]. This observational evidence [13] consists of one 414 
large, prospective, non-randomized study (briefly described in the clinical question 1) 415 
from three Institutions in the US and China including patients at nutritional risk, as 416 
defined by the NRS 2002 score, that investigated the outcomes of patients receiving 417 
either EN or PN to patients without nutritional support [13] (Level of evidence: 2+).  418 
Approximately two thirds of the patients were medical patients from the department in 419 
respiratory and gastrointestinal diseases. Because the study was non-randomized, the 420 
authors used multiple logistic regression analysis to evaluate the influence of 421 
nutritional support on the risk of infectious and non-infectious complications. Overall, 422 
the study found a significantly lower risk of overall complications and infectious 423 
complications associated with nutritional support (adjusted OR 0.54 (95%CI 0.38 to 424 
0.77), p<0.001 and adjusted OR 0.42 (95%CI 0.27 to 0.64), p<0.001, respectively). 425 
When the nutritional support group was further divided into those receiving PN and 426 
those receiving EN, the overall complication rate and the rates of infectious 427 
complications and non-infectious complications were significantly lower in those 428 
patients receiving EN than in those patients with no nutritional support (p=0.001). 429 
However, no difference in the complication rates were found between patients with PN 430 
and patients with no nutritional support (p=0.29). Because of differences in the patient 431 
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population, this analysis was also repeated in the patients undergoing major 432 
abdominal surgery who had PN or no nutritional support. Again, no significant 433 
difference in the complication rate was found between PN patients and control 434 
patients. This study has a number of important limitations regarding the observational, 435 
non-randomized design with important differences in study populations between PN 436 
and EN patients (as well as no-nutritional support patients), differences in hospital 437 
characteristics between the Chinese und the US hospitals and the lack of a 438 
standardized follow-up. Thus, causal inferences cannot be drawn. Still, the study 439 
suggests that EN may be more beneficial than PN, due to fewer infectious and non-440 
infectious complications.    441 
Although outside the scope of these guidelines, there is some evidence from critical 442 
care demonstrating that EN compared to PN results in lower complication risk; 443 
nonetheless, a recent meta-analysis including 30 RCTs did not find a mortality benefit 444 
[40]. In that meta-analysis, EN had a lower risk of both infectious complications (risk 445 
difference 8.8, 95%CI 0.0 to 17.5) and non-infectious complications (risk difference 446 
12.2, 95%CI 4.6 to 19.9) in the sub-group of medical critical care patients. Similarly for 447 
pancreatitis, a meta-analysis including 6 trials found that compared with PN, EN was 448 
associated with a significantly lower incidence of pancreatic infection complications 449 
(RR = 0.556, 95%CI 0.436 to 0.709), multi-organ failure (RR = 0.395, 95% CI 0.272 to 450 
0.573), surgical interventions (RR = 0.556, 95%CI 0.436 to 0.709), and mortality (RR = 451 
0.426, 95%CI 0.238 to 0.764) [37].  452 
In summary, high-quality randomized studies comparing EN and PN in the polymorbid 453 
medical inpatient setting are scarce. Still, when also considering high-quality evidence 454 
from critical care and in patients with pancreatitis as well as observational evidence 455 
from polymorbid medical patients, there are several arguments for the use of EN as a 456 
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first line therapy as compared to PN due to lower risks for infectious and non-infectious 457 
complications. 458 
Question 4. Does the estimation of energy requirements with a 459 
prediction equation versus a weight-based formula improve 460 
outcomes of polymorbid inpatients requiring nutritional support? 461 
Recommendation 4.1. 462 
Energy requirements in polymorbid medical inpatients can be estimated using 463 
indirect calorimetry (IC), a published prediction equation or a weight-based 464 
formula.  465 
Grade of recommendation 0 - strong consensus (96% agreement) 466 
Recommendation 4.2. 467 
In the absence of IC, total energy expenditure (TEE) for polymorbid older 468 
patients (aged > 65 years) can be estimated using the formula 27 kcal/kg actual 469 
body weight. Resting energy expenditure (REE) can be estimated using the 470 
formula 18 - 20 kcal/kg body weight with the addition of activity or stress factors 471 
to estimate TEE.  472 
Grade of recommendation 0 - strong consensus (95% agreement) 473 
Recommendation 4.3.a) 474 
In the absence of IC, REE for severely underweight patients can be estimated 475 
using the formula 30 kcal/kg body weight.  476 
Grade of recommendation 0 - consensus (agreement 89%) 477 
Recommendation 4.3.b) 478 
This target of 30 kcal/kg body weight in severely underweight patients should be 479 
cautiously and slowly achieved, as this is a population at high risk of refeeding 480 
syndrome.  481 
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Grade of recommendation GPP - strong consensus (agreement 100%) 482 
Commentary: 483 
The estimation of energy requirements is an important part of the patient assessment 484 
process and requires the determination of an individual’s total energy expenditure 485 
(TEE) i.e. the sum of resting energy expenditure (REE), diet-induced thermogenesis 486 
and the energy expended during physical activity. The gold standard to measure REE 487 
is indirect calorimetry (IC) and for TEE the gold standard is doubly-labelled water. 488 
However, these methods are rarely available in the clinical setting and require 489 
considerable expertise [43]. Practitioners therefore tend to rely on either published 490 
prediction equations (e.g. Harris-Benedict [44] or Ireton-Jones [45]) or weight-based 491 
formulae (e.g. 25 – 30 kcal/kg body weight), to estimate energy requirements. In 492 
prediction equations, energy requirements are estimated from a number of different 493 
parameters e.g. weight, age, gender, ventilation status, heart rate etc.; in weight-based 494 
formulae the prediction is based solely on patient body weight. No single, validated 495 
method for estimating requirements exists, and the evidence-base for all prediction 496 
methods currently in use is poor [46]. In the absence of indirect calorimetry there is a 497 
debate about which of the two estimation methods is the most valid for use in the 498 
clinical setting. However, no studies were identified that answered this specific 499 
question. 500 
While both published prediction equations and weight-based formulae provide valid 501 
estimates of energy requirements for groups of patients, both methods are subject to 502 
significant bias and imprecision when applied to individuals [47, 48]. More than 200 503 
prediction equations have been published in the literature, with accuracy rates ranging 504 
from 36%–75% when compared with indirect calorimetry and no single equation 505 
emerges as being the most accurate in polymorbid medical inpatients [47]. 506 
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Practitioners should therefore exercise a considerable degree of clinical judgment 507 
when determining the energy requirements of a polymorbid medical inpatient. 508 
This also includes the choice of activity or stress factors, which relies on the clinical 509 
judgment, knowledge, and experience of the individual calculating the predicted 510 
requirements - it should be undertaken with caution since their misapplication can lead 511 
to clinically significant errors. 512 
Individuals requiring nutritional support range from paralyzed and sedated, critically ill 513 
patients to fully mobile patients on the ward or in the community.  To date, however, 514 
there is a relative lack of research on the effects of illness and injury on physical 515 
activity levels [49] although a recent consensus document concluded that since acute 516 
illness is usually accompanied by a decrease in physical activity that compensates for 517 
any increase in BMR, TEE is rarely above that of healthy, sedentary individuals of the 518 
same sex and age [50].  519 
In a review designed to determine the energy requirements of frail older people [51], 520 
including polymorbid patients, 33 studies (2450 subjects) were identified where REE 521 
was measured by indirect calorimetry in subjects aged 65 years or more and the 522 
results were compared with healthy older individuals (Level of evidence 2++). Only 523 
studies that measured REE by IC after a fast and at rest were considered eligible for 524 
inclusion in the review.  The mean age was 73.0 (±6.6) years with no significant 525 
difference in BMI between the healthy and sick cohorts (25.6 (±1.5) kg/m2 and 25.2 526 
(±2.5) kg/m2 respectively) and no differences in fat mass or fat-free mass. The 527 
weighted mean for the whole group was 20.4 kcal/kg body weight whereas the 528 
weighted mean for the polymorbid hospitalized older group was lower at 18.5 kcal/kg 529 
body weight. The mean TEE in sick older individuals was 27 (±1.8) kcal/kg body 530 
weight and the weighted physical activity level in these patients was 1.36 (±0.03) 531 
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reflecting the relative physical inactivity of this population. The results of this review 532 
should be interpreted with caution since relatively few data were available in the sick 533 
older individuals (n=248) compared with the healthy older individuals (n=1970). 534 
Furthermore the methods described in the paper failed to comply fully with guidelines 535 
for the conduct of systematic reviews [52]. For example, only one database 536 
(MEDLINE) was searched when it is recommended that at least three should be 537 
searched, and only studies published in English were included. 538 
In a study designed to evaluate the accuracy of prediction equations against IC in 539 
hospitalized patients [47], REE was measured by IC in 395 inpatients referred for 540 
nutritional support. REE measurements were compared with three prediction 541 
equations including one specifically for obese individuals [44, 45, 53] and one weight-542 
based formula recommended by the American College of Chest Physicians (25 kcal/kg 543 
body weight). The mean age of the population was 56 (+18) years and the mean BMI 544 
was 24 (+5.6) kg/m2. Measured REE was 1,617 (+355) kcal/day for the entire group 545 
and 1,790 (+397) kcal/day in the obese group (n=51). In this study the authors 546 
concluded that no single prediction equation was accurate (i.e. within 90-110% of 547 
measured REE) in the majority of the population. 548 
In a study designed to determine the energy requirements of severely underweight 549 
hospitalized patients [54] energy expenditure was measured by IC in 14 patients.  550 
Mean BMI was 15.8 (±1.8) kg/m2 and mean age was 66.5 (±13.9) years. In this study 551 
mean REE by IC was 1,300 (+160) kcal/day equating to 31.4 kcal/kg body weight. 552 
These results should be interpreted with caution since the sample size was very small. 553 
Furthermore, patients received continuous EN or PN during IC and thus measured 554 
energy expenditure included not only REE but also diet-induced thermogenesis.  555 
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This target of approximately 30 kcal/kg body weight in severely underweight patients 556 
may need to be achieved with caution, as this is a population at high risk of refeeding 557 
syndrome. The diagnostic criteria and the factors proposed for screening of refeeding 558 
syndrome have been proposed elsewhere [55].  559 
Clinicians should be aware of the limitations of using precise numbers on weight-560 
based formulae (or prediction equations) since in all studies there is considerable 561 
variation around the effect estimate. They should recognize that all prediction methods 562 
are imprecise when applied to individuals and therefore should only be used as a 563 
starting point when estimating requirements. In fact, this highlights the need for input 564 
from a suitable and experienced healthcare professional to adequately assess the 565 
nutritional needs of the patient e.g. a dietitian. 566 
From the review of the literature it is not possible to determine which method of 567 
estimating energy requirements (or which prediction equation) is the best in terms of 568 
promoting better outcomes in the polymorbid medical inpatient population. 569 
Although the scope of this guideline is the general group of polymorbid patients, the 570 
available evidence for recommendation 4.2. is limited to the subgroup of polymorbid 571 
older patients. For further information regarding the nutritional care of older patients, 572 
please refer to the existing ESPEN guidelines on EN [56] and PN [57] for geriatric 573 
patients.  574 
Question 5. Do protein targets higher than 1.0g/kg BW/day versus a 575 
lower target improve outcomes in polymorbid inpatients requiring 576 
nutritional support? 577 
Recommendation 5.1. 578 
Polymorbid medical inpatients requiring nutritional support shall receive a 579 
minimum of 1.0 g of protein/kg of body weight per day in order to prevent body 580 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
29 
 
weight loss, reduce the risk of complications and hospital readmission and 581 
improve functional outcome.  582 
Grade of recommendation A - strong consensus (95% agreement) 583 
Commentary: 584 
One high quality RCT [19] (Level of evidence 1++) and a subsequent secondary 585 
analysis of the same data [58] (Level of evidence 1++) compared the effect of protein 586 
intakes of 1g/Kg of patient's body weight per day versus lower intakes.  587 
The trial by Starke et al. included adult patients hospitalized in a general medical ward, 588 
with a NRS score of 3 or more. The IG received 1 g of protein/kg of body weight per 589 
day in the form of individual food supply, fortified meals, in-between snacks and oral 590 
nutritional supplements for an average of 17.0 (+10.4) days. The control group 591 
received standard nutritional care for an average of 18.6 (+17.1) days, with a mean 592 
protein intake of 0.7g/kg of body weight per day.  593 
At discharge, patients receiving 1 g of protein/kg of body weight per day (and 594 
significantly more energy) experienced less weight loss (0.0 (+2.9) kg vs. -1.4 (+3.2) 595 
kg, p=0.008), had an improved functional status (SF-36 function summary scale (37 596 
(+11) % vs. 32 (+ 9) %, p=0.030), a lower risk for complications (4/66 vs. 13/66, 597 
p=0.035) and a reduced number of antibiotic therapies (1/66 vs. 8/66, p=0.033), 598 
compared to the CG patients receiving less protein [19]. Drommer and colleagues 599 
confirmed that the number of complications was inversely correlated with the mean 600 
daily protein intake (p=0.017). After 6 months, patients from the IG were less 601 
frequently readmitted to the hospital compared to the patients from the CG (17/64 vs. 602 
28/61, p=0.027) [19]. 603 
Although these analyses were both undertaken using the same RCT patient data, the 604 
strong design and high methodological quality supports the recommendation to 605 
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provide at least 1 g of protein per kg of body weight in polymorbid inpatients. Recent 606 
guidelines from the American College of Gastroenterology about nutritional therapy in 607 
the adult hospitalized patients [41] suggest that protein targets as high as 1.5–2.0 g/kg 608 
body weight per day may even be needed to optimize nutritional support. In another 609 
recent publication evaluating practical procedures for nutritional support of medical 610 
inpatients, the authors investigated the question of protein intake targets needed to 611 
improve patients’ outcomes. They used studies included in existing recommendations 612 
for particular diseases and medical specialties [34]. They also concluded that a 613 
minimum of 1.2 g of protein per kg of body weight per day is suitable for the vast 614 
majority of patients hospitalized in medical wards except for patients with renal 615 
impairment. 616 
In the case of polymorbid medical inpatients with a renal condition, the amount of 617 
protein included in the daily nutritional plan may be different and should be cautiously 618 
assessed. Guidelines for renal patients recommend to lower the protein intake to 0.8-1 619 
g/kg of body weight per day for at-risk or malnourished medical inpatients with acute 620 
and chronic renal failure and without renal replacement therapy [34, 59].  621 
Our search did not yield any study assessing the effects of different protein intakes on 622 
outcomes of patients with clear evidence of kidney diseases in addition to one or 623 
several others. Therefore, it is not possible to know how the different diseases 624 
affecting polymorbid patients with a renal condition might interplay and to provide a 625 
recommendation in regard to protein intakes in polymorbid inpatients with a renal 626 
condition. 627 
Question 6.  In patients exclusively fed orally, does the 628 
supplementation of micronutrients (vitamins and trace elements) 629 
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compared to no supplements improve outcomes in polymorbid 630 
inpatients? 631 
Recommendation 6.1. 632 
In polymorbid medical inpatients exclusively fed orally adequate intake of 633 
micronutrients (vitamins and trace elements) to meet daily estimated 634 
requirements should be ensured.  635 
Grade of recommendation GPP - strong consensus (100% agreement) 636 
Recommendation 6.2. 637 
Polymorbid medical inpatients exclusively fed orally with documented or 638 
suspected micronutrient deficiencies should be repleted.  639 
Grade of recommendation GPP - strong consensus (93% agreement) 640 
Commentary: 641 
Polymorbid medical inpatients may be at risk of micronutrient deficiency as a result of 642 
decreased intake or greater micronutrient utilization, which can compromise health as 643 
well as recovery from illness or disease. The need for micronutrient supplementation is 644 
often based on clinical assessment of the subject and in some cases estimated daily 645 
micronutrient requirements may temporarily exceed recommended daily intakes in 646 
order to account for depleted stores and/or increased utilization (particularly in patients 647 
who are exclusively fed orally). For example, a study by Joosten et al. found hospital 648 
inpatients > 65 years of age likely to be deficient of vitamin B12, folate and/or vitamin 649 
B6, even though the same subjects had apparently normal reported levels of the same 650 
micronutrients [60]. A study by Kilonzo et al. [61] on self-reported morbidity from 651 
infections in free-living patients (rather than inpatients) aged > 65 years randomized to 652 
receive either a daily vitamin and mineral supplement or placebo found fewer QALYs 653 
per person in the supplemented group. This result is counter-intuitive, however 654 
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incomplete supplements not designed to replete micronutrient stores were used 655 
despite almost one third of the participants being judged at risk of micronutrient 656 
deficiency on recruitment. General micronutrient supplementation, with or without 657 
supplementation of specific micronutrients, based only on the provision of 658 
multivitamins rather than a combined multivitamin and multi-trace element appears to 659 
be common, and often based on financial cost of the supplement. However, if a 660 
subject may have general micronutrient depletion or generally increased micronutrient 661 
requirements then there is likely to be a need to provide trace elements as well as 662 
vitamins. Therefore, in the absence of specific toxicity risks or known micronutrient 663 
adequacy, supplementation should aim to deliver a complete range of both 664 
multivitamins and multi-trace elements rather than multivitamins alone. Complete 665 
micronutrient supplementation to meet reference nutrient intakes or otherwise 666 
estimated daily requirements could be particularly important in polymorbid inpatients 667 
due to the potential for any deficiencies to affect multiple and already compromised 668 
organ systems. 669 
No studies were identified that reported the supplementation of multivitamins (with or 670 
without trace elements) compared to no supplements in polymorbid inpatients 671 
exclusively fed orally. 672 
Question 7. Does disease-specific nutritional supplementation (e.g. 673 
fiber, omega 3 fatty acids, BCAA, glutamine, etc.) versus standard 674 
formulations improve outcomes in polymorbid inpatients? 675 
Many specialized ONS/EN feeds have been developed for specific diseases that 676 
usually involve chronic/acute inflammation, specific micronutrient deficiency or specific 677 
metabolic disorders [62]. However, most studies were not conducted in identified 678 
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hospitalized polymorbid patients, even though some of these patients may well be 679 
polymorbid, and the number of usable studies identified was extremely low. 680 
Recommendation 7.1. 681 
In polymorbid medical inpatients with pressure ulcers, specific amino-acids 682 
(arginine and glutamine) and β-hydroxy β-methylbutyrate (βHMB) can be added 683 
to oral/enteral feeds to accelerate the healing of pressure ulcers.  684 
Grade of recommendation 0 - consensus (90% agreement) 685 
Commentary: 686 
Pressure ulcers are responsible for protein loss, hypermetabolism and 687 
hypercatabolism, and are often associated with malnutrition, including nutrient 688 
deficiencies that are critical to the different phases of wound healing (conditionally 689 
essential amino acids and anti-oxidant micronutrients). A RCT from Singapore which 690 
included 26 polymorbid patients hospitalized for more than 2 weeks [63] showed a 691 
marginal albeit significant effect of an arginine/glutamine/ βHMB mixture on the healing 692 
of pressure ulcers (greatest improvement of viable tissues at two weeks in the IG, by 693 
43% vs. 26%, p=0.02) (level of evidence 1+). The amino acid mixture (14 g arginine, 694 
14 g glutamine and 2.4 g calcium βHMB per day) was not part of a nutritional formula, 695 
but all patients were fed per recommendations for hypermetabolic and hypercatabolic 696 
patients (30-35 kcal and 1.2-2.0 g protein/kg body weight/day according to the stage of 697 
the ulcer). As the basic nutritional needs were covered in both groups, the supplement 698 
(administered orally or enterally) was likely responsible for the beneficial effects 699 
observed. 700 
Other positive studies have been published using an oral nutritional supplement 701 
enriched in arginine, zinc and anti-oxidants in patients outside the scope of these 702 
guidelines [64, 65]. 703 
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Recommendation 7.2. 704 
In polymorbid medical older inpatients requiring enteral nutrition, formulas 705 
enriched in a mixture of soluble and insoluble fibers can be used to improve 706 
bowel function.  707 
Grade of recommendation 0 - strong consensus (95% agreement) 708 
Commentary: 709 
Diarrhea and constipation are the most frequent complications of EN in hospitalized 710 
patients. A Belgian study of 145 older patients receiving enteral feeding [66] found 711 
positive effects of a formula enriched with 30 g fiber including 33% insoluble (cellulose 712 
and hemicellulose A) and 67% soluble (pectin, hemicellulose B, inulin) fiber (IG) vs. 713 
the CG, which received the same EN with no fiber (level of evidence 1++). The 714 
frequency of stools was lower (4.1±2.6 per week versus 6.3±4.7 per week; p<0.001) 715 
and the stool consistency higher in the IG (31% had solid form stools in the IG vs. 21% 716 
in the CG, and 2% had liquid-watery stool in the IG vs. 13% in the CG, p<0.001); 717 
however, patients in the CG received more laxatives during the study period than 718 
patients in the fiber group. A global 4-week mortality of 24% underlines the severity of 719 
the patients’ conditions. 720 
The effects on bowel function associated with the absence of detrimental metabolic 721 
effect argue for a recommendation for a first intention use of EN formulae enriched 722 
with a mixture of soluble and insoluble fibers (supposed to match the multiple sources 723 
of fibers in normal food). 724 
Recommendations 7.1 and 7.2 were downgraded from grade of recommendation B to 725 
0, due to the limited amount of available studies. 726 
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Question 8. Does early nutritional support (i.e. provided less than 48 727 
hours post hospital admission) compared to later nutritional support 728 
improve outcomes in polymorbid inpatients? 729 
Recommendation 8.1. 730 
Early nutritional support (i.e. provided in less than 48 hours post hospital 731 
admission) compared to later nutritional support should be performed in 732 
polymorbid medical inpatients, as sarcopenia could be decreased and self-733 
sufficiency could be improved.  734 
Grade of recommendation B - strong consensus (95% agreement) 735 
Commentary: 736 
Polymorbid medical inpatients are at high risk of developing DRM, so it is possible that 737 
this population could benefit from early nutritional support during hospital admission to 738 
avoid worsening of DRM with subsequent negative outcomes.  739 
The use of early nutritional support is debated in different clinical scenarios and patient 740 
populations. Critically ill patients have been extensively studied, but still there is 741 
controversy. A recent meta-analysis conducted in populations with acute pancreatitis 742 
demonstrated that early EN was associated with significant reductions in infections, 743 
catheter-related septic complications, hyperglycemia, length of hospitalization and 744 
mortality, but the studies included did not show evidence of polymorbidity [67]. In one 745 
of the "Feed Or Ordinary Diet" trials [68], early tube feeding, defined as “as soon as 746 
possible”, vs. avoiding any enteral tube feeding for at least seven days, was 747 
associated with an absolute reduction in risk of death but again, it is not known 748 
whether this population (where stroke was the primary insult) was polymorbid.    749 
From the available literature addressing this question in medical inpatient populations 750 
with confirmed polymorbidity, two studies were identified. 751 
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First, a prospective RCT from Heregova et al. [23] aimed to determine whether early 752 
nutritional therapy and exercise would influence the development of sarcopenia and 753 
impaired self-sufficiency during acute illness. Two hundred inpatients >78 years old 754 
were randomized to a CG receiving standard treatment or to an IG, which consisted of 755 
ONS (600 kcal, 20 g/d protein) added to a standard diet and a simultaneous intensive 756 
rehabilitation program from day 1 of hospitalization. The amount of lean body mass in 757 
CG patients decreased during their hospital stay but did not change in the IG. Three 758 
months post-discharge, lean body mass was 3.5 kg lower in the control group but only 759 
0.4 kg lower in the treated group. Lean body mass did not reach its original value even 760 
12 months post-discharge in the CG, but it did in the IG. Regarding self-sufficiency 761 
(measured by independency in the activities of daily living through the Barthel index), it 762 
diminished during the course of annual monitoring in both groups of patients, but the 763 
decline was sharper in the CG (Level of evidence 1+). 764 
Second, Zheng et al. [69] compared early EN (started on first day, n=75) with "family 765 
managed nutrition" (n=71) in a RCT of patients with acute stroke and dysphagia. The 766 
infection rate in the IG was significantly lower than that in the CG (33.3% vs. 52.1%, 767 
p=0.022). Also, the IG showed a better NIHSS score than that of the CG after 21 days 768 
(12.04 (±2.55) vs. 10.78 (±2.69); p=0.008). However, patients were admitted to the 769 
stroke unit in the IG and to the regular ward in the CG, which entails a high risk of bias 770 
(Level of evidence 1-). 771 
Question 9. Does the continued use of nutritional support after 772 
discharge compared to nutritional support during inpatient stay 773 
alone affect the outcome of polymorbid patients? 774 
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For the present question, only interventions initiated in the hospital (and continued 775 
after discharge) were considered for inclusion. In case of doubt, authors were 776 
contacted to confirm this information. 777 
Recommendation 9.1. 778 
In malnourished polymorbid medical inpatients or those at risk of malnutrition 779 
nutritional support shall be continued after hospital discharge in order to 780 
maintain or improve body weight and nutritional status.  781 
Grade of recommendation A - strong consensus (95% agreement) 782 
Commentary: 783 
Polymorbid medical inpatients are commonly malnourished and frequently nutritional 784 
status does not improve but instead deteriorates during their hospital stay. As a result, 785 
many patients leave the hospital malnourished, or more malnourished, which 786 
increases the risk for functional decline, loss of independence and greater morbidity. 787 
Poor nutritional status is acknowledged to contribute to the recently described post 788 
hospital syndrome that represents a 30-day “generalized transient vulnerability 789 
following hospital discharge” leading to higher morbidity and an increased rate of 790 
unplanned readmissions [70]. Therefore, ensuring adequate nutritional intake during 791 
the transition from hospital to home is an important goal in malnourished patients. 792 
Recent systematic reviews found evidence for improved body weight and nutritional 793 
status in older patients after discharge either with individualized nutritional support [71] 794 
or intervention with ONS [72]. Very few studies have, however, directly compared 795 
nutritional intervention in and after hospital discharge vs. nutritional support in hospital 796 
alone. 797 
One study by Feldblum et al. which directly compared 6-month individualized 798 
nutritional support from a dietitian in hospital followed by three home visits after 799 
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discharge (group 1, n=66 (IG)) to either a single consultation with the dietitian in 800 
hospital or standard care (group 2 and 3, n=102 (CG)), showed that continued 801 
nutritional support in malnourished patients aged 65 or older resulted in a significantly 802 
higher change in mean MNA score, compared to the combined group 2 and 3 (3.01 803 
(±2.65) in the IG vs. 1.81 (±2.97) in the CG, p=0.004) [73] (Level of evidence 1-). 804 
Similarly, in a prospective RCT of 80 patients aged 75 or more admitted for acute 805 
disease and at risk for malnutrition, a 60-day intervention with ONS which started in 806 
hospital and was continued at home or in the nursing home resulted in maintained 807 
body weight and improved MNA scores (3.01 (±2.65) vs. 1.81 (±2.97), p=0.004), 808 
whereas CG patients continued to lose weight [74] (Level of Evidence 1++).  809 
Similar results were obtained in other RCTs. In a RCT of malnourished hospital 810 
inpatients (47 in the IG and 46 in the CG) by Casals et al., the intervention resulted in 811 
increased body weight (4.750 (±5.12) Kg in the IG vs. −0.903 (±6.12) Kg in the CG, 812 
p<0.001) and improved the "Malnutrition Universal Screening Tool" score (−2.457 813 
(±1.39) in the IG vs. −1.170 (±1.67) in the CG, p<0.001) after 6 months of continued 814 
nutritional counseling by case manager nurses (frequency of visits depending on 815 
severity of malnutrition, either every month or every second month) [75] (Level of 816 
Evidence 1-) and similarly, in a RCT of malnourished patients (according to the MNA-817 
sf) aged 85±6 years, individualized nutritional support for four months after discharge 818 
maintained body weight in the intention-to-treat analysis (difference in mean weight 819 
from baseline to 4-month follow-up was 0.6Kg in the IG vs. -1.5Kg in the CG, 820 
p<0.001), although a high dropout rate was reported [76] (Level of Evidence 1+). 821 
Recommendation 9.2. 822 
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In malnourished polymorbid medical inpatients or those at high risk of 823 
malnutrition, nutritional support should be continued post hospital discharge to 824 
maintain or improve functional status and quality of life.  825 
Grade of recommendation B - strong consensus (95% agreement) 826 
Commentary: 827 
Improving functional status is one of the most important goals of nutritional therapy 828 
after discharge to prevent prolonged recovery, unplanned readmissions or loss of 829 
autonomy. Functional status can be assessed by objective measures such as hand 830 
grip strength or walking speed, or by subjective measures, for example through the 831 
use of questionnaires on mobility and physical ability. QoL is a multidimensional 832 
construct to evaluate the success of treatments which has been increasingly used in 833 
RCTs of nutritional interventions. Due to the many influencing factors on health-related 834 
QoL, sufficient sample sizes are needed and effects of nutritional therapy on QoL 835 
might depend on the subjects’ age, the underlying disease or the duration of nutritional 836 
therapy. 837 
In one RCT conducted in malnourished adults aged 60 or older admitted to an acute 838 
hospital for medical or surgical conditions, 3-month nutritional intervention (with energy 839 
and protein rich diets, ONS and calcium + Vit D supplements, providing 600 kcal/day 840 
and 24 g protein/day as well as 400 IE vitamin D3 and 500 mg calcium) resulted in a 841 
reduction in the number of falls (10% vs. 24%, p=0.02) [77] (Level of Evidence 1++), 842 
significant improvement in self-reported functional limitations (mean difference -0.72, 843 
95%CI -1.15 to -0.28) [78], and was neutral in financial cost [79] (Level of Evidence 844 
1++). On the other hand, increase in QoL did not differ between IG and CG receiving 845 
standard care [79] (Level of Evidence 1++). In the study by Persson et al., which 846 
included old patients at risk of malnutrition (85±6 years), treatment with complete or 847 
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incomplete liquid supplements (providing an average intake of 60 kcals and 11.25 g 848 
protein per day) and dietary advice for 4 months resulted in improvement of Katz 849 
activities of daily living index (p<0.001; p=0.05 between the groups), but not in QoL 850 
assessed by the 36-Item Short Form Health Survey [76] (Level of Evidence 1+). On 851 
the other hand, Casals et al. reported significantly improved QoL scores (assessed by 852 
the Short Form 12 Health Survey, being the difference between IG and CG 13.72, 853 
p<0.001)) after 6 months of individualized nutritional support [75].  854 
In younger malnourished patients (50.6 ± 16.1 years) with benign gastrointestinal or 855 
liver disease who received ONS during their hospital stay and for three months post 856 
discharge, QoL assessed by the 36-Item Short Form Health urvey questionnaire was 857 
significantly improved in the IG patients (n=60) compared to the CG patients (n=54) 858 
(mean improvement at 3 months was 0.128 (95%CI 0.095 to 0.161) in the IG vs. 0.067 859 
(95%CI 0.031–0.103) in the CG) [80] (Level of Evidence 1+). Grip strength and peak 860 
expiratory flow increased after three months only in the intervention patients (grip 861 
strength improved from 26.1 (±11.3) to (31.5±10.1) kg, p<0.0001; and peak flow from 862 
329.2 (±124.0) to 388.9 (±108.4) l/min, p=0.004)) [81] (Level of Evidence 1+). 863 
Recommendation 9.3. 864 
In polymorbid medical inpatients at high risk of malnutrition or with established 865 
malnutrition aged 65 and older, continued nutritional support post hospital 866 
discharge with either ONS or individualized nutritional intervention shall be 867 
considered to lower mortality.  868 
Grade of recommendation A - strong consensus (95% agreement) 869 
Commentary: 870 
The effect of nutritional intervention with ONS on mortality has not been frequently 871 
studied in sufficiently sized patient cohorts. One of the largest RCTs to date (n=652 872 
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patients aged 65 years or more with medical conditions) on in- and post hospital (= 873 
continued) nutritional support reported lower 90-day mortality in the IG receiving ONS 874 
twice a day (one drink providing 350 kcal, 20 g protein, 1.5 g calcium-βHMB), 160 IU 875 
vitamin D and other essential micronutrients) for three months compared to the CG 876 
patients who received a placebo (4.8% in the IG vs. 9.7% in the CG, p=0.018) [28] 877 
(Level of evidence 1++). In the study by Feldblum et al., the IG patients (>65 years) 878 
who received individualized nutritional support from a dietitian during hospitalization 879 
and for 6 month after discharge (three home visits after discharge) exhibited a 880 
significantly lower mortality rate (3.8%) than the CG (vs. 11.6%, p=0.03) at month 6 881 
[73]. 882 
Although the scope of this guideline is the general group of polymorbid patients, the 883 
available evidence for recommendation 9.3. is limited to the subgroup of polymorbid 884 
older patients. For further information regarding the nutritional care of older patients, 885 
please refer to the existing ESPEN guidelines on EN [56] and PN [57] for geriatric 886 
patients.  887 
The present recommendations highlight the need for ongoing review or monitoring 888 
nutritional support against patient specific goals post discharge (to establish whether 889 
continuation of medical nutrition therapy is needed) and the need for good quality 890 
communication of medical nutrition therapy regimens (whether oral, EN or PN) and 891 
goals of treatment in discharge documentation. 892 
Question 10. Does the monitoring of physical functions, when it is 893 
possible, compared to monitoring of nutritional parameters (e.g. 894 
body weight, energy and protein intakes) improve other outcomes in 895 
polymorbid inpatients receiving nutritional support? 896 
Recommendation 10.1. 897 
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Nutritional parameters should be monitored to assess responses to nutritional 898 
support, while functional indices should be used to asses other clinical 899 
outcomes (i.e., survival, quality of life) in polymorbid medical inpatients.  900 
Grade of recommendation B - strong consensus (95% agreement) 901 
Commentary: 902 
Limited evidence exists to answer this clinical question precisely. Most trials assessing 903 
the impact of nutritional support in polymorbid inpatient used nutritional and functional 904 
status as outcome rather than as monitoring tools of the efficacy of nutrition 905 
intervention in improving other outcomes. 906 
Mendehall et al. [25] studied 271 polymorbid inpatients with severe alcoholic hepatitis 907 
and randomly assigned to oxandrolone therapy plus a high-energy, high-protein 908 
supplement (active treatment) or placebo plus a low-energy, low protein supplement 909 
(standard treatment). Both groups initiated the nutritional support during hospitalization 910 
(30 days) and continued it at home when discharged (90 days). During hospitalization, 911 
patients in both groups were offered an identical hospital diet providing approximately 912 
2500 kcal/d. Nutritional (i.e., body weight, triceps skinfold thickness), functional (i.e., 913 
handgrip strength) and clinical (i.e., laboratory tests) assessments were performed at 914 
baseline, after 1 month of hospitalization and after 2 months of outpatient therapy. 915 
Mendehall et al. also performed survival analysis at 6 months (i.e., 3 months after 916 
completion of nutrition therapy). All patients in both groups were malnourished. During 917 
treatment, energy and protein intake increased significantly in the active treatment 918 
group vs. standard treatment (2312Kcal vs. 1495Kcal (p<0.001) and 89g vs. 57g 919 
protein (p<0.001), respectively), leading to a significantly better mid-arm muscle area 920 
(change 4.5 vs. 0.3, p=0.02), creatinine-height index (change 18.4 vs. 2.6, p=0.03) and 921 
% ideal body weight (change 8.1 vs. 2.3, p=0.04). Interestingly, active treatment did 922 
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not improve handgrip strength better than standard treatment. However, when 923 
assessing the impact of nutrition intervention on 6-month mortality, Mendehall et al. 924 
reported that creatinine-height index, total lymphocyte count and handgrip strength are 925 
the stronger predictors. This suggests that although nutrition therapy improves 926 
nutritional status and outcome (i.e., they are tools to assess the response to therapy), 927 
functional parameters are more robust prognosticators of outcome. (Level of 928 
evidence: 1-) 929 
Norman et al. [81] studied 80 malnourished polymorbid patients with gastrointestinal 930 
benign disease. After discharge from the hospital, patients were randomized into two 931 
groups: one group received for three months dietary counseling plus a standard oral 932 
nutritional supplement (IG) whereas the other group received only dietary counseling 933 
(CG group). At baseline, no difference was observed in nutritional (i.e., Subjective 934 
Global Assessment (SGA), body composition) and functional parameters (i.e., peak 935 
flow, handgrip strength) as well as in QoL (i.e., 36-item short form questionnaire) 936 
between the two groups. At the end of the study, both body weight and body cell mass 937 
improved significantly in both groups. However, handgrip strength (change from 26.1 938 
to 31.5 kg, p<0.0001) and peak flow (change from 329.2 to 388.9 l/min, p=0.004) 939 
improved only in the IG. Also, all QoL subscales of 36-item short form questionnaire 940 
(n=8) significantly improved in IG patients, whereas only three (physical functioning, 941 
bodily pain and vitality) improved in CG patients. Of interest, the change in handgrip 942 
strength correlated with the change in two 36-item short form questionnaire physical 943 
scales (i.e., physical functioning and physical role). By applying the reasoning used for 944 
Mendehall et al.’s trial, it appears that Norman et al. confirm that functional parameters 945 
may be superior to nutritional parameters in assessing other clinical outcomes in 946 
polymorbid medical inpatients receiving nutritional support. (Level of evidence: 1-) 947 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
44 
 
Supporting our interpretation of the available literature, Koretz et al. [82] analysed 99 948 
RCTs of nutritional support vs. no nutritional support which reported at least one 949 
clinical outcome and at least one nutritional outcome. The authors’ assumption was 950 
that if changes in nutritional markers predict clinical outcome, changes in both 951 
outcomes should go in the same direction. Therefore, the 99 clinical trials were 952 
assessed for concordance. The results showed that the rates of concordance were 953 
quite low and never >75%. The discordance was usually a result of the nutritional 954 
outcome being stronger than the clinical outcome. Koretz et al. then concluded that 955 
based on their analysis, changes in nutritional markers do not predict clinical 956 
outcomes. More recently, Jeejeebhoy et al. [83] prospectively studied 733 patients 957 
with complete nutritional intervention data to assess which nutrition indicator better 958 
predicts LOS and readmission within 30 days after discharge. After having controlled 959 
for age, sex, and diagnosis, only SGA C and reduced food intake during the first week 960 
of hospitalization resulted as independent predictors of length of stay. SGA C and 961 
hand grip strength but not food intake were independent predictors of 30-d 962 
readmission. This very recent study appears to suggest that nutritional parameters 963 
may serve well as monitoring tools to predict other clinical outcomes.  964 
Question 11. Does meeting more than 75% of energy and/or protein 965 
requirements (as an indicator of compliance) versus a lower 966 
percentage improve outcomes in polymorbid inpatients receiving 967 
nutritional support? 968 
Recommendation 11.1. 969 
In polymorbid medical inpatients with reduced food intake and hampered 970 
nutritional status at least 75% of calculated energy and protein requirements 971 
should be achieved in order to reduce the risk of adverse outcomes.  972 
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Grade of recommendation B - strong consensus (100% agreement) 973 
Recommendation 11.2. 974 
Energy and protein fortified foods can be used in order to reach those relevant 975 
energy and protein targets in polymorbid medical inpatients.  976 
Grade of recommendation 0 - strong consensus (100% agreement) 977 
Commentary: 978 
In polymorbid medical inpatients reduced food intake is more the rule than the 979 
exception [84] and is often an important part of the complex symptomatology that 980 
forces the patient to the hospital. Reduced food intake has several commonly 981 
occurring pathophysiologies including anorexia/reduced appetite, dysphagia or oral 982 
and dental problems. When reduced food intake is chronic or severe over longer and 983 
shorter periods of time, respectively, weight loss and malnutrition ensues. Since 984 
weight loss with malnutrition and reduced food intake are so closely linked it may be 985 
difficult to distinguish which of the syndromes are most detrimental for the patient. 986 
There are numerous studies indicating that reduced food intake is associated with 987 
increased mortality and with complications like infections in medical patients. For 988 
example, reports from the large database of the "NutritionDay" initiative demonstrate 989 
that reduced food intake during the day of food intake assessment is related to 990 
increased in-hospital mortality [85, 86]. Likewise, a study on approximately 1100 991 
recently hospital-admitted patients with mixed diagnoses showed that 16% had a food 992 
intake below 70% of calculated energy requirement [87]. This energy intake was 993 
cross-sectionally associated with an increased risk of infections; adjusted odds ratio 994 
being 2.26 (95%CI 1.24 to 4.11).  995 
In a good quality prospective observational study [88] (Level of evidence 2++), of 996 
close to 500 polymorbid patients admitted either to a medical service or to a surgical 997 
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service with mixed diagnoses, 21% had an average nutrient intake of less than 50% of 998 
calculated energy needs. Only patients with a hospital stay of more than four days 999 
were included in this study. Although baseline characteristics according to 1000 
demography and diseases were quite similar, patients with reduced food intake had a 1001 
higher in-hospital mortality as well as 90-day mortality with relative risks of 8.0 (95%CI 1002 
2.8 to 22.6) and 2.9 (95%CI 1.4 to 6.1), respectively.   1003 
Similar results were observed in a supportive study conducted in the critically ill 1004 
population [89]. Twenty-eight day mortality was registered in a sequential series of 886 1005 
mechanically ventilated critically ill patients with both medical and surgical diagnoses 1006 
where nutrition was provided either by the enteral (73%) or enteral combined with 1007 
parenteral routes (26%). The energy target was guided by indirect calorimetry and 1008 
protein target calculated as 1.2-1.5g/kg body weight/day. The group of the patients 1009 
who received their target for both energy and protein needs had a 28-day mortality that 1010 
was half that of those patients who did not achieve their target.  1011 
Thus, observational cohort studies clearly indicate that achieving goals for energy and 1012 
protein intake during hospital stay is associated with better clinical outcomes. Such 1013 
studies are unable to indicate whether or not the clinical outcome would be improved if 1014 
sufficient nutrition could be provided. Such evidence can only be achieved by RCTs. A 1015 
further question is what the optimal amount of nutrition is, or what is the least dose of 1016 
nutrition needed to achieve potential beneficial effects. It has to be taken into account 1017 
that an acute disease triggers inflammation and several catabolic processes in the 1018 
body, which will hamper the body’s capability to handle energy and protein for growth. 1019 
Therefore, it is sometimes suggested (on expert opinion ground) that 75% of 1020 
calculated needs could be a goal to achieve for energy and protein intake during the 1021 
hospital stay and when the disease is still in an acute catabolic phase.  1022 
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We aimed at finding studies that could answer the question: Does meeting more than 1023 
75% of energy and or protein requirements (as an indicator of compliance) versus a 1024 
lower percentage improve outcomes in polymorbid inpatients receiving nutritional 1025 
support? For this reason, we looked for RCTs in the literature. Unfortunately, no such 1026 
studies were found. However, a Danish RCT [90] tested the hypothesis that protein 1027 
fortification of a novel energy dense menu supplementary to the standard hospital food 1028 
service could increase the food based nutrition intake of energy and protein beyond 1029 
75% of calculated requirements (Level of evidence 1+). The target population was 1030 
newly-admitted polymorbid medical patients classified as at nutritional risk by NRS-1031 
2002. The RCT was well-conducted but too small for providing any evidence on 1032 
clinical outcome measures. Altogether 81 patients fulfilled the study protocol. The 1033 
novel menu consisted of protein fortified small energy dense dishes that could be 1034 
ordered by telephone from the hospital kitchen by the patients from 7h to 22h. This 1035 
intervention significantly improved the energy and protein intakes and also the number 1036 
of patients that reached the protein target (calculated as 18% of energy intake), i.e. 1037 
66% reached the target compared to 30% in the control group. Handgrip strength and 1038 
LOS were also reported but there were no differences to be observed, as expected 1039 
when the study was not powered for such end-points. 1040 
Question 12. Do organizational changes in nutritional support (e.g. 1041 
intervention of a steering committee, implementation of protected 1042 
mealtimes, different budget allocation) versus no changes improve 1043 
outcomes of polymorbid inpatients? 1044 
Recommendation 12.1. 1045 
Organizational changes in nutritional support provision should be implemented 1046 
for polymorbid medical inpatients who are malnourished or at risk of 1047 
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malnutrition. In particular, interventions that ensure the provision of fortified 1048 
menus for at-risk patients, establishing a nutrition support team and the use of 1049 
multi-disciplinary nutrition protocols should be implemented.  1050 
Grade of recommendation B - strong consensus (100% agreement) 1051 
Commentary: 1052 
The organization of nutritional support in hospitals requires a multi-disciplinary 1053 
approach involving finance, catering, nursing and therapy services. Some studies have 1054 
suggested that changes to the organization of nutritional support for in-patients may 1055 
improve outcomes. One cohort study implemented the use of nutritional healthcare 1056 
assistants. Medical patients who were deemed at high risk of malnutrition by the NRS 1057 
2002 were allocated a nutritional healthcare assistant, who was responsible for 1058 
ensuring they received any necessary assistance to eat and drink and prepared 1059 
individual meals for them. This study did not evaluate the impact on nutritional 1060 
outcomes; however, the patient’s perception of their nutritional care  was improved 1061 
and food wastage reduced [91].  Food fortification implemented in a non-randomized 1062 
trial with medical, orthopedic and older inpatients, showed an increase in energy 1063 
intake  of 17.5% (p=0.007) over a 3-day recorded period [92]. Furthermore, collated 1064 
results from three cross-sectional studies reported as one paper have suggested that 1065 
introducing a nutrition screening tool and making changes to catering services may 1066 
lead to a reduced prevalence of DRM across the general hospital population [93]. In 1067 
this study, the investigators devised their own local nutrition screening tool as none 1068 
was used at their organization prior to the intervention. 1069 
Despite these interesting studies in non-polymorbid patients, a systematic review of 1070 
non-randomized studies showed that improvements are not consistently 1071 
demonstrated. Forty-one studies were included in the review considering changes to 1072 
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the organization of nutrition services, feeding environment and meal modification in 1073 
hospital in-patients or those living in residential care.  Due to the variability in reporting 1074 
outcomes, it was not possible to assess the beneficial effects of specific interventions 1075 
[94]. Therefore, it is important to consider the specific impact of organizational 1076 
changes on polymorbid medical inpatients. From the identified literature, three studies 1077 
were found. A single-blinded RCT [90] demonstrated how the use of a protein fortified 1078 
menu was effective in increasing the protein intake of patients. Eighty-four patients 1079 
were randomized to the study with a completion rate of 96%. The intervention group 1080 
was able to choose from a protein enriched menu in addition to the standard hospital 1081 
menu. The control group received the standard hospital menu. Patients were 1082 
monitored for seven days. There was no significant difference in energy intake, length 1083 
of stay or handgrip strength between the groups. However, mean protein intake was 1084 
significantly increased in the IG; with 27/41 compared to 12/40 in the CG meeting ≥ 1085 
75% protein requirements (p=0.001). Protein requirements were set at 18% of total 1086 
energy requirements. Energy requirements were calculated by using the Harris-1087 
Benedict equation to estimate basal metabolic rate, which was then multiplied by a 1088 
stress/activity factor according to Danish guidelines. (Level of Evidence 1+) 1089 
A further, prospective controlled trial [22] involving 298 polymorbid geriatric inpatients, 1090 
demonstrated the use of an early multi-disciplinary intervention protocol. The protocol 1091 
included activities such as nutrition and dysphagia screening, ensuring better patient 1092 
positioning for mealtimes and individualizing time of meals. This was compared to 1093 
standard care in the management of older patients at high risk of protein energy 1094 
malnutrition across two sites. A significant weight gain (average 0.9 kg) was observed 1095 
in the IG whereas a weight loss (average 0.8 kg) was observed in the CG, during 1096 
admission. Mean LOS was approximately 32 days in both groups. In addition, the IG 1097 
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developed fewer hospital acquired infections (33/140 compared to 58/158, p=0.01). 1098 
There was no statistically significant difference in the development of pressure ulcers 1099 
or LOS. (Level of Evidence 2+) 1100 
Finally, a cohort study [95] demonstrated the impact of a nutrition support team on the 1101 
management of patients requiring, or referred for, PN. Though the primary aim was to 1102 
show cost- savings with nutrition support team management of PN, secondary clinical 1103 
outcomes were also measured. Following a nutrition support team-lead, structured 1104 
teaching program for nursing staff the catheter related sepsis rate in PN patients fell 1105 
from 71% pre-NST to 29% in their first year (p=0.05). Additionally, 55 episodes of PN 1106 
(41% of referrals) were avoided by appropriate nutrition support team assessment and 1107 
rapid instigation of enteral feeding. (Level of Evidence 2+) Thus, the evidence shows 1108 
that organizational changes in nutritional support provision can reduce the risk of 1109 
adverse outcomes in polymorbid medical inpatients.   1110 
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4. Discussion  1111 
Although the key areas of nutritional support in polymorbid medical inpatients were 1112 
covered by the development of questions in the PICO format, there were a few clinical 1113 
questions particularly relevant for the polymorbid inpatient population that were also 1114 
developed by the WG but unable to be transformed into the required PICO format. 1115 
These questions are presented below, with proposed statements (which were 1116 
subjected to voting) and supportive text. These statements are informative points of 1117 
the evidence rather than guides for action (i.e. they are not recommendations).  1118 
a) Does underlying disease have an impact on expected outcome 1119 
from nutritional support? 1120 
Statement a.1.  1121 
The severity of acute-phase response may be used by clinicians as part of the 1122 
criteria for selecting patients for nutritional screening, follow-up, and 1123 
intervention.  1124 
Level of evidence 1+ - strong consensus (100% agreement) 1125 
Statement a.2. 1126 
Inadequate nutritional intake is common, and patient factors contributing to 1127 
poor intake should be considered in designing nutritional interventions. Energy 1128 
and protein intake are frequently inadequate to meet requirements in most older 1129 
acute medical inpatients, worsening malnutrition during hospitalization and 1130 
leading to poor outcomes. Poor intake is associated with several common 1131 
patient/environmental characteristics, such as disease severity, symptoms 1132 
compromising intake, anorexia, bedridden, hospital routines, dietary habits and 1133 
possible therapeutic diets adopted at home.  1134 
Level of evidence 4 - strong consensus (100% agreement) 1135 
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Commentary: 1136 
There are two main challenges in answering this question. One is the validity and 1137 
reliability of nutritional assessment in acutely ill aging patients; the other is to 1138 
understand if the relationship between poor nutritional status and acute-phase 1139 
response is causal or an association.  1140 
Gariballa et al. [96] published a study in 2006 investigating the effects of the acute-1141 
phase response on nutritional status and clinical outcome of hospitalized medical 1142 
polymorbid patients. The study was conducted in 445 patients in a double-blind RCT 1143 
of nutritional supplementation and participants had their nutritional status assessed 1144 
from anthropometric, hematologic, and biochemical data at baseline, 6 weeks, and 6 1145 
months. Outcome measures including disability, length of stay, and 1-year mortality 1146 
were recorded. C-reactive protein concentration, a marker of acute-phase response, 1147 
was also measured. Multivariate analysis was used to measure the association 1148 
between acute-phase response and nutritional assessment variables after adjusting 1149 
for age, disability, chronic illness, medications, and smoking. This study concluded that 1150 
the acute-phase response is associated with poor nutritional status and poor clinical 1151 
outcome in older patients. Yet, there was still an unanswered question which was 1152 
whether nutritional support removes or mitigates the hazard of poor outcome 1153 
associated with the acute-phase response. Confirmation of the relationship between 1154 
underlying disease and expected outcome from nutritional support will need larger 1155 
interventional studies to determine the optimal timing and composition of nutritional 1156 
therapy relative to a patient’s metabolic state. 1157 
In another paper, Mudge et al. [97] conducted a prospective study of patient factors 1158 
associated with inadequate nutritional intake in older medical polymorbid inpatients, 1159 
including 134 medical inpatients ≥65 years old. Primary outcome was energy intake 1160 
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less than resting energy expenditure. Explanatory variables included age, gender, 1161 
number of comorbidities, number of medications, diagnosis, usual residence, 1162 
nutritional status, functional and cognitive impairment, depressive symptoms, poor 1163 
appetite, poor dentition, and dysphagia.  1164 
b) How long should nutritional support be given in order to have an 1165 
impact on the clinical course in a polymorbid inpatient? 1166 
Statement b. 1167 
Although there is evidence to recommend the continued nutritional support 1168 
post-hospital discharge on polymorbid medical inpatients who are 1169 
malnourished or at risk of malnutrition, the ideal duration of the intervention has 1170 
not yet been determined.  1171 
Level of evidence 4 - strong consensus (95% agreement)  1172 
Commentary: 1173 
The ideal duration of post discharge nutritional intervention has not yet been 1174 
determined but, in all likelihood, varies according to patients’ age, underlying disease, 1175 
initial nutritional status, type of nutritional support and endpoint of interest. In most 1176 
RCTs on intervention with ONS, the sip feeds were given for three months [28, 77-81], 1177 
whereas individualized nutritional support (which might include ONS where necessary) 1178 
was usually carried out for longer periods (e.g. 4 months in the study by Persson et al. 1179 
[76], or 6 months in the studies of Feldblum et al. [73] or Casals et al. [75]). Neelemaat 1180 
et al. argue that while they were able to show an effect on functional limitations in their 1181 
older intervention patients after three months, the length of nutritional support might 1182 
not have been sufficient to show an effect on QoL [79]. Milne et al. also conclude in 1183 
their systematic review on supplementation that the duration of treatment is frequently 1184 
too short to expect any improvement in QoL or physical activities in older adults [98]. 1185 
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c) Are there risks of polypharmacy and drug-nutrient interaction in 1186 
polymorbid inpatients? 1187 
Statement c. 1188 
In polymorbid medical inpatients there is an important possibility of drug-drug 1189 
or drug-nutrient interactions that needs to be taken into account, by 1190 
establishing a pharmacist-assisted management plan for any interactions.  1191 
Level of evidence 3 - consensus (90% agreement) 1192 
Commentary:  1193 
Polymorbid inpatients will often require the prescription of multiple medicines in order 1194 
to manage their comorbidities. Whilst the use of multiple medicines is often essential, it 1195 
can present a number of risks that include potential ‘drug-drug’ and/or ‘drug-nutrient’ 1196 
interactions. Indeed, as the number of medicines required increases so does the risk 1197 
of these interactions. Doses of medicines may need to be adjusted or other changes to 1198 
the clinical management and monitoring of patients may be necessary, with examples 1199 
including patients with co-morbidities in addition to human immunodeficiency virus 1200 
infection [99, 100] or psoriasis [101]. It is, however, important that care is taken to not 1201 
only consider interactions that may be more familiar. For example, many healthcare 1202 
professionals are familiar with the physical binding of drugs such as tetracyclines to 1203 
the divalent and trivalent cations found in milk or antacid preparations [102] or in many 1204 
of the ONS and enteral formulas, which limits absorption from the gastrointestinal 1205 
tract. Fewer are likely to be familiar with the potential for physical binding of 1206 
ceftriaxone to calcium salts when each is given intravenously [103]. It is also important 1207 
that care is taken to not only account for dietary intake but also oral fluid intake when 1208 
considering potential drug-nutrient interactions. This is because whilst drugs such as 1209 
simvastatin have no specific requirement to be taken with or without food it has the 1210 
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potential to be toxic when taken concurrently with grapefruit juice [104]. Advice on the 1211 
complexities of all of these potential interactions in polymorbid inpatients may be 1212 
obtained from a pharmacist or a pharmacologist. We suggest that a review of 1213 
medication is undertaken to identify unnecessary medications or medications that 1214 
have side-effects which may compromise nutritional intake. 1215 
In summary, while some of the recommendations for screening, assessment and 1216 
provision of nutritional support in polymorbid medical inpatients may not differ 1217 
significantly from those recommendations applicable to single-disease patients, we 1218 
have identified certain aspects of these patients' care that require particular attention, 1219 
such as the identification of drug-drug or drug-nutrient interactions and the importance 1220 
of continuing nutritional support after hospital discharge. 1221 
One of the strengths of this study was the conduct of the literature searches for all the 1222 
clinical questions by a single author, which allowed the use of a systematic 1223 
methodology to identify potentially relevant publications. This is particularly important 1224 
for the present guidelines because, when compared to disease-specific guidelines, the 1225 
methodology used for the identification of potentially relevant studies was more 1226 
complex, as many of the published studies did not report data on the presence of 1227 
multiple comorbidities or did not use typical key terms for this purpose. Additionally, 1228 
there are no MeSH terms dedicated to multiple chronic conditions [1]. Consequently, 1229 
we have not used search terms to define polymorbidity during the literature searches; 1230 
instead we used different strategies to identify studies conducted in polymorbid 1231 
populations, including the contact of authors to obtain further information on the 1232 
presence of multiple comorbidities. In this context, we would encourage all authors of 1233 
future trials to report data on polymorbidity. 1234 
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Furthermore, due to the complex nature of the needs of polymorbid medical inpatients, 1235 
we would encourage access to dietetic expertise to assess, manage and monitor 1236 
nutritional status and nutritional intervention, whenever possible. Community-based 1237 
approaches are also encouraged for the non-hospitalized polymorbid patients at 1238 
nutritional risk, allowing for prevention (of the deterioration of their nutritional status) 1239 
and an early intervention.   1240 
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5. Conclusions 1241 
Despite the methodological difficulties in creating non-disease specific guidelines, we 1242 
managed to review the evidence behind several important aspects of nutritional 1243 
support for polymorbid medical inpatients. This resulted in the development of 22 1244 
practical recommendations and four statements intended to guide clinicians working 1245 
with this patient population. This work also allowed gaps in the literature (areas with 1246 
little or no evidence) to be identified which require further research. 1247 
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Appendix 1  - Supplementary data: example of a search strategy 1563 
 1564 
Search strategy used for question 2 in the Cochrane Library, on the 22nd April 2016 1565 
 1566 
#1 "oral nutrition* supplement*":ti,ab,kw  (Word variations have been searched) 1567 
#2 "oral nutrition* support"  1568 
#3 energy near protein supplementation  1569 
#4 "protein supplement*"  1570 
#5 "energy supplement*"  1571 
#6 "nutritional counseling"  1572 
#7 "dietary advice"  1573 
#8 "food fortification"  1574 
#9 "food enrichment"  1575 
#10 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9  1576 
#11 MeSH descriptor: [Hospitals] 1 tree(s) exploded 1577 
#12 hospital*:ti,ab,kw  (Word variations have been searched) 1578 
#13 "ward":ti,ab,kw  (Word variations have been searched) 1579 
#14 in?patient*:ti,ab,kw  (Word variations have been searched) 1580 
#15 #11 or #12 or #13 or #14  1581 
#16 #10 and #15  1582 
#17 MeSH descriptor: [Letter] explode all trees 1583 
#18 MeSH descriptor: [Editorial] explode all trees 1584 
#19 MeSH descriptor: [Case Reports] explode all trees 1585 
#20 MeSH descriptor: [Animals] explode all trees 1586 
#21 MeSH descriptor: [Child] explode all trees 1587 
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#22 MeSH descriptor: [Pediatrics] explode all trees 1588 
#23 MeSH descriptor: [Pregnant Women] explode all trees 1589 
#24 MeSH descriptor: [Outpatients] 1 tree(s) exploded 1590 
#25 MeSH descriptor: [Ambulatory Care] explode all trees 1591 
#26 MeSH descriptor: [Terminal Care] 2 tree(s) exploded 1592 
#27 MeSH descriptor: [Palliative Care] 2 tree(s) exploded 1593 
#28 letter or editorial or "case report" or "case study" or animal or rodent* or child* or 1594 
infant or infancy or p?diatric* or pregnant or ambulatory or outpatient* or "nursing 1595 
home*" or "long term care" or palliative or "end of life" or "terminal care" or animal* or 1596 
rodent*  1597 
#29 #17 or #18 or #19 #20 #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28  1598 
#30 #16 not #29 1599 
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Appendix 2 - Supplementary data: evidence table 1600 
 1601 
Clinical question 1. Does nutritional support based on screening and/or assessment versus no screening and/or assessment improve outcomes in 1602 
polymorbid inpatients? 1603 
Recommendation 1.1: 1604 
In polymorbid medical inpatients, a quick and simple nutritional screening method using a validated tool should be applied to identify malnutrition 1605 
risk. In patients at risk, a more detailed assessment should be performed and a treatment plan should be developed to detect nutritional 1606 
impairment, to consent an early adequate nutritional therapy and to define quality outcome measures of success. 1607 
Grade of recommendation B – strong consensus (100% agreement) 1608 
1. Rypkema G, Adang E, Dicke H, Naber T, De Swart B, Disselhorst L, Goluke-Willemse G, Rikkert MO. Cost-effectiveness of an interdisciplinary 
intervention in geriatric inpatients to prevent malnutrition. Journal of Nutrition Health and Aging. 2004; 2: 122-127. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
prospective, 
controlled study 
2+ 
Countries: Netherlands 
Centers: The inpatient 
geriatric service of a 
university hospital (UMC 
Nijmegen) and a geriatric 
ward of a non-academic 
teaching hospital (Rijnstate 
Hospital, Arnhem) 
Setting:  
Funding Sources: research 
grant from the joint society of 
Dutch Universities (VAZ) and 
partly by Nutricia‚ Inc. 
Dropout rates: 
Study limitations: Missing 
data might have been caused 
by selection bias, intervention 
and control group were 
located in two 
separate geriatric units in two 
Total no. patients: n = 298 
Inclusion criteria: All patients admitted to the geriatrics units (aged 
over 60 years) during a 10 month period in the year 2001 who were 
non-terminally ill and admitted for more than two days were eligible 
for inclusion 
Exclusion criteria: Patients admitted for over 150 days (and 
waiting for institutional care) were excluded from the study. 
In order to reduce protein-energy 
malnutrition in older people during 
hospitalization, an early 
interdisciplinary intervention is 
needed. We developed a protocol 
which includes screening for 
malnutrition, dysphagia and 
dehydration on admission, followed 
by immediate interventions. One of 
the geriatric wards applied the 
protocol (N=140) while the other 
provided standard care (N=158). 
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different hospitals 
Notes Author’s Conclusion: An early interdisciplinary intervention approach can be effective in reducing protein-energy malnutrition and related 
hospital-acquired infections and appears to be economically feasible. 
Outcome 
measures/results 
primary outcome measure: Weight, 
Body Mass Index (BMI), Barthel Index, 
MNA-sf, date of birth and sex, Nosocomial 
infections, pressure score, length of stay, 
edema, heart failure 
There was a 0.8 kg loss (SEM 0.3 kg) in average weight in the standard care group and a 0.9 
kg gain (SEM 0.2 kg) in the intervention group (p<0.001). The number of hospital acquired 
infections was significantly lower in the intervention group (33/140 versus 58/158, p=0.01) but 
no significant difference in number of patients with pressure sores (23/140 versus 33/158) was 
found. Costs were not significantly different: 7516 versus 7908 Euro/patient for intervention 
versus controls, respectively 
Evidence of 
polymorbidity 
Agreement within working group, following attempt to contact author 
 1609 
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2. Jie B, Jiang Z, Nolan MT, Efron DT, Zhu S, Yu K, Kondrup J. Impact of nutritional support on clinical outcome in patients at nutritional risk: a 
multicenter, prospective cohort study in Baltimore and Beijing teaching hospitals. Nutrition. 2010; 11: 1088-1093. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
prospective cohort 
study  
2+ 
Countries: China, United 
States 
Centers: three departments 
in Johns Hopkins Hospital in 
Baltimore, two teaching 
hospitals in Beijing 
Setting: 
Funding Sources: CSPEN, 
CMB and a grant from Wu JP 
Medical Research 
Foundation 
Dropout rates: appr. 5 % 
Study limitations: 
Total no. patients: n = 1831 
Inclusion criteria: medical patients with gastrointestinal disease or 
respiratory disease and surgical patients undergoing intra-
abdominal surgery 
1) age 18–80 y;  
2) well oriented to time and place;  
3) speaking/understanding English in the United States/Chinese in 
China 
4) providing a written informed consent form; and 5) a hospital LOS 
of at least 4 d. 
Exclusion criteria: not specified 
To evaluate the impact of nutritional 
support (PN and EN) on clinical 
outcomes in patients at nutritional 
risk defined by the Nutritional Risk 
Screening 2002. 
Notes Author’s Conclusion: The preliminary results suggest that nutritional support (especially EN) is beneficial to patients nutritionally at risk as 
it is related to a lower complication rate, especially in those with obviously reduced oral intake. In contrast, nutritional support is not beneficial 
to the patients at no nutritional risk as defined by the NRS-2002. 
Outcome 
measures/results 
primary outcome measure: nutritional 
status and disease severity, nutritional 
parameters, application of PN and EN, 
surgery, medication, complications and 
LOS 
The overall complication rate was significantly lower in the nutritional-support group than in the 
no-support group, mainly because of the lower rate of infectious complications. 
Evidence of 
polymorbidity 
Agreement within working group, following attempt to contact author 
 1610 
 1611 
 1612 
 1613 
 1614 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
70 
 
Clinical question 2. In polymorbid inpatients whose nutritional requirements can be met orally, does the use of oral nutritional supplements (ONS), 1615 
with or without nutritional counseling, versus no ONS, improve outcomes? 1616 
Recommendation 2.1: 1617 
In malnourished polymorbid medical inpatients or those at high risk of malnutrition who can safely reach their nutritional requirements orally, ONS 1618 
high in energy and protein shall be considered to improve their nutritional status and quality of life.  1619 
Grade of recommendation A – strong consensus (95% agreement) 1620 
Recommendation 2.2: 1621 
In malnourished polymorbid medical inpatients or those at high risk of malnutrition, nutrient-specific ONS should be administered, when they may 1622 
maintain muscle mass, reduce mortality or improve quality of life. 1623 
Grade of recommendation B – consensus (89% agreement) 1624 
Recommendation 2.3:  1625 
In polymorbid medical inpatients who are malnourished or at high risk of malnutrition and can safely reach their nutritional requirements orally, 1626 
ONS should be considered as a cost-effective way of intervention towards improved outcomes. 1627 
Grade of recommendation B – strong consensus (95% agreement) 1628 
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3. Hegerová P, Dědková Z, Sobotka L. Early nutritional support and physiotherapy improved long-term self-sufficiency in acutely ill older patients. 
Nutrition. 2015; 1: 166-170. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
prospective, 
randomized 
controlled study 
1++ 
Countries: Czech Republic 
Centers: 
Setting: Third Internal 
Department of Metabolic Care 
and Gerontology, Faculty 
Hospital in Hradec Králové 
Funding Sources: research 
grant PRVOUK P 37-12 
Dropout rates: no dropout 
Study limitations: 
Total no. patients: n = 200 
Inclusion criteria: age >78 y, admission to the hospital as a 
result of acute illness, self-sufficiency of the patient before 
admission based on a Barthel Index (BI) score >60, and 
patient’s consent to participate in the Study 
Exclusion criteria:  terminal stage of disease, terminal 
organ failure, hospitalization in the previous 3 mo. or more 
than two hospitalizations in the previous 6 months, indication 
for immediate nutritional support (recent weight loss, reduced 
food intake of <50% of the normal amount for more than 2 d 
before admission, and body mass index [BMI] <18.5 kg/m2), 
low self-sufficiency before the acute disease (BI ≤ 60), 
advanced stage of dementia associated with loss of 
independence, and refusal to participate in the study 
The aim of this study was to determine 
whether an active approach based on 
early nutritional therapy and exercise 
would influence the development of 
sarcopenia and impaired self-sufficiency 
during acute illness. The patients were 
randomized to a control group receiving 
standard treatment (n = 100) or to an 
intervention group (n = 100). The 
intervention consisted of nutritional 
supplements (600 kcal, 20 g/d protein) 
added to a standard diet and a 
simultaneous intensive rehabilitation 
program. The tolerance of supplements 
and their influence on spontaneous food 
intake, self-sufficiency, muscle strength, 
and body composition were evaluated 
during the study period. The patients 
were then regularly monitored for 1 y 
post discharge. 
Notes Author’s Conclusion: The early nutritional intervention together with early rehabilitation preserves muscle mass and independence in ill 
older patients hospitalized because of acute disease. 
Outcome 
measures/results 
primary outcome measure: Age, sex, 
diagnosis, number of hospitalization days, 
anthropometry, Body composition (lean 
tissue mass and adipose tissue), Self-
sufficiency, Nutritional risk screening 
(NRS) 
The provision of nutritional supplements together with early rehabilitation led to increased total 
energy and protein intake while the intake of standard hospital food was not reduced. The loss 
of lean body mass and a decrease in self-sufficiency were apparent at discharge from the 
hospital and 3 mo. thereafter in the control group. Nutritional supplementation and the 
rehabilitation program in the study group prevented these alterations. A positive effect of 
nutritional intervention and exercise during the hospital stay was apparent at 6 mo. post-
discharge. 
Evidence of 
polymorbidity 
Confirmed by author 
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4. Gariballa S, Forster S. Dietary Supplementation and Quality of Life of Older Patients: A Randomized, Double‐Blind, Placebo‐Controlled Trial. J Am 
Geriatr Soc. 2007; 12:2030-2034. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled Trial  
1++ 
Countries: United Kingdom 
Centers: 
Setting:  
Funding Sources: Health 
Foundation project grant 
Dropout rates: no dropouts  
Study limitations: improvement 
in quality-of-life scores as a 
result of nutritional support could 
be a chance finding; inclusion 
criteria and baseline 
characteristics suggest that the 
study population represented a 
better-nourished group of 
patients than those who were 
excluded because of severe 
illness or dementia 
Total no. patients: n = 225 
Inclusion criteria:  aged 65 and older, in stable medical 
condition, and able to swallow and sign an informed written 
consent form 
Exclusion criteria: patients with severe medical or 
psychiatric illness, dementia, or malignancy and those living 
in an institution or already taking supplements 
Normal hospital diet plus 400-mL oral 
nutritional supplements daily for 6 
weeks. The composition of the 
supplement was such as to provide 995 
kcal for energy and 100% of the 
Reference Nutrient Intakes for a healthy 
older person for vitamins and minerals. 
Notes Author’s Conclusion: Oral nutritional supplementation of acutely ill hospitalized older patients led to a statistically significant benefit in 
quality of life. 
Outcome 
measures/results 
outcome measure: Baseline, 6-week, 
and 6-month nutritional status and quality 
of life. 
Randomization to the supplement group led to significantly better quality-of-life scores than in 
the placebo group at 6 months but not at 6 weeks, after adjustment for baseline quality of life, 
age, and sex. The effect of supplementation was seen in higher physical function, role physical, 
and social function scores. Corresponding treatment effects were 7.0 (95% confidence interval 
(CI) 50.5–13.6, P5.04), 10.2 (95% CI50.1–20.2, P5.047), and 7.8 (95% CI50.0 – 15.5, P5.05), 
respectively. There was no evidence of difference in Barthel scores at 6 months. 
Evidence of 
polymorbidity 
Mean number of chronic diseases and drugs: 1.7 and 3.5 in the control group, respectively; 1.9 and 3.5 in the intervention group, 
respectively. 
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5. Gariballa S, Forster S. Effects of dietary supplements on depressive symptoms in older patients: a randomised double-blind placebo-controlled trial. 
Clinical Nutrition. 2007; 5: 545-551. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled Trial  
1++ 
Countries: United Arab Emirate, 
United Kingdom 
Centers: 
Setting: 
Funding Sources: The Health 
Foundation project grant 
Dropout rates: 
Study limitations: the decrease 
in depressive symptoms as a 
result of nutritional support could 
be a chance finding; follow-up 
assessments on depression, 
cognitive function and nutritional 
were only carried out on a sub-
sample (51%) of study patients; 
inclusion criteria and baseline 
characteristics suggest that our 
study population represents a 
better-nourished group of 
patients 
Total no. patients: n = 225 
Inclusion criteria: age ≥ 65 years; stable medical condition; 
able to swallow and able to sign an informed written consent 
form 
Exclusion criteria: patients with severe medical or 
psychiatric illness, dementia (abbreviated mental test < 6), 
malignancy, living in institution and patients already on 
supplements 
We randomly assigned 225 hospitalized 
acutely ill older patients to receive either 
normal hospital diet plus 400 mL oral 
nutritional supplements (106 subjects) or 
normal hospital diet plus a placebo (119 
subjects) daily for 6 weeks. The 
composition of the supplement was such 
as to provide 995 kcal for energy and 
100% of the Reference Nutrient Intakes 
for a healthy old person for vitamins and 
minerals. 
Notes Author’s Conclusion: Oral nutritional supplementation of hospitalized acutely ill older patients led to a statistically significant benefit on 
depressive symptoms. 
Outcome 
measures/results 
outcome measure: 6 weeks and 6 months 
changes in nutritional status, depressive 
symptoms and cognitive state. 
Randomization to the supplement group led to a significant increase in red-cell folate and 
plasma vitamin B12 concentrations, in contrast to a decrease seen in the placebo group. There 
were significant differences in symptoms of depression scores in the supplement group 
compared with the placebo group at 6 months (p = 0.021 for between groups difference). The 
effect of supplement was seen in all patient groups including those with no symptoms of 
depression, mild depression and those with severe depression (p = 0.007). There was no 
evidence of a difference in cognitive function scores at 6 months. 
Evidence of 
polymorbidity 
Mean number of chronic diseases and drugs: 1.7 and 3.5  in the control group, respectively;  1.9 and 3.5 in the intervention group, 
respectively 
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6. Gariballa S, Forster S, Walters S, Powers H. A randomized, double-blind, placebo-controlled trial of nutritional supplementation during acute illness. 
Am J Med. 2006; 8: 693-699. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial  
1++ 
Countries: United Arab 
Emirate 
Centers: 
Setting: 
Funding Sources: 
Dropout rates: no dropouts 
Study limitations: Our 
inclusion criteria and baseline 
characteristics suggest that 
our study population 
represent a better-nourished 
group of patients. 
Total no. patients: n = 445 
Inclusion criteria: age 65 years or more, able to swallow, and 
able to sign an informed written consent form 
Exclusion criteria: patients who had undergone gastric surgery, 
with diagnosed malabsorption or morbid obesity (BMI > 40), in a 
coma, with diagnosed severe dementia (abbreviated mental test 
< 6) and malignancy, living in an institution, and already taking 
supplements 
We randomly assigned 445 hospitalized 
patients aged 65 to 92 years to receive 
either a normal hospital diet plus 400 mL 
oral nutritional supplements (223 
subjects) or a normal hospital diet plus a 
placebo (222 subjects) daily for 6 
weeks. The composition of the 
supplement was such as to provide 995 
kcal of energy and 100% of the 
Reference Nutrient Intakes for vitamins 
and minerals for a healthy older person. 
Notes Author’s Conclusion: Oral nutritional supplementation of acutely ill patients improved nutritional status and led to a statistically significant 
reduction in the number of non-elective readmissions. 
Outcome 
measures/results 
outcome measure: 6 months of disability 
(Barthel score), non-elective readmission 
and length of stay in hospital, discharge 
destination (own home or institution), 
morbidity (infective complications), and 
mortality, nutritional status, 
Randomization to the supplement group led to a significant improvement in nutritional status. 
Over 6 months, 65 patients (29%) in the supplements group were readmitted to the hospital 
compared with 89 patients (40%) in the placebo group (adjusted hazard ratio 0.68 [95% 
confidence interval 0.49-0.94]). The mean length of hospital stay was 9.4 days in the 
supplements group compared with 10.1 days in the placebo group. Thirty-two people (14%) 
died in the supplement group compared with 19 people (9%) in the placebo group at 6 months. 
Evidence of 
polymorbidity 
Mean number of chronic diseases and drugs: 1.7 and 3.5 in the control group, respectively;  1.9 and 3.5 the intervention group, 
respectively 
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7. Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, Schiff ER, Mcclain CJ, Marsano LS, Allen JI. Protein energy 
malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. J Parenter Enteral Nutr. 1995; 4: 258-265. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
intervention study 
2+ 
Countries: 
Centers: eight Department of 
Veterans Affairs (DVA) 
Medical 
Centers. 
Setting: 
Funding Sources: 
Cooperative Studies Program 
of the Department of Veterans 
Affairs Medical Research 
Service. 
Dropout rates: no dropout 
Study limitations: 
Total no. patients: n = 271 
Inclusion criteria: Male patients with a clinical diagnosis of 
alcoholic hepatitis (AH), histologic confirmation of the etiology of 
the liver disease was not an absolute requirement so that 
severely ill patients with coagulopathy could be enrolled. 
Exclusion criteria: not mentioned 
Protein energy malnutrition (PEM) was 
evaluated and expressed as percent of 
low normal in 271 patients initially, at 1 
month and at 3 months. Active therapy 
consisted of anabolic steroid 
oxandrolone (OX) plus a high caloric 
food supplement vs a matching placebo 
and a low calorie supplement. 
Notes Author’s Conclusion: Deterioration in nutritional parameters is a significant risk factor for survival in severe patients with alcoholic hepatitis. 
This deterioration is reversible with standard hospital care. Active therapy further improves creatinine height index, mid arm muscle area and 
total lymphocyte counts. Hence, these later parameters appear to be the best indicators for follow-up assessments. 
Outcome 
measures/results 
outcome measure: Nutritional status, grip 
strength, immune status 
Most of the parameters improved significantly from baseline on standard care; the largest 
improvement seen in visceral proteins, the smallest in fat stores (skinfold thickness). Total PEM 
score significantly correlated with 6 month mortality (p=0.0012). Using logistic regression 
analysis, creatinine height index, hand grip strength and total peripheral blood lymphocytes 
were the best risk factors for survival. When CD lymphocyte subsets replaced total lymphocyte 
counts in the equation, CD8 levels became a significant risk factor (p=.004). Active treatment 
produced significant improvements in those parameters related to total body and muscle mass 
(i.e., mid arm muscle area, p=0.02; creatinine height index, p=0.03; percent ideal body weight, 
p=0.04). 
Evidence of 
polymorbidity 
> 2 co-occurring chronic diseases in > 50% of the study population 
 1629 
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8. Starke J, Schneider H, Alteheld B, Stehle P, Meier R. Short-term individual nutritional care as part of routine clinical setting improves outcome and 
quality of life in malnourished medical patients. Clinical nutrition. 2011; 2: 194-201. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled 
intervention study 
1++ 
Countries: Germany and 
Switzerland  
Centers: 
Setting: 
Funding Sources: grants for 
clinical studies and education from 
Nestlé and from the Exchange 
Organisation StudEx/Switzerland 
and the German Acadamic 
Exchange Service 
(DAAD)/Germany 
Dropout rates: 50.5 % 
Study limitations: connected to 
study design: Preferred outcome 
parameters are often influenced by 
other factors than nutrition alone; 
our study was not powered to 
statistically confirm a causal 
relation to nutrition intervention 
Total no. patients: n = 271 
Inclusion criteria:  Patients with a nutritional risk (NRS 
score ≥ 3) 
Exclusion criteria: no informed consent, terminal 
condition, expected stay <5 days (judged by physician), 
previous participation in this study, patient on starvation, on 
parenteral nutrition, and/or being on dialysis 
132 risk patients defined by Nutritional 
Risk Screening 2002, were randomized 
to individualized nutrition support 
(intervention group [n = 66]) or standard 
hospital care (control group [n = 66]). 
The present study aimed at developing 
and evaluating a routinely manageable 
concept for an improved nutritional care 
of malnourished in-hospital patients. 
Notes Author’s Conclusion: Malnourished patients profit from nutrition support regarding nutrition status and quality of life. They have fewer 
complications, need fewer antibiotics and are less often re-hospitalized. 
Outcome 
measures/results 
primary outcome measure: average daily 
energy and protein intake 
secondary outcome measure:  Body weight, 
plasma vitamin levels, quality of life, 
complications, antibiotic therapies, 
readmissions and mortality, number of 
complications, length of hospital stay, 
compliance with oral nutrition standard 
supplement consumption  
Nutrition interventions led to higher intakes (mean [standard deviation]) in energy (1553 
[341] kcal vs. 1115 [381] kcal, p < 0.001) and protein (65.4 [16.4] g vs. 43.9 [17.2] g, p < 
0.001). Intervention patients (n = 66) kept their body weight in comparison to control 
patients (n = 66; 0.0 [2.9] kg vs. -1.4 [3.2] kg, p = 0.008). Positive effects on plasma 
ascorbic acid level (46.7 [26.7] mmol/l vs. 34.1 [24.2] mmol/l, p = 0.010), SF-36 function 
summary scale (37 [11] % vs. 32 [9] %, p = 0.030), number of complications (4/66 vs. 
13/66, p = 0.035), antibiotic therapies (1/66 vs. 8/66, p ¼ 0.033) and readmissions (17/64 
vs. 28/61, p = 0.027) were recorded. 
Evidence of 
polymorbidity 
Mean number of drugs: 7 in the control group, 6 the intervention group 
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9. Volkert D, Hübsch S, Oster P, Schlierf G. Nutritional support and functional status in undernourished geriatric patients during hospitalization and 6-
month follow-up. Aging Clinical and Experimental Research. 1996; 6: 386-395. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled 
prospective 
intervention study 
2+ 
Countries: Germany 
Centers: Geriatrisches 
Zentrum Bethanien am 
Klinikum der Universität 
Heidelberg 
Setting: 
Funding Sources: grants 
from the Bundesministerium 
für Gesundheit, Bonn and 
from Fa. B. Braun, 
Melsungen, Germany 
Dropout rates: 33.1 % 
Study limitations: The 
accepted amount of oral liquid 
supplements may be a limiting 
factor: Only one patient 
eventually accepted the total 
amount of 400 ml daily at 
hospital, and only half of the 
patients accepted 
supplements at home in the 
total amount. 
Total no. patients: n = 72 
Inclusion criteria: female sex; age 75 years or older; 
undernourished by clinical judgment of the examining physician; 
no malignant disease; no need of tube-feeding or parenteral 
nutrition; expected hospital stay at least 3 weeks, and presumed 
actual life-expectancy of more than 6 months. 
Exclusion criteria: not mentioned 
The objective was to evaluate the effect 
of nutritional supplementation on 
functional status and need of care in 
undernourished geriatric patients during 
hospitalization, and up to 6 months after 
discharge. Participants consisted of 46 
undernourished geriatric patients from a 
geriatric acute care hospital aged 75 
years or older without malignant 
disease, or need for tube feeding or 
parenteral nutrition. Patients in the 
supplement group (SG, N=20) were 
offered 400 mL (2100 kJ) daily of a 
liquid supplement during hospital stay 
and 200 mL (1050 kJ) per day for the 
following 6 months at home. Patients in 
the control group (CG, N=26) had usual 
care without supplements. 
Notes Author’s Conclusion: A positive functional course was evident in supplemented patients with good acceptance during hospitalization, and 
further improvement was observed during the following 6 months at home. Nutritional support may contribute to reconvalescence and 
recovery of undernourished geriatric patients. 
Outcome 
measures/results 
primary outcome measure:  functional 
status based on the Barthel Activities of 
Daily Living score (ADL) at hospital 
admission, discharge and after 6 months 
secondary outcome measure: height, 
weight, BMI 
In supplemented patients with good acceptance (SG+, N=11), a median improvement of 20 
points was observed between admission and discharge, and a further improvement of 5 points 
at home. Median changes were 0 and -10 points in supplemented patients with poor 
acceptance (SG-, N=9) and 5 and 2.5 points in CG, respectively. In SG+, the proportion of 
independent patients (>65 points) increased continuously from 36% at admission to 63% at 
discharge, to 72% after 6 months, and was significantly higher compared to CG at discharge 
(63% vs 19%, p<0.05) and after 6 months (72% vs 39%, p<0.05). 64% of the patients in SG+ 
improved during hospitalization, compared to 23% in CG (p<0.05). In the six months at home, 
18% of SG+ improved; none of SG+ deteriorated in hospital or at home. In contrast, 
deterioration of the ADL score occurred in considerable proportions of SG- (22% in hospital, 
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22% at home) and CG (4% at hospital, 12% at home) patients. The proportion of patients who 
improved was smaller in SG- (44% at hospital, 22% at home) as well as in CG (23% at 
hospital, 35% at home), compared to SG+. 
Evidence of 
polymorbidity 
Reported in the paper: "All patients suffered from multiple diseases (...). The mean number of prescribed drugs was 2.4". 
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10. Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR, NOURISH Study Group. Readmission 
and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clinical 
Nutrition. 2016;1:18-26. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
Multicenter, 
randomized, 
placebo-
controlled, double-
blind trial 
1++ 
Countries: USA 
Centers: 
Setting: 
Funding Sources: Abbott 
Nutrition 
Dropout rates: 4.9 % 
Study limitations: Limited 
generalizability; patients 
represent a selected 
hospitalized population. 
Total no. patients: n = 652 
Inclusion criteria: aged ≥ 65 years with a recent hospital 
admission (within 72 h) with a primary diagnosis of congestive 
heart failure, acute myocardial infarction, pneumonia, or chronic 
obstructive pulmonary disease. Patients were required to have a 
Subjective Global Assessment (SGA) class of B (moderate or 
suspected malnutrition) or C (severe malnutrition) 
Exclusion criteria: diabetes mellitus (type 1 or 2) due to product 
composition not intended for patients with diabetes mellitus; 
current active or treated cancer, and impaired renal or liver 
function 
Evaluation of a high-protein oral 
nutritional supplement (HP-HMB) 
containing beta-hydroxybeta- 
methylbutyrate on post discharge 
outcomes of non-elective readmission 
and mortality in malnourished, 
hospitalized older adults. Standard-of-
care plus HP-HMB (n = 328) or a 
placebo supplement (n = 324), 2 
servings/day. 
Notes Author’s Conclusion: Although no effects were observed for the primary composite endpoint, compared with placebo HP-HMB decreased 
mortality and improved indices of nutritional status during the 90-day observation period. 
 
Outcome 
measures/results 
primary outcome measure:  90-day post 
discharge incidence of death or non-
elective readmission 
secondary outcome measure:   30- and 
60-day post discharge incidence of death 
or readmission, length of stay (LOS), SGA 
class, body weight, and activities of daily 
living (ADL) 
The primary composite endpoint was similar between HP-HMB (26.8%) and placebo (31.1%). 
No between-group differences were observed for 90-day readmission rate, but 90-day mortality 
was significantly lower with HP-HMB relative to placebo (4.8% vs. 9.7%; relative risk 0.49, 95% 
confidence interval [CI], 0.27 to 0.90; p = 0.018). The number-needed-to-treat to prevent 1 
death was 20.3 (95% CI: 10.9, 121.4). Compared with placebo, HP-HMB resulted in improved 
odds of better nutritional status (SGA class, OR, 2.04, 95% CI: 1.28, 3.25, p = 0.009) at day 90, 
and an increase in body weight at day 30 (p = 0.035). LOS and ADL were similar between 
treatments. 
Evidence of 
polymorbidity 
Mean Charlson comorbidity index: 2.05 in the control group, 2.12 in the intervention group. 
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11. Philipson TJ, Snider JT, Lakdawalla DN, Stryckman B, Goldman DP. Impact of oral nutritional supplementation on hospital outcomes. Am J Manag 
Care. 2013; 2: 121-128. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
Eleven-year 
retrospective 
study 
2++ 
Countries: USA 
Centers: 
Setting: 
Funding Sources: Abbott 
Nutrition 
Dropout rates: 
Study limitations: lack of 
detailed patient health 
information 
Total no. patients: n = 44.0 million 
Inclusion criteria:  adults 18 years or older 
Exclusion criteria: terminal episodes and all episodes involving 
tube feeding, leaving only oral feeding for examination 
To assess the effect of inpatient oral 
nutritional supplement (ONS) use on 
length of stay, episode cost, and 30-day 
readmission probability. Analyses were 
conducted using the Premier 
Perspectives Database, which contained 
information on 44.0 million adult 
inpatient episodes. 
Notes Author’s Conclusion: Use of ONS decreases length of stay, episode cost, and 30-day readmission risk in the inpatient population. 
Outcome 
measures/results 
primary outcome measure:  LOS, 
episode cost, and probability of 30-day 
readmission 
Within the database, 1.6% of 44.0 million adult inpatient episodes involved ONS use. Based on 
a matched sample of 1.2 million episodes, ONS patients had a shorter length of stay by 2.3 
days (95% confidence interval [CI] – 2.42 to –2.16), from 10.9 to 8.6 days (21.0% decline), and 
decreased episode cost of $4734 (95% CI – $4754 to – $4714), from $21,950 to $17,216 
(21.6% decline). Restricting the matched sample to the 862,960 episodes where patients were 
readmitted at some point, ONS patients had a reduced probability of early readmission (within 
30 days) of 2.3 percentage points (95% CI – 0.027 to – 0.019), from 34.3% to 32.0% (6.7% 
decline). 
Evidence of 
polymorbidity 
Mean Charlson comorbidity index: 3.5 
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12. Potter JM, Roberts MA, McColl JH, Reilly JJ. Protein energy supplements in unwell elderly patients—a randomized controlled trial. J Parenter 
Enteral Nutr. 2001; 6: 323-329. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
2++ 
Countries: Scotland 
Centers: Elderly 
Unit in a Scottish hospital 
Setting: 
Funding Sources: Chief 
Scientist’s Office of Scottish 
Office; Fresenius UK Ltd 
provided the sip feed 
supplements free of charge. 
Dropout rates: no dropouts 
Study limitations: 
Total no. patients: n = 381 
Inclusion criteria: emergency admission from home; ability to 
gain consent from patient or relatives; no known malignancy, the 
ability to swallow, and non obesity (BMI < 75th percentile). 
Exclusion criteria: not mentioned 
A prospective randomized controlled 
trial with no placebo. Consenting 
patients were stratified in 3 nutritional 
categories, and patients from each 
stratum were randomized into treatment 
or control. The intervention was a 
prescription of 120 mL sip feed, 3 times 
daily (540 kcal, 22.5 g protein per day) 
throughout hospitalization, using the 
medicine prescription chart  
Notes Author’s Conclusion: Prescribing sip feed supplements in the medicine prescription chart during hospital stay reduces weight loss. Our 
data also support other evidence for a reduction in mortality noted in elderly patients on nutritional supplementation.  
Outcome 
measures/results 
primary outcome measure: change in 
mean percentage weight 
secondary outcome measure:  
anthropometry; mortality, length of hospital 
stay, functional recovery, and rates of 
institutionalization. 
Nutritional supplementation was associated with significantly better energy intake (p = .001) 
and weight gain (p = .003) pooled across all nutritional categories. In the most poorly nourished 
patients, the intervention was associated with reduced mortality (5/34 versus 14/40, p < .05) 
and more patients improved functionally (17/25 versus 11/28, p < .04). Overall mortality results 
were 21/186 versus 33/195, odds ratio (OR) 0.62, 95% confidence interval (CI) 0.35, 1.13.  
Evidence of 
polymorbidity 
Agreement within working group, following attempt to contact author 
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13. FOOD Trial Collaboration. Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled 
trial. The Lancet. 2005; 9461: 755-763. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
1+ 
Countries: 
Centers: 
Setting: 
Funding Sources: Health 
Technology Assessment 
Board of NHS Research and 
Development in UK, the 
Stroke Association, the Chief 
Scientist Office of the Scottish 
Executive, and Chest, Heart 
and Stroke Scotland; The 
Royal Australasian College of 
Physicians 
Dropout rates: n = 11 (0, 3%) 
Study limitations: 
-lack of masking treatment 
allocation to patients and 
hospital staff 
- very few patients in the 
normal-diet groups actually 
received supplements 
-missing record of the 
proportion of eligible patients 
enrolled in each centre 
-informal assessment of 
nutritional status 
-lack of verifying on-site 
source data 
-lack of report of total 
nutritional intake (e.g., 
composition of normal 
hospital diet) 
- normal hospital diets in the 
Centers may fully met the 
nutritional needs of the 
Total no. patients: n = 4023 
• Intervention n = 2016 
• Control n = 2007 
Inclusion criteria: patients admitted with a recent stroke (first or 
recurrent stroke no more than 7 days before admission); passed 
swallow screen; enrolled within the first 30 days of admission, or 
within 30 days of a stroke occurring in hospital 
Exclusion criteria: Patients with subarachnoid hemorrhage 
The aim of this study was to establish 
whether routine oral nutritional 
supplements improve outcome after 
stroke. The outcomes of stroke patients 
who could swallow and who were 
randomly allocated normal hospital diet 
or normal hospital diet plus oral 
nutritional supplements until hospital 
discharge. 
 
Intervention 
- normal hospital diet plus oral protein 
energy supplements (equivalent to 360 
mL at 6.27 kJ/mL and 62.5 g/L in protein 
every day) until discharge 
 
Control 
- normal hospital diet 
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patients (and therefore 
inability to measure a large 
benefit occurred) 
- small proportion (8%) of 
undernourished patients at 
baseline might indicates that 
many such patients admitted 
to the hospitals were not 
enrolled but were given oral 
supplements outside the trial 
(because clinicians were not 
uncertain) 
-lack of report of information 
on nutritional outcomes (e.g., 
weight change during hospital 
stay) 
Notes Author’s Conclusion: 
We could not confirm the anticipated 4% absolute benefit for death or poor outcome from routine oral nutritional supplements for mainly well 
nourished stroke patients in hospital. Our results would be compatible with a 1% or 2% absolute benefit or harm from oral supplements. 
These results do not support a policy of routine oral supplementation after stroke. 
Outcome 
measures/results 
Primary outcome measures: 
death or poor outcome (modified Rankin 
scale [MRS] grade 3–5), overall survival 
secondary outcome measures: 
place of residence, quality of life 
(EUROQoL score), compliance with 
treatment, length of hospital stay, 
discharge destination, in-hospital 
complications, causes of death 
Between Nov 1, 1996, and July 31, 2003, 4023 patients were enrolled by 125 hospitals in 15 
countries. Only 314 (8%) patients were judged to be undernourished at baseline. Vital status 
and MRS at the end of the trial were known for 4012 and 4004 patients, respectively. 
Supplemented diet was associated with an absolute reduction in risk of death of 0·7% (95% CI 
–1·4 to 2·7) and an increased risk of death or poor outcome of 0·7% (–2·3 to 3·8). 
Evidence of 
polymorbidity 
Agreement within working group, following attempt to contact author 
 1630 
 1631 
 1632 
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Clinical Question 3. In patients where nutritional requirements cannot be met orally, does the use of enteral nutrition (EN) compared to parenteral 1633 
nutrition (PN) (total or supplemental) result in improved outcomes in polymorbid inpatients? 1634 
Recommendation 3.1: 1635 
In polymorbid medical inpatients whose nutritional requirements cannot be met orally, EN can be administered. In these cases, the use of EN may 1636 
be superior to PN because of a lower risk of infectious and non-infectious complications  1637 
Grade of recommendation 0 – strong consensus (100% agreement) 1638 
14. Jie B, Jiang Z, Nolan MT, Efron DT, Zhu S, Yu K, Kondrup J. Impact of nutritional support on clinical outcome in patients at nutritional risk: a 
multicenter, prospective cohort study in Baltimore and Beijing teaching hospitals. Nutrition. 2010; 11: 1088-1093. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
prospective cohort 
study  
2+ 
Countries: China, United 
States 
Centers: three departments 
in Johns Hopkins Hospital in 
Baltimore, two teaching 
hospitals in Beijing 
Setting: 
Funding Sources: CSPEN, 
CMB and a grant from Wu JP 
Medical Research 
Foundation 
Dropout rates: appr. 5 % 
Study limitations: 
Total no. patients: n = 1831 
Inclusion criteria: medical patients with gastrointestinal disease or 
respiratory disease and surgical patients undergoing intra-
abdominal surgery 
1) age 18–80 y;  
2) well oriented to time and place;  
3) speaking/understanding English in the United States/Chinese in 
China 
4) providing a written informed consent form; and 5) a hospital LOS 
of at least 4 d. 
Exclusion criteria: not specified 
To evaluate the impact of nutritional 
support (PN and EN) on clinical 
outcomes in patients at nutritional 
risk defined by the Nutritional Risk 
Screening 2002. 
Notes Author’s Conclusion: The preliminary results suggest that nutritional support (especially EN) is beneficial to patients nutritionally at risk as 
it is related to a lower complication rate, especially in those with obviously reduced oral intake. In contrast, nutritional support is not beneficial 
to the patients at no nutritional risk as defined by the NRS-2002. 
Outcome 
measures/results 
primary outcome measure: nutritional 
status and disease severity, nutritional 
parameters, application of PN and EN, 
surgery, medication, complications and 
LOS 
The overall complication rate was significantly lower in the nutritional-support group than in the 
no-support group, mainly because of the lower rate of infectious complications. 
Evidence of 
polymorbidity 
Agreement within working group, following attempt to contact author 
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Clinical Question 4. Does the estimation of energy requirements with a prediction equation versus a weight-based formula improve outcomes of 1639 
polymorbid inpatients requiring nutritional support? 1640 
 1641 
Recommendation 4.1: 1642 
Energy requirements in polymorbid medical inpatients can be estimated using indirect calorimetry (IC), a published prediction equation or a 1643 
weight-based formula. 1644 
Grade of recommendation 0 – strong consensus (96% agreement) 1645 
Recommendation 4.2:  1646 
In the absence of IC, total energy expenditure (TEE) for polymorbid older patients (aged > 65 years) can be estimated using the formula 27 kcal/kg 1647 
actual body weight. Resting energy expenditure (REE) can be estimated using the formula 18 - 20 kcal/kg body weight with the addition of activity 1648 
or stress factors to estimate TEE. 1649 
Grade of recommendation 0 – strong consensus (95% agreement) 1650 
 1651 
Recommendation 4.3.a: 1652 
In the absence of IC, REE for severely underweight patients can be estimated using the formula 30 kcal/kg body weight. 1653 
Grade of recommendation 0 – consensus (89% agreement) 1654 
 1655 
Recommendation 4.3.b: 1656 
This target of 30 kcal/kg body weight in severely under-weight patients should be cautiously and slowly achieved, as this is a population at high 1657 
risk of refeeding syndrome.  1658 
Grade of recommendation GPP - strong consensus (100% agreement) 1659 
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15. Gaillard C, Alix E, Salle A, Berrut G, Ritz P. Energy requirements in frail elderly people: a review of the literature. Clinical nutrition. 2007; 1: 16-24. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
Review 
2++ 
Countries: France  
Centers: 
Setting: 
Funding Sources: 
Dropout rates: 
Study limitations: small 
number of subjects, limited 
number of data sets 
Total no. patients: n = 248 from 11 studies 
Inclusion criteria:  following studies were included: (1) those in 
which subjects had a minimal mean age of 60 yr or more with all 
being at least 55 yr of age, (2) those in which indirect calorimetry 
was performed while subjects were at rest and while fasting 
Exclusion criteria: Studies that included patients on specific diets, 
mechanically ventilated, cancer or burns patients or 
patients with thyroid problems and studies that did not mention the 
mean body weight of the studied group 
This review collates studies of 
healthy, sick, underweight (BMI≤21 
kg/m2) and very elderly people (≥90 
yr), in whom resting energy 
expenditure (REE) was measured 
using indirect calorimetry. 
Notes Author’s Conclusion: To conclude, REE, which can be used in conjunction with PAL to calculate energy requirements, is approximately 20 
kcal/kg/d in sick elderly people. Further studies are needed in very elderly and sick people, taking their specific pathology into consideration. 
Outcome 
measures/results 
 outcome measure: different study 
outcomes; REE was measured in all 
studies 
(1) REE, when adjusted for differences in both body weight and fat-free mass (FFM), is similar 
in healthy and in sick elderly people being 20 and 28 kcal/kg of FFM per day, respectively, (2) 
their nutritional status influences their energy requirements given that weight-adjusted REE 
increases in line with a decrease in BMI, (3) total energy expenditure is lower in sick elderly 
people given that their physical activity level, i.e. the ratio of total energy expenditure to REE, is 
reduced during disease averaging at 1.36, (4) energy intake (EI) being only 1.23_REE is 
insufficient to cover energy requirements in sick elderly patients, whereas the EI of healthy 
elderly people appears sufficient to cover requirements, and finally, (5) gender ceases to be a 
determinant of REE in people aged 60 yr or over, with the Harris & Benedict equation capable 
of accurately predicting mean REE in this population, whether healthy or sick. 
Evidence of 
polymorbidity 
Some included studies described patients as polymorbid 
 1660 
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 1663 
 1664 
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Clinical question 5. Do protein targets higher than 1.0g/kg BW/day versus a lower target improve outcomes in polymorbid inpatients requiring 1665 
nutritional support? 1666 
Recommendation 5.1 1667 
Polymorbid medical inpatients requiring nutritional support shall receive a minimum of 1.0 g of protein/kg of body weight per day in order to 1668 
prevent body weight loss, reduce the risk of complications and hospital readmission and improve functional outcome  1669 
Grade of recommendation A – strong consensus (95% agreement) 1670 
 1671 
16. Starke J, Schneider H, Alteheld B, Stehle P, Meier R. Short-term individual nutritional care as part of routine clinical setting improves outcome and 
quality of life in malnourished medical patients. Clinical nutrition. 2011; 2: 194-201. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled 
intervention study 
1++ 
Countries: Germany and 
Switzerland  
Centers: 
Setting: 
Funding Sources: grants for 
clinical studies and education 
from Nestlé and from the 
Exchange Organisation 
StudEx/Switzerland and the 
German Acadamic Exchange 
Service (DAAD)/Germany 
Dropout rates: 50.5 % 
Study limitations: connected 
to study design: Preferred 
outcome parameters are often 
influenced by other factors 
than nutrition alone; our study 
was not powered to 
statistically confirm a causal 
relation to nutrition 
intervention 
Total no. patients: n = 271 
Inclusion criteria:  Patients with a nutritional risk (NRS score ≥ 3) 
Exclusion criteria: no informed consent, terminal condition, 
expected stay <5 days (judged by physician), previous participation 
in this study, patient on starvation, on parenteral nutrition, and/or 
being on dialysis 
132 risk patients defined by 
Nutritional Risk Screening 2002, 
were randomized to individualized 
nutrition support (intervention group 
[n = 66]) or standard hospital care 
(control group [n = 66]). The present 
study aimed at developing and 
evaluating a routinely manageable 
concept for an improved nutritional 
care of malnourished in-hospital 
patients. 
Notes Author’s Conclusion: Malnourished patients profit from nutrition support regarding nutrition status and quality of life. They have fewer 
complications, need fewer antibiotics and are less often re-hospitalized. 
Outcome 
measures/results 
primary outcome measure: average daily 
energy and protein intake 
Nutrition interventions led to higher intakes (mean [standard deviation]) in energy (1553 
[341] kcal vs. 1115 [381] kcal, p < 0.001) and protein (65.4 [16.4] g vs. 43.9 [17.2] g, p < 
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secondary outcome measure:  Body 
weight, plasma vitamin levels, quality of 
life, complications, antibiotic therapies, 
readmissions and mortality, number of 
complications, length of 
hospital stay, compliance with oral nutrition 
standard supplement consumption  
0.001). Intervention patients (n = 66) kept their body weight in comparison to control patients (n 
= 66; 0.0 [2.9] kg vs. -1.4 [3.2] kg, p = 0.008). Positive effects on plasma ascorbic acid level 
(46.7 [26.7] mmol/l vs. 34.1 [24.2] mmol/l, p = 0.010), SF-36 function summary scale (37 [11] % 
vs. 32 [9] %, p = 0.030), number of complications (4/66 vs. 13/66, p = 0.035), antibiotic 
therapies (1/66 vs. 8/66, p ¼ 0.033) and readmissions (17/64 vs. 28/61, p = 0.027) were 
recorded. 
Evidence of 
polymorbidity 
Mean number of drugs: 7 in the control group, 6 the intervention group 
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17. Drommer J, Schneider H, Alteheld B, Stehle P, Meier R. Protein is an important component of nutritional support predicting complications in 
malnourished hospitalised patients–Details of our previous randomised controlled trial (RCT). Clinical Nutrition ESPEN. 2015;3:e124-e128. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
1++ 
Setting: 
Funding Sources: grants 
from the German Academic 
Exchange Organisation 
(DAAD) and StudEx (Swiss 
Student Exchange 
Organisation) 
Dropout rates: 15 % 
Study limitations: 
fortification of natural food; 
protein as an appetite inhibitor 
by reducing food intake 
Total no. patients: n = 118 
Inclusion criteria:  same as in previous trial 
Exclusion criteria: no informed consent, no medical patient, short 
hospitalization (<5 days), previous study participation, being on 
dialysis or parenteral nutrition. 
Data of our previous randomized 
controlled nutritional trial was 
analyzed according to per protocol. 
Patients were randomized to either 
the control (CG) or intervention group 
(IG) according to a computer-
generated randomization list and 
received either standard care or an 
individual nutritional support for 5e28 
days. 
Notes Author’s Conclusion: Caloric and protein intake are important predictors of complications and the change in body weight, respectively. In 
contrast, age and disease severity did not influence the outcome in our nutritional trial. 
Outcome 
measures/results 
primary outcome measure: average daily 
caloric and protein intake 
secondary outcome measure:  body 
weight change during hospitalization, the 
number of hospital-acquired complications, 
the number of antibiotic treatments, the 
quality of life according to the SF-36, the 
length of stay (LOS) on the ward and in the 
hospital, the readmission rate (after 6 
months) and the mortality (in the hospital 
and 6 months after discharge) 
Repeated measure ANOVA revealed a highly significant intervention effect for both protein and 
caloric intake (p < 0.001) after 5 and 10 days of intervention. Patients of the intervention group 
(IG; n = 59) were able to keep their body weight in contrast to control group (CG; n = 59) 
patients (68.3 (15.5) kg vs. 64.4 (15.8) kg, p = 0.003). The mean plasma ascorbic acid level 
was higher in IG than in CG at discharge (47.2 (26.8) mmol/l vs. 34.1 (24.2) mmol/l, p = 0.005). 
The number of patients suffering from inhospital complications was lower in IG than in CG 
(4/59 vs. 13/59, p = 0.034). Positive effects on the antibiotic therapies for infectious 
complications (1/58 vs. 8/59, p = 0.032), the SF-36 physical summary scale (37 (11) % vs. 33 
(9), p = 0.039) and the readmission rates (26/54 vs. 43/58, p = 0.019) were recorded. The 
mean protein intake predicted the chance of having a complication whereas the body weight 
change was best predicted by the mean caloric intake. 
Evidence of 
polymorbidity 
Mean number of drugs: 7 in the control group, 6 in the intervention group 
 1672 
 1673 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
90 
 
Clinical question 7. Does disease-specific nutritional supplementation (e.g. fiber, omega 3 fatty acids, BCAA, glutamine, etc.) versus standard 1674 
formulations improve outcomes in polymorbid inpatients? 1675 
Recommendation 7.1 1676 
In polymorbid medical inpatients with pressure ulcers, specific amino-acids (arginine and glutamine) and β-hydroxy β-methylbutyrate (ß-HMB) can 1677 
be added to oral/enteral feeds to accelerate the healing of pressure ulcers. 1678 
Grade of recommendation 0 – consensus (90% agreement) 1679 
Recommendation 7.2 1680 
In polymorbid medical older inpatients requiring enteral nutrition, formulas enriched in a mixture of soluble and insoluble fibers can be used to 1681 
improve bowel function  1682 
Grade of recommendation 0 – strong consensus (95% agreement) 1683 
18. Wong A, Chew A, Wang C, Ong L, Zhang S, Young S. The use of a specialised amino acid mixture for pressure ulcers: a placebo-controlled trial. J 
Wound Care. 2014; 5. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
placebo-controlled 
trial 
1+ 
Countries: Singapore 
Centers: 
Setting: acute hospital 
Funding Sources: Abbott 
Laboratories 
Dropout rates: 11.5 % 
Study limitations: to 
standardize a wound care 
regimen for all patients as the 
pressure ulcers were of 
different stages, locations and 
were managed differently 
prior to this admission, bias in 
interpreting data, length of 
time of the trial 
Total no. patients: n = 26 
Inclusion criteria: patients who have a hospital stay of 2 weeks 
and above; able to attend follow-up outpatient clinics for wound 
assessment; and age more than 21 years. 
Exclusion criteria: patients with poorly controlled diabetes 
(HbA1c >7.0%); on total parenteral nutrition; medically unstable 
upon admission to the hospital; on palliative care; admission with 
severe sepsis; length of stay in hospital ≤2 weeks and unable to 
attend outpatient follow-ups; on fluid restriction <1L/day; requiring 
protein restriction; on other wound healing supplements such as 
vitamin C, vitamin A and zinc; presence of lower extremity ulcers 
with untreated peripheral vascular disease, or deep tissue 
infection and/or requiring debridement of necrotic/sloughy tissue; 
unable to tolerate oral or enteral intake >70% estimated energy 
requirements; and those who are unable to tolerate fluid intake 
30ml/kg body weight 
To compare pressure ulcer healing rates 
in patients supplemented with a 
specialized amino acid mixture 
containing β-hydroxy β-methylbutyrate 
(HMB), arginine and glutamine, and 
standard oral nutritional supplements 
versus patients supplemented with oral 
nutritional supplements and a placebo 
mixture. 
Notes Author’s Conclusion: The use of specialized amino acid does not appear to reduce wound size and PUSH scores but may improve tissue 
viability after 2 weeks. Further confirmation on a larger scale is required to determine the benefits of supplementing additional HMB, arginine 
and glutamine in patients with pressure ulcers. 
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Outcome 
measures/results 
outcome measure: Anthropometry and 
nutritional assessment, Dietary intake 
assessment, Pre-albumin and C-reactive 
protein (CRP) levels, PU assessment 
included: a) onset and duration of ulcer, 
b) acetate tracing of wound location and 
wound area, c) the estimated change in 
proportion of viable and non-viable tissue, 
determined using area derived from 
planimetry via acetate tracings, d) wound 
depth and/or undermine using a sterile 
probe, e) wound bed and periwound 
appearance and f) wound exudate type 
and amount 
There was no difference between anthropometrical measurements, biochemical parameters and 
nutritional intake pre- and post- study. Wound area did not decrease significantly in the short term 
for both groups. The proportion of viable tissues increased within 2 weeks on HMB, arginine and 
glutamine supplementation (p=0.02). PUSH scores showed significant improvement within 1 week 
of supplementation for the experimental group (p=0.013). 
Evidence of 
polymorbidity 
Confirmed by author 
 1684 
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19. Vandewoude MF, Paridaens KM, Suy RA, Boone MA, Strobbe H. Fibre-supplemented tube feeding in the hospitalised elderly. Age Ageing. 2005; 2: 
120-124. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
prospective 
randomized 
controlled trial 
1++ 
Countries: Belgium 
Centers: Department of 
Geriatrics at the University of 
Antwerp 
Setting: 
Funding Sources: 
Dropout rates: not mentioned 
Study limitations: difficult to 
measure stool weight; use of 
other medication classes 
(anticholinergic, antidepressant 
and gastrokinetic agents) was 
too limited to draw a meaningful 
conclusion 
Total no. patients: n = 172 
Inclusion criteria: patients at the Department of Geriatrics 
were considered eligible for the trial when they needed enteral 
nutrition support 
Exclusion criteria: Patients with inflammatory bowel disease, 
liver disease (transaminases >2 × normal upper limit), renal 
dysfunction (creatinine >2 mg/dl), progressive malignant 
disease or metabolic instability 
to evaluate the effect of fiber 
supplementation in enteral feeding on 
bowel function in hospitalized geriatric 
patients, and to assess its metabolic and 
nutritional efficiency an enteral nutritional 
regimen consisting of 30 kcal/kg in 2000 ml 
with a calorie/nitrogen ratio of 156 with or 
without fiber was instituted. 
Notes Author’s Conclusion: fiber supplementation improved bowel function with reduced stool frequency and more solid stool consistency. 
It did not affect the nutritional efficiency of enteral feeding in hospitalized geriatric patients. Diabetes may be a risk factor for mortality in 
malnourished patients requiring tube feeding. 
Outcome 
measures/results 
primary outcome measure: stool output 
was qualitatively evaluated by recording 
frequency, volume (small <1/2 cup, large 
>1/2 cup) and consistency (solid-formed, 
soft-pasty or liquid-watery).  
secondary outcome measure: gender, 
age, presence of depression and dementia, 
Mid-arm circumference (MAC), triceps 
skin-fold thickness (TSF) and arm muscle 
circumference (AMC), Blood parameters 
(blood cell count, glycaemia, total 
cholesterol, HDL-cholesterol, LDL-
cholesterol, triglycerides, albumin, pre-
albumin, transferrin and total protein) 
Overall mortality was 24% with a trend for excess mortality in diabetic patients (33.3% versus 
21.6% in non-diabetics; P = 0.176). There was no difference in duration of feeding between the 
fiber group (27.5 days; 95% CI = 19.1−35.9) and the no fiber group (27.9 days; 95% CI = 
20.2−35.5). In the fiber-supplemented group, stool frequency was lower (4.1 per week; 95% CI = 
3.7−4.6) than in controls (6.3 per week; 95% CI = 5.6−6.9). Qualitatively, stool consistency was 
higher (P<0.001) but no difference in volume was noted. There were no differences in final 
laboratory parameters between groups. 
Evidence of 
polymorbidity 
Confirmed by author 
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Clinical question 8. Does early nutritional support (i.e. provided less than 48 hours post hospital admission) compared to later nutritional support 1685 
improve outcomes in polymorbid inpatients? 1686 
Recommendation 8.1  1687 
Early nutritional support (i.e. provided in less than 48 hours post hospital admission) compared to later nutritional support should be performed in 1688 
polymorbid medical inpatients, as sarcopenia could be decreased and self-sufficiency could be improved 1689 
Grade of recommendation: B – strong consensus (95% agreement) 1690 
 1691 
20. Hegerová P, Dědková Z, Sobotka L. Early nutritional support and physiotherapy improved long-term self-sufficiency in acutely ill older patients. 
Nutrition. 2015; 1: 166-170. 
prospective, 
randomized 
controlled study 
1++ 
Countries: Czech Republic 
Centers: 
Setting: Third Internal 
Department of Metabolic Care 
and Gerontology, Faculty 
Hospital in Hradec Králové 
Funding Sources: research 
grant PRVOUK P 37-12 
Dropout rates: no dropout 
Study limitations: 
Total no. patients: n = 200 
Inclusion criteria: age >78 y, admission to the hospital as a 
result of acute illness, self-sufficiency of the patient before 
admission based on a Barthel Index (BI) score >60, and 
patient’s consent to participate in the Study 
Exclusion criteria:  terminal stage of disease, terminal organ 
failure, hospitalization in the previous 3 mo or more than two 
hospitalizations in the previous 6 months, indication for 
immediate nutritional support (recent weight loss, reduced food 
intake of <50% of the normal amount for more than 2 d before 
admission, and body mass index [BMI] <18.5 kg/m2), low self-
sufficiency before the acute disease (BI ≤ 60), advanced stage 
of dementia associated with loss of independence, and refusal 
to participate in the study 
The aim of this study was to determine 
whether an active approach based on 
early nutritional therapy and exercise 
would influence the development of 
sarcopenia and impaired self-
sufficiency during acute illness. The 
patients were randomized to a control 
group receiving standard treatment (n = 
100) or to an intervention group (n = 
100). The intervention consisted of 
nutritional supplements (600 kcal, 20 
g/d protein) added to a standard diet 
and a simultaneous intensive 
rehabilitation program. The tolerance of 
supplements and their influence on 
spontaneous food intake, self-
sufficiency, muscle strength, and body 
composition were evaluated during the 
study period. The patients were then 
regularly monitored for 1 y post 
discharge. 
Notes Author’s Conclusion: The early nutritional intervention together with early rehabilitation preserves muscle mass and independence in ill older 
patients hospitalized because of acute disease. 
Outcome 
measures/results 
primary outcome measure: Age, sex, 
diagnosis, number of hospitalization days, 
anthropometry, Body composition (lean tissue 
mass and adipose tissue), Self-sufficiency, 
The provision of nutritional supplements together with early rehabilitation led to increased 
total energy and protein intake while the intake of standard hospital food was not reduced. 
The loss of lean body mass and a decrease in self-sufficiency were apparent at discharge 
from the hospital and 3 mo thereafter in the control group. Nutritional supplementation and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
94 
 
Nutritional risk screening (NRS) the rehabilitation program in the study group prevented these alterations. A positive effect 
of nutritional intervention and exercise during the hospital stay was apparent at 6 mo post-
discharge. 
Evidence of 
polymorbidity 
Confirmed by author 
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21. Zheng T, Zhu X, Liang H, Huang H, Yang J, Wang S. Impact of early enteral nutrition on short term prognosis after acute stroke. Journal of Clinical 
Neuroscience. 2015; 9: 1473-1476. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
1- 
Countries: China 
Centers: 
Setting: 
Funding Sources:  
Dropout rates: not mentioned 
Study limitations: 
Total no. patients: n = 146 
Inclusion criteria:  
(1) cerebral infarction, intracranial hemorrhage or both 
confirmed with a CT scan or MRI within 72 hours of onset;  
(2) all patients who met the diagnostic standard of the Fourth 
National Cerebrovascular Events Conference (Chinese 
Neuroscience Society and Chinese Neurosurgery Society);  
(3) patients who might have a medical history of stroke but no 
apparent neurological deficit remaining prior to the onset of the 
current stroke;  
(4) focal neurological signs and dysphagia  
Exclusion criteria: transient ischemic attack, subarachnoid 
hemorrhage, severe endocrine or metabolic disorders, 
hematological disorders, malignancies, chronic lung and heart 
dysfunction, severe liver or kidney failure, stress ulcer of the 
digestive system, and those who died within a week of 
admission. Patients who received thrombolytic therapy were not 
included in the present study 
To investigate the impact of complete 
enteral nutrition on Chinese patients with 
acute stroke, we conducted a randomized 
controlled trial of 146 patients with acute 
stroke and dysphagia, among whom 75 
were supported with nasogastric nutrition 
and 71 received family managed nutrition 
after randomization. 
Notes Author’s Conclusion: Early nasogastric nutrition improves short term nutritional status and reduces complications in patients with acute stroke 
and dysphagia. 
Outcome 
measures/results 
primary outcome measure:  
1 Nutritional status and rate of malnutrition: 
calculated TSF, AMC, Hb, Alb, TG and the rate of 
malnutrition on the first, seventh, and twenty-first day 
of admission. 
2 Nosocomial infection and mortality rates. 
3 Neurological evaluation: National Institutes of 
Health Stroke Scale (NIHSS, activities of daily living 
Barthel index (ADLBI), and modified Rankin scale 
(mRS) on the first and twenty-first day of admission. 
We found that the nasogastric nutrition group had a better nutritional status and 
reduced nosocomial infection and mortality rates after 21 days compared with patients 
in the family managed nutrition group. In addition, the nasogastric nutrition group 
showed a lower score on the NIHSS than the control group. However, the differences in 
the scores of the ADLBI and the 90 day mRS between the groups were not significant. 
Evidence of 
polymorbidity 
> 2 co-occurring chronic diseases in > 50% of the study population 
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Clinical question 9. Does the continued use of nutritional support after discharge compared to nutritional support during inpatient stay alone affect 1692 
the outcome of polymorbid patients? 1693 
Recommendation 9.1 1694 
In malnourished polymorbid medical inpatients or those at risk of malnutrition nutritional support shall be continued after hospital discharge in 1695 
order to maintain or improve body weight and nutritional status. 1696 
Grade of recommendation A – strong consensus (95% agreement) 1697 
 1698 
Recommendation 9.2 1699 
In malnourished polymorbid medical inpatients or those at high risk of malnutrition, nutritional support should be continued post hospital 1700 
discharge to maintain or improve functional status and quality of life. 1701 
Grade of recommendation B – strong consensus (95% agreement) 1702 
Recommendation 9.3  1703 
In polymorbid medical inpatients at high risk of malnutrition or with established malnutrition aged 65 and older, continued nutritional support post 1704 
hospital discharge with either oral nutritional supplements or individualized nutritional intervention shall be considered to lower mortality.  1705 
Grade of recommendation A – strong consensus (95% agreement) 1706 
 1707 
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22. Gazzotti C, Arnaud-Battandier F, Parello M, Farine S, Seidel L, Albert A, Petermans J. Prevention of malnutrition in older people during and after 
hospitalisation: results from a randomised controlled clinical trial. Age Ageing. 2003; 3: 321-325. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
1++ 
Countries: Belgium 
Centers: Centre Hospitalier 
de la Citadelle in Liége 
Setting: 
Funding Sources: not 
mentioned 
Dropout rates: 5 % 
Study limitations: 
Total no. patients: n = 80 
Inclusion criteria: aged 75 or over, admitted for acute 
conditions, Patients were eligible for the study only if their total 
MNA score ranged between 17 and 23.5 (= ‘at risk of 
malnutrition’) 
Exclusion criteria:  Patients with a medical condition 
preventing oral feeding, end-of-life patients, patients with 
severe dementia (Mini Mental Score <10), patients presenting 
clinical signs of dehydration or heart failure, and those suffering 
from diseases requiring special dietary treatment (kidney or 
liver failure) 
To prevent the occurrence of weight loss 
during hospitalization and following 
discharge by daily oral supplementation. 
Patients were randomized into a control 
group or one receiving oral 
supplementation. The intervention was a 
prescription of 200 ml sweet or salty sip 
feed twice daily (500 kcal, 21 g protein per 
day) throughout hospitalization and 
convalescence. 
Notes Author’s Conclusion: Use of daily oral supplementation during and after hospitalization maintains body weight and increases 
Mini Nutritional Assessment score in patients at risk of undernutrition. 
Outcome 
measures/results 
primary outcome measure: MNA score, 
weight  
secondary outcome measure: 
Demographic and medical data recorded 
during the inclusion period (from day 0 to 
day 3), included age, sex, place of origin 
(home or nursing-home), reason for 
hospitalization and therapy, digestive side 
effects (bloating, nausea, diarrhea, 
constipation and abdominal pain) 
Compliance with oral supplementation was good and daily extra energy intake was 407±184 kcal. 
On day 60, significant weight loss from upon admission was observed in the control group (-
1.23±2.5 kg; P=0.01), but not in the supplemented group (0.28±3.8 kg; NS). At the end of the 
study, Mini Nutritional Assessment scores were higher in the supplemented group than in the 
control group (23.5±3.9 versus 20.8±3.6; P-0.01). 
Evidence of 
polymorbidity 
Mean number of drugs: 5.8 in the control group, 5.5 in the intervention group 
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23. Norman K, Kirchner H, Freudenreich M, Ockenga J, Lochs H, Pirlich M. Three month intervention with protein and energy rich supplements improve 
muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease—a randomized controlled trial. Clinical 
nutrition. 2008; 1: 48-56. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
1+ 
Countries: Germany 
Centers: Charité University 
Medicine Berlin 
Setting:  
Funding Sources: grant from 
Fresenius Kabi, Bad Homburg, 
Germany 
Dropout rates: 20.8 % 
Study limitations: 
mechanisms by which ONS 
improve outcomes are 
probably multifactorial, no 
placebo for the nutritional 
supplements 
Total no. patients: n = 101 
Inclusion criteria: Patients classified malnourished according 
to the Subjective Global Assessment13 (SGA B or C) suffering 
from a benign gastrointestinal disease 
Exclusion criteria: malignant disease, renal insufficiency 
(serum creatinine 41.3 mg/dl), life expectancy less than three 
months or age under 18 years, hyperhydration, implanted 
defibrillators, neuromuscular disease, hemiplegia or rheumatoid 
arthritis  
We investigated the effect of a three-month 
post-hospital nutritional intervention with 
high protein and energy supplements on 
body composition, muscle function and 
quality of life (QoL) in malnourished GI 
patients. Eighty malnourished patients with 
benign digestive disease were randomized 
to receive either oral nutritional 
supplements (ONS) for three months in 
addition to dietary counseling (DC) (ONS 
patients) or only dietary counseling (DC 
patients). 
Notes Author’s Conclusion: A three month intervention with high protein oral supplements improves outcome in malnourished patients with digestive 
disease in terms of functional status, QoL and rehospitalization. 
Outcome 
measures/results 
primary outcome measure: 
Readmissions to hospital as a rough 
measure of clinical outcome) 
secondary outcome measure: Nutritional 
status (subjective global assessment), 
body composition (bioelectrical 
impedance), anthropometry, muscle 
function (handgrip strength and peak flow), 
QoL (36-item short-form questionnaire) 
Age, body cell mass (BCM), muscle function, gender distribution and QoL did not differ between 
ONS patients (n = 38) and DC patients (n = 42) at baseline. Body weight and BCM improved 
significantly in both groups after three months. However, hand-grip strength (26.1±11.3–
31.5±10.1 kg, p<0.0001) and peak flow (329.2±124.0–388.9±108.4 l/min, p = 0.004) improved 
only in the ONS patients and remained unchanged in the DC patients. Similarly, all eight scales of 
the QoL improved in the ONS patients compared with merely three in the DC patients. DC 
patients experienced significantly more readmissions (n = 20) than ONS patients (n = 10) during 
the study period (p = 0.041). 
Evidence of 
polymorbidity 
Mean number of drugs: 6 in the control group, 4 in the intervention group 
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24. Norman K, Pirlich M, Smoliner C, Kilbert A, Schulzke J, Ockenga J, Lochs H, Reinhold T. Cost-effectiveness of a 3-month intervention with oral 
nutritional supplements in disease-related malnutrition: a randomised controlled pilot study. Eur J Clin Nutr. 2011; 6: 735-742. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled pilot 
study 
1+ 
Countries: Germany 
Centers: Department of 
Gastroenterology, Hepatology 
and Endocrinology, Charité 
University Medicine 
Setting: 
Funding Sources: grant from 
Fresenius Kabi, Bad Homburg, 
Germany 
Dropout rates: 28,75 % 
Study limitations: design of 
economic evaluation, only 
direct costs of the intervention 
were considered  
Total no. patients: n = 160 
Inclusion criteria: classified as malnourished, according to the 
Subjective Global Assessment (Detsky et al., 1987) (SGA B or 
C), and suffering from a benign gastrointestinal disease 
Exclusion criteria: malignant disease, renal insufficiency 
(serum creatinine 41.3 mg/dl), and life expectancy o3 months or 
age o18 years 
Nutritional intervention with oral nutritional 
supplements (ONS) has been shown to 
increase quality of life in malnourished 
patients. We investigated whether post-
hospital supplementation with ONS is cost-
effective according to international 
benchmarks in malnourished patients. In 
total, 114 malnourished patients (50.6±16.1 
years, 57 female) with benign 
gastrointestinal disease were included and 
randomized to receive either ONS for 3 
months and dietary counseling at discharge 
(intervention, n=60) or only dietary 
counseling at discharge (control group, 
n=54). 
Notes Author’s Conclusion: A 3-month intervention with ONS increases quality of life in malnourished patients. This treatment appears to be cost-
effective according to international benchmarks.  
Outcome 
measures/results 
primary outcome measure: incremental 
cost-effectiveness ratio (ICER) 
secondary outcome measure: Nutritional 
status, daily intake of ONS, quality of life 
(Short-Form (SF)-36 Health Survey) 
transformed into health-status utilities, 
Quality-adjusted life years (QALYs)  
Intervention patients consumed 2.4±0.8 ONS per day. Intervention and control patients did not 
differ in their health status utilities at baseline (0.594±0.017 vs 0.619±0.018), but after 3 months, 
the health status utilities were significantly higher in intervention patients than in control patients 
(0.731±0.015 vs 0.671±0.016, P=0.028). Intervention was associated with significantly higher 
costs (ICER: €9497 and €12 099/additional QALY, respectively) but deemed cost-effective 
according to international thresholds (<€50 000/QALY). 
Evidence of 
polymorbidity 
Mean number of chronic diseases and drugs: 4.6 and 3.9 in the control group, respectively;  5 and 5 in the intervention group, 
respectively 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
100 
 
25. Feldblum I, German L, Castel H, Harman‐Boehm I, Shahar DR. Individualized nutritional intervention during and after hospitalization: the nutrition 
intervention study clinical trial. J Am Geriatr Soc. 2011; 1: 10-17. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized, 
controlled trial 
1- 
Countries: Israel 
Centers: Internal medicine departments 
Setting: 
Funding Sources: Israel National Institute 
for Health Policy and Health Services 
Research 
Dropout rates: 25.8% 
Study limitations: high dropout rate in the 
nonintervention groups, results cannot be 
directly generalized as strict exclusion 
criteria were used 
Total no. patients: n = 259 
Inclusion criteria:  hospitalized adults aged 65 
and older at nutritional risk with a MNA-sf score 
less than 10 or those who had lost more than 10% 
of their weight in the previous 6 months 
Exclusion criteria: current diagnosis of cancer, 
cognitive impairment (Mini Mental State 
Examination (MMSE) score <23), an inability to be 
interviewed, language difficulties, or an 
unwillingness to provide informed consent 
To test the hypothesis that individualized 
nutritional treatment during and after 
discharge from acute hospitalization will 
reduce mortality and improve nutritional 
outcomes. Group 1 (intervention group) 
received individualized nutritional treatment 
from a dietitian in the hospital and three 
home visits after discharge. Group 2 
received one meeting with a dietitian in the 
hospital. Group 3 received standard care. 
Groups 2 and 3 were combined into a 
single group that served as the control 
group in the analysis. 
Notes Author’s Conclusion: Lower mortality and moderate improvement in nutritional status were found in patients receiving individualized 
nutritional treatment during and after acute hospitalization. 
Outcome 
measures/results 
outcome measure: Mortality, health 
status, nutritional outcomes, blood tests, 
cognition, emotional, and functional 
parameters 
After 6 months, rise in Mini Nutritional Assessment score, adjusted for education and 
hospitalization ward, was significantly higher in the intervention group than in the control groups 
(3.01 ± 2.65 vs 1.81 ± 2.97, P=.004) mainly on the subjective assessment part (0.34 ± 0.86 vs. -
0.04 ± 0.87, P=.004). The only laboratory parameter for which a difference was observed 
between the groups was albumin; 9.7%of the intervention group had serum albumin levels of less 
than 3.5 g/dL, versus 22.9% of the control group (P=.03). Mortality was significantly lower in the 
intervention group (3.8%) than in the control group (11.6%, P=.046). 
Evidence of 
polymorbidity 
Mean Charlson comorbidity index: 2.5 in the control group, 2.2 in the intervention group, 2.4 in the "in-hospital" treatment group 
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26. Casals C, García-Agua-Soler N, Vázquez-Sánchez M, Requena-Toro M, Padilla-Romero L, Casals-Sánchez J. Randomized clinical trial of nutritional 
counseling for malnourished hospital patients. Revista Clínica Española (English Edition). 2015; 6: 308-314. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
clinical trial 
1- 
Countries: Spain 
Centers: Hospital Clinic Virgen de la 
Victoria of Malaga 
Setting: 
Funding Sources: research grant from the 
Government of Andalusia 
Dropout rates: 12.3 % 
Study limitations: lack of masking of the 
patients and health professionals 
Total no. patients: 
Inclusion criteria:  (a) hospitalization, (b) medium-
high risk of malnutrition on the MUST scale, (c) 
older than 18 years, (d) willingness to participate in 
the study and signing of the informed consent form 
(in the event of cognitive impairment, the consent 
form was signed by the patient’s caregiver) and (e) 
resident of the geographical area corresponding to 
the participating health center. 
Exclusion criteria: (a) treatment with oral food 
supplements, enteral or parenteral nutrition, (b) 
treatment with chemotherapy or radiation therapy 
and (c) malabsorption syndrome. 
The aim of this study is to assess the 
impact of dietary counseling for 
malnourished hospital patients. In a 
prospective, randomized, open-label study 
of 106 hospital patients with malnutrition 
(54 in the control group and 52 in the 
intervention group), the intervention group 
received dietary counseling, and the control 
group underwent standard treatment. 
Notes Author’s Conclusion: Nutritional counseling improved the patients’ nutritional state, quality of life and degree of dependence and decreased 
the number of hospital readmissions. 
Outcome 
measures/results 
outcome measure: nutritional state (body 
mass index, laboratory parameters, 
malnutrition universal screening tool), 
degree of dependence (Barthel index), 
quality of life (SF-12), degree of 
satisfaction (CSQ-8), the number and 
length of readmissions and mortality. 
The patients who underwent the ‘‘intervention’’ increased their weight at 6 months, while the 
controls lost weight (difference in body mass index, 2.14 kg/m2; p < .001). The intervention group 
had better results when compared with the control group in the Malnutrition Universal Screening 
Tool scores (difference, −1.29; p < .001), Barthel index (difference, 7.49; p = .025), SF-12 
(difference, 13.72; p < .001) and CSQ-8 (difference, 4.34, p < .001) and required fewer 
readmissions (difference, −0.37; p = .04) and shorter stays for readmissions (difference, −6.75; p 
= .035). Mortality and laboratory parameters were similar for the 2 groups. 
Evidence of 
polymorbidity 
Agreement within working group, following attempt to contact author 
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27. Persson M, Hytter-Landahl Å, Brismar K, Cederholm T. Nutritional supplementation and dietary advice in geriatric patients at risk of malnutrition. 
Clinical nutrition. 2007; 2: 216-224. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
Intervention study 
1+ 
Countries: Sweden 
Centers: Department of Geriatric Medicine 
at Rosenlund Hospital, Stockholm 
Setting: 
Funding Sources: financial support from 
The Swedish Research Council (04224), 
Karolinska Institutet and by grants from S. 
Persson Family Foundation (18:35) and 
Sempers Foods AB. 
Dropout rates: 50 % 
Study limitations: high dropout rate due 
to advanced age, multiorgan disease and 
cognitive dysfunction, lack of placebo 
treatment to the control group 
Total no. patients: n = 108 
Inclusion criteria: not described in detail (one 
ward mainly treated elderly adults after trauma with 
or without fracture; the other ward mainly took care 
of acutely ill elderly patients with various somatic 
disorders) 
Exclusion criteria: not described  
Effects of combined nutritional treatment of 
patients at risk of protein-energy 
malnutrition (PEM) discharged from a 
geriatric service were evaluated. Patients 
(n = 108, age 85±6 years) at risk of 
malnutrition according to the short form of 
the mini nutritional assessment were 
randomly allocated to dietary counseling, 
including liquid and multivitamin 
supplementation, i.e. intervention (I, n = 51) 
and to controls (C, n = 57). 
Notes Author’s Conclusion: Combined nutritional intervention prevented weight loss and improved ADL functions in discharged geriatric patients at 
risk of malnutrition. 
Outcome 
measures/results 
primary outcome measure: Body weight, 
biochemical indices (e.g. insulin-like growth 
factor I (IGF-I)), Katz activities of daily 
living (ADL) index, mini mental status 
examination (MMSE) and quality of life 
(QoL) by SF-36 
Fifty-four patients, 29 in the I-group (86±7 years, 66% females) and 25 in the C-group (85±7 
years, 72% females) completed the study according to the protocol. Both modes of analysis 
revealed a significant positive effect of the combined nutritional intervention on weight 
maintenance. Treated-as-protocol analyses showed that Katz ADL index improved in the I-group 
(p<0.001; p<0.05 between the groups). Serum IGF-I levels increased in the I-group (p<0.001), 
but were unchanged in the C-group (p = 0.07 between the groups). QoL was assessed to be low 
and had not changed after nutritional treatment. 
Evidence of 
polymorbidity 
Confirmed by author 
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28. Neelemaat F, Bosmans JE, Thijs A, Seidell JC. Oral nutritional support in malnourished elderly decreases functional limitations with no extra costs. 
Clinical nutrition. 2012; 2: 183-190. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial  
1++ 
Countries: Netherlands 
Centers: University Medical Center, 
Amsterdam 
Setting: 
Funding Sources: The Netherlands 
Organisation for Health Research and 
Development (ZonMw) 
Dropout rates: 31.9 % 
Study limitations: follow-up period of this 
study was three months only, numbers of 
patients were not large enough to detect 
relevant cost differences. 
Total no. patients: n = 210 
Inclusion criteria: malnourished according to the 
following criteria: (1) Body Mass Index (BMI in 
kg/m2) < 20 and/or (2) >5% unintentional weight 
loss in the previous month and/or (3) >10% 
unintentional weight loss in the previous six 
months. 
Exclusion criteria: Patients, who suffered from 
senile dementia, could not understand the Dutch 
language or were not able to or willing to give 
informed consent. 
The aim of this study was to evaluate the 
cost-effectiveness of nutritional 
supplementation from a societal 
perspective Patients in the intervention 
group received nutritional supplementation 
(energy and protein enriched diet, oral 
nutritional support, calcium-vitamin D 
supplement, telephone counseling by a 
dietician) until three months after discharge 
from hospital. Patients in the control group 
received usual care (control). 
Notes Author’s Conclusion: A multi-component nutritional intervention to malnourished elderly patients for three months after hospital discharge 
leads to significant improvement in functional limitations and is neutral in costs. A follow-up of three months is probably too short to detect 
changes in QALYs or physical activities. 
Outcome 
measures/results 
primary outcome measure: Quality 
Adjusted Life Years (QALYs), physical 
activities and functional limitations 
secondary outcome measure: 
Incremental cost-effectiveness ratios 
210 patients were included, 105 in each group. After three months, no statistically significant 
differences in quality of life and physical activities were observed between groups. Functional 
limitations decreased significantly more in the intervention group (mean difference -0.72, 95% CI-
1.15; -0.28). There were no differences in costs between groups. Cost-effectiveness for QALYs 
and physical activities could not be demonstrated. For functional limitations we found a 0.95 
probability that the intervention is cost effective in comparison with usual care for ceiling ratios 
>€6,500. 
Evidence of 
polymorbidity 
Confirmed by author 
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29. Neelemaat F, Bosmans JE, Thijs A, Seidell JC. Post-discharge nutritional support in malnourished elderly individuals improves functional limitations. 
Journal of the American Medical Directors Association. 2011; 4: 295-301. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial  
1++ 
Countries: Netherlands 
Centers: University Medical Center, 
Amsterdam 
Setting: 
Funding Sources: The Netherlands 
Organisation for Health Research and 
Development (ZonMw) 
Dropout rates: 31.9 % 
Study limitations: a follow-up of only 3 
months 
Total no. patients: n = 210 
Inclusion criteria: malnourished according to the 
following criteria: (1) Body Mass Index (BMI in 
kg/m2) < 20 and/or (2) >5% unintentional weight 
loss in the previous month and/or (3) >10% 
unintentional weight loss in the previous six 
months. 
Exclusion criteria: Patients, who suffered from 
senile dementia, could not understand the Dutch 
language or were not able to or willing to give 
informed consent. 
Hospital-admitted malnourished elderly 
patients ($60 years) were randomized to 
receive either nutritional supplementation 
(energy and protein enriched diet, oral 
nutritional support, calcium, vitamin D 
supplement, telephone counseling by a 
dietitian) for 3 months post discharge or 
usual care. 
Notes Author’s Conclusion: Three months of oral nutritional support to malnourished elderly decreased functional limitations and increased body 
weight. It can be questioned if a follow-up of only 3 months was not too short to detect differences on physical performance and physical 
activities as well. 
Outcome 
measures/results 
primary outcome measure: functional 
limitations, physical performance, physical 
activities, body weight, fat free mass, and 
handgrip strength 
secondary outcome measure: 
Body weight increased more in the intervention group than in the control group; this was 
significant for the highest body weight category (mean difference 3.4 kg, 95% CI 0.2–6.6). 
Functional limitations decreased more (mean difference –0.5 (95% CI –1.0–0.1) in the 
intervention group than in the control group. When excluding patients who had already received 
nutritional support before the start of the study, this reached significance. No significant 
differences could be demonstrated for physical performance, physical activities, fat-free mass, or 
handgrip strength. 
Evidence of 
polymorbidity 
Confirmed by author 
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30. Neelemaat F, Lips P, Bosmans JE, Thijs A, Seidell JC. Short‐term oral nutritional intervention with protein and vitamin D decreases falls in 
malnourished older adults. J Am Geriatr Soc. 2012; 4: 691-699. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
1++ 
Countries: Netherlands 
Centers: University 
Medical Center, Amsterdam 
Setting: 
Funding Sources: The 
Netherlands Organization for 
Health Research and 
Development (ZonMw) 
Dropout rates: 28.6 % 
Study limitations: not 
blinded, method of collection 
of nutrition data was not 
optimal, loss to follow-up was 
30% 
Total no. patients: n = 210 
Inclusion criteria:  All older adults (aged ≥ 60) newly admitted 
(expected length of hospital stay > 2 days) to an acute hospital who 
are malnourished according to the following criteria: body mass 
index (BMI) of 20.0 kg/m2 or less, 5% or more self-reported 
unintentional weight loss in the previous month, or 10% or more 
self-reported unintentional weight loss in the previous 6 months  
Exclusion criteria:  Individuals with dementia 
To evaluate the effects of a short-
term nutritional intervention with 
protein and vitamin D on falls in 
malnourished older adults, 
participants were randomized to 
receive nutritional intervention 
(energy- and protein enriched diet, 
oral nutritional supplements, calcium, 
vitamin D supplement, telephone 
counseling by a dietitian) for 3 
months after discharge or usual care. 
Notes Author’s Conclusion: short-term nutritional intervention consisting of oral nutritional supplements and calcium and vitamin D 
supplementation and supported by dietetic counseling in malnourished older adults decreases the number of patients who fall and fall 
incidents. 
Outcome 
measures/results 
Primary outcome measure: Number of 
participants who fell, fall incidents, serum 
25-hydroxyvitamin D, and dietary intake. 
Secondary outcome measure: Fat-Free 
Mass, Hand Grip Strength, Physical 
Activities, Functional Limitations, and 
Physical Performance 
Three months after discharge, 10 participants (10%) in the intervention group had fallen at 
least once, compared with 24 (23%) in the control group (hazard ratio = 0.41, 95% confidence 
interval (CI) = 0.19–0.86). There were 57 fall incidents (16 in the intervention group; 41 in the 
control group). A significantly higher intake of energy (280 kcal, 95% CI = 37–524 kcal) and 
protein (11 g, 95% CI = 1–25 g) and significantly higher serum 25-hydroxyvitamin D levels 
(10.9 nmol/L, 95% CI = 2.9–18.9 nmol/L) were found in participants in the intervention group 
than in controls. 
Evidence of 
polymorbidity 
Confirmed by author 
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31. Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR, NOURISH Study Group. Readmission and 
mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clinical 
Nutrition. 2016;1:18-26. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
Multicenter, 
randomized, 
placebo-
controlled, double-
blind trial 
1++ 
Countries: USA 
Centers: 
Setting: 
Funding Sources: Abbott 
Nutrition 
Dropout rates: 4.9 % 
Study limitations: Limited 
generalizability; patients 
represent a selected 
hospitalized population. 
Total no. patients: n = 652 
Inclusion criteria: aged ≥ 65 years with a recent hospital 
admission (within 72 h) with a primary diagnosis of CHF, AMI, PNA, 
or COPD. Patients were required to have a Subjective Global 
Assessment (SGA) class of B (moderate or suspected malnutrition) 
or C (severe malnutrition) 
Exclusion criteria: diabetes mellitus (type 1 or 2) due to product 
composition not intended for patients with diabetes mellitus; current 
active or treated cancer, and impaired renal or liver function 
Evaluation of a high-protein oral 
nutritional supplement (HP-HMB) 
containing beta-hydroxybeta- 
methylbutyrate on post discharge 
outcomes of non elective 
readmission and mortality in 
malnourished, hospitalized older 
adults. Standard-of-care plus HP-
HMB (n = 328) or a placebo 
supplement (n = 324), 2 
servings/day. 
Notes Author’s Conclusion: Although no effects were observed for the primary composite endpoint, compared with placebo HP-HMB decreased 
mortality and improved indices of nutritional status during the 90-day observation period. 
 
Outcome 
measures/results 
primary outcome measure: 90-day post 
discharge incidence of death or non-
elective readmission 
secondary outcome measure: 30- and 
60-day post-discharge incidence of death 
or readmission, length of stay (LOS), SGA 
class, body weight, and activities of daily 
living (ADL) 
The primary composite endpoint was similar between HP-HMB (26.8%) and placebo (31.1%). 
No between-group differences were observed for 90-day readmission rate, but 90-day mortality 
was significantly lower with HP-HMB relative to placebo (4.8% vs. 9.7%; relative risk 0.49, 95% 
confidence interval [CI], 0.27 to 0.90; p = 0.018). The number-needed-to-treat to prevent 1 
death was 20.3 (95% CI: 10.9, 121.4). Compared with placebo, HP-HMB resulted in improved 
odds of better nutritional status (SGA class, OR, 2.04, 95% CI: 1.28, 3.25, p = 0.009) at day 
90, and an increase in body weight at day 30 (p = 0.035). LOS and ADL were similar between 
treatments. 
Evidence of 
polymorbidity 
Mean Charlson comorbidity index: 2.05 in the control group, 2.12 in the intervention group. 
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Clinical question 10. Does the monitoring of physical functions, when it is possible, compared to monitoring of nutritional parameters (e.g. body 1712 
weight, energy and protein intakes) improve other outcomes in polymorbid inpatients receiving nutritional support? 1713 
 1714 
Recommendation 10.1: 1715 
Nutritional parameters should be monitored to assess responses to nutritional support, while functional indices should be used to asses other 1716 
clinical outcomes (i.e., survival, quality of life) in polymorbid medical inpatients.  1717 
Grade of recommendation B – strong consensus (95% agreement) 1718 
32. Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, Schiff ER, Mcclain CJ, Marsano LS, Allen JI. Protein energy 
malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. J Parenter Enteral Nutr. 1995; 4: 258-265. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
Intervention study 
2+ 
Countries: 
Centers: eight Department of 
Veterans Affairs (DVA) 
Medical 
Centers. 
Setting: 
Funding Sources: 
Cooperative Studies Program 
of the Department of Veterans 
Affairs Medical Research 
Service. 
Dropout rates: no dropout 
Study limitations: 
Total no. patients: n = 271 
Inclusion criteria: Male patients with a clinical diagnosis of 
alcoholic hepatitis (AH), histologic confirmation of the etiology of the 
liver disease was not an absolute requirement so that severely ill 
patients with coagulopathy could be enrolled. 
Exclusion criteria: not mentioned 
Protein energy malnutrition (PEM) 
was evaluated and expressed as 
percent of low normal in 271 patients 
initially, at 1 month and at 3 months. 
Active therapy consisted of anabolic 
steroid oxandrolone (OX) plus a high 
caloric food supplement vs a 
matching placebo and a low calorie 
supplement. 
Notes Author’s Conclusion: Deterioration in nutritional parameters is a significant risk factor for survival in severe patients with alcoholic hepatitis. 
This deterioration is reversible with standard hospital care. Active therapy further improves creatinine height index, mid arm muscle area and 
total lymphocyte counts. Hence, these later parameters appear to be the best indicators for follow-up assessments. 
Outcome 
measures/results 
outcome measure: Nutritional status, grip 
strength, immune status 
Most of the parameters improved significantly from baseline on standard care; the largest 
improvement seen in visceral proteins, the smallest in fat stores (skinfold thickness). Total 
PEM score significantly correlated with 6 month mortality (p=0.0012). Using logistic regression 
analysis, creatinine height index, hand grip strength and total peripheral blood lymphocytes 
were the best risk factors for survival. When CD lymphocyte subsets replaced total lymphocyte 
counts in the equation, CD8 levels became a significant risk factor (p=.004). Active treatment 
produced significant improvements in those parameters related to total body and muscle mass 
(i.e., mid arm muscle area, p=0.02; creatinine height index, p=0.03; percent ideal body weight, 
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p=0.04). 
Evidence of 
polymorbidity 
> 2 co-occurring chronic diseases in > 50% of the study population 
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33. Norman K, Kirchner H, Freudenreich M, Ockenga J, Lochs H, Pirlich M. Three month intervention with protein and energy rich supplements improve 
muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease—a randomized controlled trial. Clinical 
nutrition. 2008; 1: 48-56.  
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
1+ 
Countries: Germany 
Centers: Charité University 
Medicine Berlin 
Setting:  
Funding Sources: grant from 
Fresenius Kabi, Bad Homburg, 
Germany 
Dropout rates: 20.8 % 
Study limitations: 
mechanisms by which ONS 
improve outcomes are 
probably multifactorial, no 
placebo for the nutritional 
supplements 
Total no. patients: n = 101 
Inclusion criteria: Patients classified malnourished according 
to the Subjective Global Assessment13 (SGA B or C) suffering 
from a benign gastrointestinal disease 
Exclusion criteria: malignant disease, renal insufficiency 
(serum creatinine 41.3 mg/dl), life expectancy less than three 
months or age under 18 years, Hyperhydration, implanted 
defibrillators, neuromuscular disease, hemiplegia or rheumatoid 
arthritis  
We investigated the effect of a three-month 
post-hospital nutritional intervention with 
high protein and energy supplements on 
body composition, muscle function and 
quality of life (QoL) in malnourished GI 
patients. Eighty malnourished patients with 
benign digestive disease were randomized 
to receive either oral nutritional 
supplements (ONS) for three months in 
addition to dietary counseling (DC) (ONS 
patients) or only dietary counseling (DC 
patients). 
Notes Author’s Conclusion: A three month intervention with high protein oral supplements improves outcome in malnourished patients with digestive 
disease in terms of functional status, QoL and rehospitalization. 
Outcome 
measures/results 
primary outcome measure: 
Readmissions to hospital as a rough 
measure of clinical outcome) 
secondary outcome measure: Nutritional 
status (subjective global assessment), 
body composition (bioelectrical 
impedance), anthropometry, muscle 
function (handgrip strength and peak flow), 
QoL (36-item short-form questionnaire) 
Age, body cell mass (BCM), muscle function, gender distribution and QoL did not differ between 
ONS patients (n = 38) and DC patients (n = 42) at baseline. Body weight and BCM improved 
significantly in both groups after three months. However, hand-grip strength (26.1±11.3–
31.5±10.1 kg, p<0.0001) and peak flow (329.2±124.0–388.9±108.4 l/min, p = 0.004) improved 
only in the ONS patients and remained unchanged in the DC patients. Similarly, all eight scales of 
the QoL improved in the ONS patients compared with merely three in the DC patients. DC 
patients experienced significantly more readmissions (n = 20) than ONS patients (n = 10) during 
the study period (p = 0.041). 
Evidence of 
polymorbidity 
Mean number of drugs: 6 in the control group, 4 in the intervention group 
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Clinical question 11. Does meeting more than 75% of energy and/or protein requirements (as an indicator of compliance) versus a lower 1721 
percentage improve outcomes in polymorbid inpatients receiving nutritional support? 1722 
 1723 
Recommendation 11.1: 1724 
In polymorbid medical inpatients with reduced food intake and hampered nutritional status at least 75% of calculated energy and protein 1725 
requirements should be achieved in order to reduce the risk of adverse outcomes  1726 
Grade of recommendation B – strong consensus (100% agreement) 1727 
 1728 
Recommendation 11.2: 1729 
Energy and protein fortified foods can be used in order to reach those relevant energy and protein targets in polymorbid medical inpatients  1730 
Grade of recommendation 0 – strong consensus (100% agreement) 1731 
34. Sullivan DH, Sun S, Walls RC. Protein-energy undernutrition among elderly hospitalized patients: a prospective study. JAMA. 1999; 21: 2013-2019. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
Prospective 
cohort study 
2++ 
Countries: 
Centers: University-affiliated 
Department of Veterans 
Affairs hospital 
Setting: 
Funding Sources: with an 
observational study we cannot 
determine whether poor 
nutrient intake caused 
increased in-hospital and 90-
day mortality 
Dropout rates: 28 % 
Study limitations: with an 
observational study we cannot 
determine whether poor 
nutrient intake caused 
increased in-hospital and 90-
day mortality 
Total no. patients: n = 691 
Inclusion criteria: patients 65 years or older admitted to a general 
medical or surgical ward 
Exclusion criteria: Patients with metastatic cancer and those 
receiving palliative care for other terminal conditions, patients with a 
length of stay of fewer than 4 days 
To identify the distribution of average 
daily nutrient intake among the non-
terminally ill hospitalized elderly, 
ascertain what factors contribute to 
persistently low intakes, and 
determine whether the adequacy of 
nutrient intake correlates with the risk 
of mortality. 
Notes Author’s Conclusion: Throughout their hospitalization, many elderly patients were maintained on nutrient intakes far less than their 
estimated maintenance energy requirements, which may contribute to an increased risk of mortality. Given the difficulties reversing 
established nutritional deficits in the elderly, greater efforts should be made to prevent the development of such deficits during hospitalization. 
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Outcome 
measures/results 
primary outcome measure: daily in-
hospital nutrient intake 
secondary outcome measure: Admission 
illness severity, average length of stay, and 
admission albumin and prealbumin levels 
A total of 102 patients (21%) had an average daily in-hospital nutrient intake of less than 50% 
of their calculated maintenance energy requirements. Admission illness severity, average 
length of stay, and admission albumin and prealbumin levels for this low nutrient group did not 
differ significantly from those of the remaining patients. However, the low nutrient group had 
lower mean (SD) discharge serum total cholesterol (154 [44] mg/dL [4 [1.1] mmol/L] vs 173 [42] 
mg/dL [4.5 [1.1] mmol/L]; P=.001), albumin (29.1 [6.7] vs 33.2 [6.1] g/L, P=.001), and 
prealbumin (162 [69] vs 205 [68] mg/L; P=.001) concentrations and a higher rate of in-hospital 
mortality (relative risk, 8.0; 95% confidence interval, 2.8-22.6) and 90-day mortality (relative 
risk, 2.9; 95% confidence interval, 1.4-6.1). Contributing to the problem of inadequate nutrient 
intake, patients were frequently ordered to have nothing by mouth and were not fed by another 
route. Neither canned supplements nor nutritional support were used effectively. 
Evidence of 
polymorbidity 
Confirmed by author 
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35. Munk T, Beck A, Holst M, Rosenbom E, Rasmussen H, Nielsen M, Thomsen T. Positive effect of protein‐supplemented hospital food on protein 
intake in patients at nutritional risk: a randomised controlled trial. Journal of Human Nutrition and Dietetics. 2014; 2: 122-132. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
1+ 
Countries: Denmark 
Centers: Departments of 
Oncology, Orthopaedics and 
Urology, University Hospital, 
Herlev, Denmark 
Setting: 
Funding Sources: Herlev 
University Hospital Research 
Unit, ‘Toft Care System’ 
(protein powder used free of 
charge) 
Dropout rates: 4 % 
Study limitations: no 
blinding of ward staff and data 
assessors 
Total no. patients: n = 84 
Inclusion criteria:   
• newly-admitted patients ≥18 years old who were at nutritional risk 
according to the validated Nutritional Risk Screening-2002 (NRS-
2002) tool (≥3)  
• patients who were able to eat orally, 
• an anticipated length of hospitalization of ≥3 days, 
• sufficient language proficiency. 
Exclusion criteria:  • dysphagia, 
• food allergy or intolerance, 
• anatomical obstructions preventing oral food intake, 
• patients who exclusively received enteral or parenteral nutrition, 
• terminal patients. 
A single-blinded randomized 
controlled trial was conducted. 
Eighty-four participants at nutritional 
risk, recruited from the departments 
of Oncology, Orthopedics and 
Urology, were included. The 
intervention group (IG) received the 
protein-supplemented food service 
concept. The control group (CG) 
received the standard hospital menu. 
Primary outcome comprised the 
number of patients achieving ≥75% 
of energy and protein requirements. 
Secondary outcomes comprised 
mean energy and protein intake, 
body weight, handgrip strength and 
length of hospital stay. 
Notes Author’s Conclusion: The novel food service concept had a significant positive impact on overall protein intake and on weight-adjusted 
energy intake in hospitalized patients at nutritional risk. 
Outcome 
measures/results 
primary outcome measure: number of 
patients achieving ≥75% of energy and 
protein requirements 
secondary outcome measure: mean 
energy and protein intake, body weight, 
handgrip strength and length of hospital 
stay. 
In IG, 76% versus 70% CG patients reached ≥75% of their energy requirements (P = 0.57); 
66% IG versus 30% CG patients reached ≥75% of their protein requirements (P = 0.001). The 
risk ratio for achieving ≥75% of protein requirements: 2.2 (95% confidence interval = 1.3–3.7); 
number needed to treat = 3 (95% confidence interval = 2–6). IG had a higher mean intake of 
energy and protein when adjusted for body weight (CG: 82 kJ kg-1 versus IG: 103 kJ kg-1, P = 
0.013; CG: 0.7 g protein kg-1 versus 0.9 g protein kg-1, P = 0.003). Body weight, handgrip 
strength and length of hospital stay did not differ between groups. 
Evidence of 
polymorbidity 
Agreement within working group, following attempt to contact author 
 1732 
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 1734 
Clinical question 12. Do organizational changes in nutritional support (e.g. intervention of a steering committee, implementation of protected 1735 
mealtimes, different budget allocation) versus no changes improve outcomes of polymorbid inpatients? 1736 
 1737 
Recommendation 12.1: 1738 
Organizational changes in nutritional support provision should be implemented for polymorbid medical inpatients who are malnourished or at risk 1739 
of malnutrition. In particular, interventions that ensure the provision of fortified menus for at-risk patients, establishing a nutrition support team 1740 
and the use of multi-disciplinary nutrition protocols should be implemented  1741 
Grade of recommendation B – strong consensus (100% agreement) 1742 
 1743 
36. Kennedy JF, Nightingale JM. Cost savings of an adult hospital nutrition support team. Nutrition. 2005; 11: 1127-1133. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
Applied nutritional 
investigation 
2+ 
Countries: United Kingdom 
Centers: university hospital 
Leicester Royal Infirmary 
Setting: 
Funding Sources: -  
Dropout rates: -  
Study limitations: clear cost 
savings have not yet been 
Reported as ongoing costs of 
bed occupancy and staff time 
are not included 
Total no. patients: pre-NST: n = 54 
                                 NST: n= 133 
Inclusion criteria:  no formal process for selecting patients for PN 
Exclusion criteria: -  
Hospital-based nutrition support team 
(NST) may need to demonstrate cost 
savings and quality benefits. The 
primary aim of this study was to 
determine whether an NST could 
show tangible cost savings 
(equipment, investigations, and 
medication costs) from managing 
patients considered for parenteral 
nutrition (PN). Secondary aims 
related to the quality issues of 
placement of PN catheters, catheter-
related sepsis (CRS), duration of 
parenteral nutrition, and mortality. An 
NST was formed in 1999 and worked 
in all adult areas of a university 
hospital (Leicester Royal Infirmary). 
Comparative data about all patients 
given PN were collected for 2 
consecutive years (a retrospective 
pre-NST year and a prospective NST 
year). 
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Notes Author’s Conclusion: Although the number of PN days increased with an NST, tangible cost savings of £50 715 were demonstrated within 
the NST year by avoided PN episodes and a decreased incidence of CRS. These savings justify the salaries of a nutrition nurse specialist 
and a senior dietitian. 
Outcome 
measures/results 
primary outcome measure: Tangible cost 
saving 
secondary outcome measure: diagnosis, 
reasons for PN, Duration of PN, 
complications (especially CRS), days of 
feeding, Mortality,  
In the pre-NST year there were 82 PN episodes (54 patients), 665 PN days, and a CRS rate of 
71% (seven infections/100 PN days). In the NST year, there were 133 referrals for PN but only 
78 PN episodes (75 patients, 59% of referrals), 752 PN days, and a decreased overall CRS 
rate of 29% (three infections/100 PN days, P < 0.05) but a rate of 7% (0.6 infection/100 PN 
days) in the final 3 months of the NST year. Tangible cost savings for the NST year were 
derived from 55 avoided PN episodes (£42 741) and 35 avoided CRS episodes (£7974). Thirty-
nine percent of PN catheters were inserted by the NST with no insertion-related complications. 
Competency-based training of ward nursing staff decreased the CRS rate. Mean duration of 
PN increased from 8 to 10 d (P not significant). In-hospital mortality for patients who had PN 
was 23 of 54 (43%) in the pre-NST year compared with 18 of 75 (24%) in the NST year (P < 
0.05). 
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37. Munk T, Beck A, Holst M, Rosenbom E, Rasmussen H, Nielsen M, Thomsen T. Positive effect of protein‐supplemented hospital food on protein 
intake in patients at nutritional risk: a randomised controlled trial. Journal of Human Nutrition and Dietetics. 2014; 2: 122-132. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
randomized 
controlled trial 
1+ 
Countries: Denmark 
Centers: Departments of 
Oncology, Orthopaedics and 
Urology, University Hospital, 
Herlev, Denmark 
Setting: 
Funding Sources: Herlev 
University Hospital Research 
Unit, ‘Toft Care System’ 
(protein powder used free of 
charge) 
Dropout rates: 4 % 
Study limitations: no 
blinding of ward staff and data 
assessors 
Total no. patients: n = 84 
Inclusion criteria:  • newly-admitted patients ≥18 years old who 
were at nutritional risk according to the validated Nutritional Risk 
Screening-2002 (NRS-2002) tool (≥3)  
• patients who were able to eat orally, 
• an anticipated length of hospitalization of ≥3 days, 
• sufficient language proficiency. 
Exclusion criteria:  • dysphagia, 
• food allergy or intolerance, 
• anatomical obstructions preventing oral food intake, 
• patients who exclusively received enteral or parenteral nutrition, 
• terminal patients. 
A single-blinded randomized 
controlled trial was conducted. 
Eighty-four participants at nutritional 
risk, recruited from the departments 
of Oncology, Orthopedics and 
Urology, were included. The 
intervention group (IG) received the 
protein-supplemented food service 
concept. The control group (CG) 
received the standard hospital menu. 
Primary outcome comprised the 
number of patients achieving ≥75% 
of energy and protein requirements. 
Secondary outcomes comprised 
mean energy and protein intake, 
body weight, handgrip strength and 
length of hospital stay. 
Notes Author’s Conclusion: The novel food service concept had a significant positive impact on overall protein intake and on weight-adjusted 
energy intake in hospitalized patients at nutritional risk. 
Outcome 
measures/results 
primary outcome measure: number of 
patients achieving ≥75% of energy and 
protein requirements 
secondary outcome measure: mean 
energy and protein intake, body weight, 
handgrip strength and length of hospital 
stay. 
In IG, 76% versus 70% CG patients reached ≥75% of their energy requirements (P = 0.57); 
66% IG versus 30% CG patients reached ≥75% of their protein requirements (P = 0.001). The 
risk ratio for achieving ≥75% of protein requirements: 2.2 (95% confidence interval = 1.3–3.7); 
number needed to treat = 3 (95% confidence interval = 2–6). IG had a higher mean intake of 
energy and protein when adjusted for body weight (CG: 82 kJ kg-1 versus IG: 103 kJ kg-1, P = 
0.013; CG: 0.7 g protein kg-1 versus 0.9 g protein kg-1, P = 0.003). Body weight, handgrip 
strength and length of hospital stay did not differ between groups. 
Evidence of 
polymorbidity 
Agreement within working group, following attempt to contact author 
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38. Rypkema G, Adang E, Dicke H, Naber T, De Swart B, Disselhorst L, Goluke-Willemse G, Rikkert MO. Cost-effectiveness of an interdisciplinary 
intervention in geriatric inpatients to prevent malnutrition. Journal of Nutrition Health and Aging. 2004; 2: 122-127. 
Study Type/  
Evidence Level 
Study details/limitations Patient characteristics Interventions 
prospective, 
controlled study 
2+ 
Countries: Netherlands 
Centers: The inpatient 
geriatric service of a 
university hospital (UMC 
Nijmegen) and a geriatric 
ward of a non-academic 
teaching hospital (Rijnstate 
Hospital, Arnhem) 
Setting:  
Funding Sources: research 
grant from the joint society of 
Dutch Universities (VAZ) and 
partly by Nutricia‚ Inc. 
Dropout rates: 
Study limitations: Missing 
data might have been caused 
by selection bias, intervention 
and control group were 
located in two 
separate geriatric units in two 
different hospitals 
Total no. patients: n = 298 
Inclusion criteria: All patients admitted to the geriatrics units (aged 
over 60 years) during a 10 month period in the year 2001 who were 
non-terminally ill and admitted for more than two days were eligible 
for inclusion 
Exclusion criteria: Patients admitted for over 150 days (and 
waiting for institutional care) were excluded from the study. 
In order to reduce protein-energy 
malnutrition in older people during 
hospitalization, an early 
interdisciplinary intervention is 
needed. We developed a protocol 
which includes screening for 
malnutrition, dysphagia and 
dehydration on admission, followed 
by immediate interventions. One of 
the geriatric wards applied the 
protocol (N=140) while the other 
provided standard care (N=158). 
Notes Author’s Conclusion: An early interdisciplinary intervention approach can be effective in reducing protein-energy malnutrition and related 
hospital-acquired infections and appears to be economically feasible. 
Outcome 
measures/results 
primary outcome measure: Weight, 
Body Mass Index (BMI), Barthel Index, 
MNA-sf, date of birth and sex, Nosocomial 
infections, pressure score, length of stay, 
Edema, heart failure 
There was a 0.8 kg loss (SEM 0.3 kg) in average weight in the standard care group and a 0.9 
kg gain (SEM 0.2 kg) in the intervention group (p<0.001). The number of hospital acquired 
infections was significantly lower in the intervention group (33/140 versus 58/158, p=0.01) but 
no significant difference in number of patients with pressure sores (23/140 versus 33/158) was 
found. Costs were not significantly different: 7516 versus 7908 Euro/patient for intervention 
versus controls, respectively 
Evidence of 
polymorbidity 
Agreement within working group, following attempt to contact author 
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Appendix 3 - Supplementary data: summary of clinical questions and 1747 
recommendations  1748 
 1749 
Topic Clinical question and recommendation(s)/ statement(s) 
Indication  
 
1. Does nutritional support based on screening and/or assessment versus no 
screening and/or assessment improve outcomes in polymorbid inpatients?  
 
Recommendation 1.1 
In polymorbid medical inpatients, a quick and simple nutritional screening method using 
different validated tools should be applied to identify malnutrition risk. In patients at risk, 
a more detailed assessment should be performed and a treatment plan should be 
developed, to consent an early adequate nutritional therapy and to define quality 
outcome measures of success.  
(Grade of recommendation B) - strong consensus (100% agreement) 
 
Route of 
feeding  
 
2.  In polymorbid inpatients whose nutritional requirements can be met orally, 
does the use of oral nutritional supplements (ONS), with or without nutritional 
counseling, versus no ONS, improve outcomes? 
 
Recommendation 2.1 
In malnourished polymorbid medical inpatients or those at high risk of malnutrition who 
can safely reach their nutritional requirements orally, ONS high in energy and protein 
shall be considered to improve their nutritional status and quality of life.  
(Grade of recommendation A) - strong consensus (95% agreement) 
 
Recommendation 2.2 
In malnourished polymorbid medical inpatients or those at high risk of malnutrition, 
nutrient-specific ONS should be administered, when they may maintain muscle mass, 
reduce mortality or improve quality of life. 
(Grade of recommendation B) -  consensus (89% agreement) 
 
Recommendation 2.3 
In polymorbid medical inpatients who are malnourished or at high risk of malnutrition 
and can safely reach their nutritional requirements orally, ONS should be considered as 
a cost-effective way of intervention towards improved outcomes.  
(Grade of recommendation B) - strong consensus (95% agreement) 
 
 
3. In patients where nutritional requirements cannot be met orally, does the use of 
enteral nutrition (EN) compared to parenteral nutrition (PN) (total or 
supplemental) result in improved outcomes in polymorbid inpatients?  
 
Recommendation 3.1 
In polymorbid medical inpatients whose nutritional requirements cannot be met orally, 
EN can be administered. In these cases, the use of EN may be superior to PN because 
of a lower risk of infectious and non-infectious complications.  
(Grade of recommendation 0) - strong consensus (100% agreement) 
 
Energy 
requirements  
 
4. Does the estimation of energy requirements with a prediction equation versus 
a weight-based formula improve outcomes of polymorbid inpatients requiring 
nutritional support? 
 
Recommendation 4.1 
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Energy requirements in polymorbid medical inpatients can be estimated using indirect 
calorimetry (IC), a published prediction equation or a weight-based formula.  
(Grade of recommendation 0) - strong consensus (96% agreement) 
 
Recommendation 4.2 
In the absence of IC, total energy expenditure (TEE) for polymorbid older patients (aged 
> 65 years) can be estimated using the formula 27 kcal/kg actual body weight. Resting 
energy expenditure (REE) can be estimated using the formula 18 - 20 kcal/kg body 
weight with the addition of activity or stress factors to estimate TEE.  
(Grade of recommendation 0) – strong consensus (95% agreement) 
 
Recommendation 4.3.a 
In the absence of IC, REE for severely underweight patients can be estimated using the 
formula 30 kcal/kg body weight.  
(Grade of recommendation 0) - consensus (89% agreement) 
 
Recommendation 4.3.b 
This target of 30 kcal/kg body weight in severely underweight patients should be 
cautiously and slowly achieved, as this is a population at high risk of refeeding 
syndrome.  
(Grade of recommendation GPP) - strong consensus (100% agreement) 
 
Protein  
requirements 
 
5. Do protein targets higher than 1.0g/kg BW/day versus a lower target improve 
outcomes in polymorbid inpatients requiring nutritional support?  
 
Recommendation 5.1 
Polymorbid medical inpatients requiring nutritional support shall receive a minimum of 
1.0 g of protein/kg of body weight per day in order to prevent body weight loss, reduce 
the risk of complications and hospital readmission and improve functional outcome. 
(Grade of recommendation A) - strong consensus (95% agreement) 
 
Micronutrients  
requirements   
 
6.  In patients exclusively fed orally, does the supplementation of micronutrients 
(vitamins and trace elements) compared to no supplements improve outcomes in 
polymorbid inpatients? 
 
Recommendation 6.1. 
In polymorbid medical inpatients exclusively fed orally adequate intake of micronutrients 
(vitamins and trace elements) to meet daily estimated requirements should be ensured. 
(Grade of recommendation GPP) - strong consensus (100% agreement) 
 
Recommendation 6.2. 
Polymorbid medical inpatients exclusively fed orally with documented or suspected 
micronutrient deficiencies should be repleted.  
(Grade of recommendation GPP) -  strong consensus (93% agreement) 
 
Disease-
specific 
nutrients  
 
7. Does disease-specific nutritional supplementation (e.g. fibre, omega 3 fatty 
acids, BCAA, glutamine, etc.) versus standard formulations improve outcomes in 
polymorbid inpatients?  
 
Recommendation 7.1 
In polymorbid medical inpatients with pressure ulcers, specific amino-acids (arginine 
and glutamine) and β-hydroxy β-methylbutyrate (ßHMB) can be added to oral/enteral 
feeds to accelerate the healing of pressure ulcers.  
(Grade of recommendation 0) - consensus (90 % agreement) 
 
Recommendation 7.2 
In polymorbid medical older inpatients requiring enteral nutrition, formulas enriched in a 
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mixture of soluble and insoluble fibers can be used to improve bowel function.  
(Grade of recommendation 0) - strong consensus (95% agreement) 
Timing  
 
8. Does early nutritional support (i.e. provided less than 48h post hospital 
admission) compared to later nutritional support improve outcomes in 
polymorbid inpatients?  
 
Recommendation 8.1 
Early nutritional support (i.e. provided in less than 48 hours post hospital admission) 
compared to later nutritional support should be performed in polymorbid medical 
inpatients, as sarcopenia could be decreased and self-sufficiency could be improved 
(Grade of recommendation B) - strong consensus (95% agreement) 
 
 
9. Does the continued use of nutritional support after discharge compared to 
nutritional support during inpatient stay alone affect the outcomes of polymorbid 
inpatients?   
 
Recommendation 9.1  
In malnourished polymorbid medical inpatients or those at risk of malnutrition nutritional 
support shall be continued after hospital discharge in order to maintain or improve body 
weight and nutritional status.  
(Grade of recommendation A) - strong consensus (95% agreement) 
 
Recommendation 9.2  
In malnourished polymorbid medical inpatients or those at high risk of malnutrition, 
nutritional support should be continued post hospital discharge to maintain or improve 
functional status and quality of life.  
(Grade of recommendation B) - strong consensus (95% agreement) 
 
Recommendation 9.3  
In polymorbid medical inpatients at high risk of malnutrition or with established 
malnutrition aged 65 and older, continued nutritional support post hospital discharge 
with either ONS or individualized nutritional intervention shall be considered to lower 
mortality.  
(Grade of recommendation A) - strong consensus (95% agreement) 
 
Monitoring  
 
10. Does the monitoring of physical functions, when it is possible, compared to 
monitoring of nutritional parameters (e.g. body weight, energy and protein 
intakes) improve other outcomes in polymorbid inpatients receiving nutritional 
support?  
 
Recommendation 10.1  
Nutritional parameters should be monitored to assess responses to nutritional support, 
while functional indices should be used to asses other clinical outcomes (i.e., survival, 
quality of life) in polymorbid medical inpatients.  
(Grade of recommendation B) - strong consensus (95% agreement) 
 
 
11. Does meeting more than 75% of energy and/or protein requirements (as an 
indicator of compliance) versus a lower percentage improve outcomes in 
polymorbid inpatients receiving nutritional support?  
 
Recommendation 11.1  
In polymorbid medical inpatients with reduced food intake and hampered nutritional 
status at least 75% of calculated energy and protein requirements should be achieved 
in order to reduce the risk of adverse outcomes.  
(Grade of recommendation B) - strong consensus (100% agreement) 
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 1750 
 
Recommendation 11.2  
Energy and protein fortified foods can be used in order to reach those relevant energy 
and protein targets in polymorbid medical inpatients.  
(Grade of recommendation 0) -  strong consensus (100% agreement) 
 
Procedure of 
intervention  
 
12. Do organizational changes in nutritional support (e.g. intervention of a 
steering committee, implementation of protected mealtimes, different budget 
allocation) versus no changes improve outcomes of polymorbid inpatients?  
 
Recommendation 12.1  
Organizational changes in nutritional support provision should be implemented for 
polymorbid medical inpatients who are malnourished or at risk of malnutrition. In 
particular, interventions that ensure the provision of fortified menus for at-risk patients, 
establishing a nutrition support team and the use of multi-disciplinary nutrition protocols 
should be implemented.  
(Grade of recommendation B) - strong consensus (100% agreement) 
 
Non-PICO 
questions, 
under  
section 
"Discussion
" 
a) Does underlying disease have an impact on expected outcome from nutritional 
support? 
 
Statement a.1.  
The severity of acute-phase response may be used by clinicians as part of the criteria 
for selecting patients for nutritional screening, follow-up, and intervention.  
(Level of evidence 1+) - strong consensus (100% agreement) 
 
Statement a.2. 
Inadequate nutritional intake is common, and patient factors contributing to poor intake 
should be considered in designing nutritional interventions. Energy and protein intake 
are frequently inadequate to meet requirements in most older acute medical inpatients, 
worsening malnutrition during hospitalization and leading to poor outcomes. Poor intake 
is associated with several common patient/environmental characteristics, such as 
disease severity, symptoms compromising intake, anorexia, bedridden, hospital 
routines, dietary habits and possible therapeutic diets adopted at home.  
(Level of evidence 4) - strong consensus (100% agreement) 
 
b) How long should nutritional support be given in order to have an impact on the 
clinical course in a polymorbid patient? 
 
Statement b 
Although there is evidence to recommend the continued nutritional support post-hospital 
discharge on polymorbid medical inpatients who are malnourished or at risk of 
malnutrition, the ideal duration of the intervention has not yet been determined.  
(Level of evidence 4) - strong consensus (95% agreement) 
 
c)  Are there risks of polypharmacy and drug-nutrient interaction in polymorbid 
inpatients? 
 
Statement c 
In polymorbid medical inpatients there is an important possibility of drug-drug or drug-
nutrient interactions that needs to be taken into account, by establishing a pharmacist-
assisted management plan for any interactions. 
(Level of evidence 3) - consensus (90% agreement) 
 
